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Abstract 
Streptomyces subrutilus ATCC 27467, when grown on a glucose- 
containing soyabean medium, produces both 1-deoxymannonojirimycin 
(DMJ) and 1-deoxynojirimycin (DNJ) in its culture medium. When 1- or 
2-[2H]-D-glucose is used, the deuterium label appears at C6 in both 
alkaloids and the labelling pattern suggests that the first step in the 
biosynthesis of both DNJ and DMJ is a glucose to fructose isomerisation. 
Studies with 5-[2H]-D-glucose and 6,6-[2H2]-D-glucose indicate that 
oxidation of the 6-position of the glucose/ fructose occurs during the 
biosynthesis and that mannonojirimycin is the first amino sugar to be 
formed. Mannonojirimycin can then undergo dehydration and reduction 
to DMJ. Alternatively, epimerisation of mannonojlrlmycin can occur at 
C2 to give nojirimycin which is then dehydrated and reduced to DNJ. 
Studies with another microorganism, B. subtilis var niger ATCC 
9372, indicate that a similar biosynthetic pathway is in operation. DMJ, 
however, is not produced by this microorganism and only low levels of 
NJ are postulated from enzyme inhibition and deuterium labelling 
studies. A minor biosynthetic route is also evident from labelling studies 
with 1-[13C]-D-glucose and 1-[13C]-D, L-glyceraldehyde. It is suggested that 
the fructose at the beginning of the biosynthesis can split into two C3 
trioses which are in equilibrium with each other. These can then re- 
combine to continue in the usual biosynthetic pathway. 
New chemical routes to 542H]-D-glucose and 2-[2H]-D-glucose are 
described in Chapter 3 along with a method for introducing deuterium or 
tritium into DNJ or NJ. Other isotopically enriched glucoses or 
intermediates have also been prepared using literature methodology. 
Studies have been undertaken to assess whether S. subrutilus can 
utilise glucose analogues in the biosynthetic pathway. To this end, new or 
modified routes to these glucose derivatives have been investigated and 
some work has focused on the chemical synthesis of DNJ analogues 
themselves. 
xv 
CHAPTER ONE. 
General Background 
Nojirimycin is a piperidine alkaloid that was first isolated from strains 
of Streptomyces in 19671. It aroused interest at this time because it acted as an 
antibiotic towards Sarcina lutea and various other microorganisms. Its 
similarity towards glucose was striking - it merely differed by having an 
amine group in place of the oxygen within the pyranose ring. As might be 
expected, it existed as the a and P anomers like glucose and adopted a chair 
conformation in aqueous solution. 
Structure of nojirimycin and 1-deoxynojirimycin 
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The first chemical synthesis of nojirimycin was completed less than a 
year later2, although Paulsen3 had done extensive research/ including NMR 
1 
and mass spectrometry studies, into carbohydrates containing nitrogen or 
sulphur in the "hemiacetal ring". The first synthesis of nojirimycin included 
detailed work on chemical and physical properties of the alkaloid, reinforcing 
the earlier observations that it was not particularly stable under neutral or 
acidic conditions. The compound could, however, be easily isolated as the 
bisulphite adduct and subsequently converted to the free base under alkaline 
conditions. From this comprehensive work by Inouye et a12, a new deoxy 
derivative was synthesised, 1-deoxynojirimycin, that was much more acid 
stable than nojirimycin and which aroused much interest in future years. 
Several years elapsed until 1976 when 1-deoxynojirimycin was isolated 
as the natural product from the root bark of the mulberry4. Subsequently, four 
years later a trehalase inhibitor was purified from the fermentation broth of 
Streptomyces lavendulae which was found to have an identical structure to 
1-deoxynojirimycin5 (trehalase is a glycohydrolase hydrolysing the 
disaccharide trehalose into its constituent glucose units, see page 42). 
The inhibition of glycohydrolases was to become the most important 
application of this alkaloid and related compounds for the next decade and 
consequently new derivatives were isolated from plant sources at a rapid rate. 
Perhaps the single biggest reason for not discovering these polyhydroxylated 
compounds sooner was the fact that they were water soluble. Extraction 
techniques using plant sources had traditionally relied upon partitioning the 
alkaloid between an organic solvent such as chloroform and a basic aqueous 
mediUM6. This had served chemists reliably for a number of years leading to 
the isolation of such important drugs as morphine. 
Swainsonine was isolated in 19797 and was found to be an inhibitor of 
mannosidases, those enzymes that hydrolyse oligosaccharides containing 
mannose residues. A further indolizidine alkaloid was discovered very soon 
afterwards in the Moreton Bay chestnut (Castanospermum australe)8. It was 
named castanospermine and bore a resemblance in the stereochemistry of its 
2 
hydroxyl groups to 1-deoxynojirimycin. Again it was a potent inhibitor of 
glucosidase enzymes. A few of the alkaloids which resemble pyranose sugars 
are shown below, fig 1.01. 
Figure 1.01 
OH 
HOIO %%OH 
N CH20H 
H 
1 -deoxvnojirimycin (Streptomyces sp. ) 
(Bacillus sp. ) 
H 
1 
. %, %OH 
OH 
%%%OH 
HO 0 CH20H 
glucose 
swainsonine 
(Swainsona sp. 
(Rhizoctonia leguminicola) 
OH 
HO 
%%OH 
N CH20H 
H 
1-deoxymannojirimycin 
(Streptomgees sp. ) 
OH 
HO 
%%%OH 
HO 0 CH20H 
mannose 
1 
OH 
HOoo 
, %OH %%OH 
OH 
castanospennine 
(Castanospermum 
austrate. ) 
3 
Inhibition of glycosidases by plant alkaloids 
Before discussing a mechanism of inhibition by these plant alkaloids, it 
is important to consider in what context these compounds could become 
useful. To do this it is necessary to examine the biosynthesis of glycoproteins 
within the cell. 
All N-linked oligo sa ccha rides are first constructed inside the 
endoplasmic reticulum within the cell, originating from a common 
precursor9: 
Glc3Mang(GIcNAC)2-PP-dolichol 
(where Glc=glucose, Man=mannose, GIcNAc=N-acetylglucosamine and dolichoMsoprene 
oligomer). 
This precursor is then transferred to an asparagine residue on the 
polypeptide to produce GlC3Manq(GlcNAc)2-protein. The glucose residues are 
then trimmed off using two (x-glucosidases. Glucosidase I catalyses the 
hydrolysis of the first glucose unit whilst glucosidase II catalyses the removal 
of the remaining two. The high mannose glycoprotein that results from 
these reactions may remain in this state avoiding all further trimming 
reactions and subsequently new sugars will be added to this "stump" to 
produce the mature structure. Alternatively, mannosidases can act on the 
remaining mannose residues producing an even shorter chain to which new 
sugars can be attached. The plant alkaloids inhibit various enzymes 
throughout this process as outlined below1o. 
4 
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Further glycosylation reactions can take place using the fully trimmed 
glycoprotein to build up the various types of oligosaccharide. For instance, 
galactose, sialic acid, N-acetyl glucosamine etc. can all be added to produce 
complex structures. 
Recently, considerable effort has been directed towards evaluating the 
importance of glycoproteins in cell-cell interactions1l and their function 
generally. What is required is to understand the contribution the 
oligosaccharide chains make to the activity of the glycoprotein and whether 
alterations to the sequence of sugars in the chains modifies this in any way12. 
In this respect plant alkaloids are ideal for this application. Many 
glycoproteins require their carbohydrate moiety for conformational stability as 
well as recognition, therefore it may be advantageous for the carbohydrate to 
be added to the protein in a single step and then study subsequent 
oligosaccharide modifications using a glycosidase inhibitor. A widely used 
inhibitor which blocks the formation of Glc3Mang(GlcNAc)2-PP-dolichol is 
tunicamycin, but this compound suffers from the disadvantage that it 
completely prevents glycosylation and alterations at different points in the 
oligosaccharide chain cannot be madelo. For instance, 1-deoxynojirimycin 
altered the composition of the (xl -proteinase inhibitor in rats. Normal 
proteinase inhibitor contains high mannose-type glycoprotein, but on 
incubation with 1-deoxynojirimycin, glycoprotein containing significantly 
more glucose residues was found. The modification to the precursor 
oligosaccharide affected ultimately the type of glycoprotein produced and its 
secretion13. Care needs to be exercised in these experiments though, as it is 
important that the concentration of alkaloid is sufficient to keep the activity 
of inhibited enzyme to a low level. Furthermore, many of the plant alkaloids 
are not entirely specific to a particular enzyme ( 1-deoxynojirimycin, for 
example, is a better inhibitor of glucosidase II than glucosidase I)11- 
6 
Other applications 
One of the main incentives for the study of alkaloid inhibitors has been 
the inhibition of HIV. Studies in 1987 showed that castanospermine, 1- 
deoxynojirimycin and various analogues of these all inhibited HIV in vitro 
to varying degreeS14. Furthermore, the susceptibility of HIV to inhibition by 
these plant alkaloids was at a concentration which was not lethal to the host 
cell. Even at this early stage., it was suggested that they impaired the 
maturation of glycoproteins associated with the virus and it is now believed 
that one glycoprotein in particular, gp120, is involved. 
The site of infection by HIV is the T4 lymphocyte, a white blood cell 
which recognises foreign antigens and activates other lymphocytes to produce 
antibodies to counteract any infection. There are receptors in the outer plasma 
membrane of the T4 cell, known as CD4 receptors, which bind to gp120. This 
glycoprotein is found on the surface of the HIV and once virus-cell binding 
has occurred, viral genetic material can be incorporated into the host cell. 
Here replication of the HIV takes place and further viral particles are 
produced. As illustrated in figure 1.02138, the new particles can break the cell 
membrane as they bud off (case a), or alternatively, the viral protein, which is 
displayed on the surface of the infected cell, can interact with more T4 cells. 
This interaction causes the T4 cells to clump together and eventually merge 
with the original cell, causing the formation of syncytia (case b). Cell lysis in 
both cases kills the T4 cells. 
HIV is also capable of eliciting normal immune defences against 
infected cells. An infected T4 cell, displaying gp120 on its surface, will be 
attacked by the natural killer cells (case c). A healthy T4 cell could also be 
destroyed in this way if unbound gp120 in the blood binds to the CD4 receptor 
(case d). 
7 
Figure 1.02. 
Mechanisms of HIV infection. 
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Research in 198715 indicated that the level of gp120 synthesis was not 
affected by the presence of glucosidase inhibitors. The infectivity of the virus 
and the formation of clumped T4 cells (syncitia) was, however, reduced 
because of the continued presence of glucose residues in the glycoprotein. The 
perturbed structure of the gp120 due to the plant alkaloids was said to have 
lowered the affinity for the CD4 receptor. Further research at the same time 
suggested, however, that the abnormal gp 120 had the same affinity for the 
CD4 receptors and that it was the formation of syncitia that was affected by the 
16,17 altered glycan 
Castanospermine was found to have the strongest effect, with I- 
deoxymannojirimycin showing little decrease in infectivity. This encouraged 
many research groups into trying to find even better inhibitors of HIV and as 
a result a whole range of compounds emerged with varying efficaCy18,19. A 
particularly promising drug was N-(n-butyl) 1-deoxynojirimycin which 
showed greater anti-HIV activity than castanospermine at a given 
concentration, but also had the benefit of lower cell toxicity, fig 1.03 
Figure 1.03 
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Interestingly, the attachment of a fatty acid moiety to castanospermine 
at position 6 also gave a drug that was twenty times as effective at inhibiting 
HIV as the parent cornpoundýo 
Many of the plant alkaloid drugs are non-specific and consequently 
cause side effects. 1-deoxynojirimycin and cas tanosp ermine, 
for example, both 
inhibit intestinal cc-glucosidase which is responsible for the hydrolysis of 
9 
sucrose and starch1l. Maintaining the concentration of the drug in vivo to 
produce inhibition of HIV represents a problem with existing alkaloids 
because of this lack of specificity, again reinforcing the need to examine new 
analogues2l. 
A few of the plant alkaloids have aroused interest as insecticides and 
insect anti-feedants, i. e. those drugs which deter the insect from feeding 
whilst not actually killing it. Two areas can be identified. Firstly, the 
inhibition of digestive enzymes in the insect (preferably without inhibiting 
enzymes from other species) and secondly, blocking receptor sites that inform 
the insect of the presence of food. 
Dihydroxymethyldihydroxypyrrolidine (DMDP, figure 1.04) has 
featured predominantly in both respeCtS22,6,12. For instance, this compound 
inhibits the enzyme trehalase, which is a glucosidase hydrolysing trehalose to 
glucose. Trehalose is an important carbohydrate reserve in insects, but it is 
not found in mammals so any specific inhibitor of the enzyme would 
obviously be useful. DMDP is relatively inactive against cc-glucosidases in the 
mammalian gut (e. g. maltase, sucrase), but it does show inhibition of some 
other insect glucosidases, such as maltase in Bruchid beetles (a common pest 
of stored beans in tropical regions). Various organisms react differently to 
DMDP and it is impossible to say, without trial and error, whether a particular 
glycosidase in one species will behave similarly to that in another. This 
difference in specificity can be utilised to distinguish which glycosidases from 
various sources have the same mechanism of action. 
The blocking of feeding receptor sites occurs in an entirely different 
way. The presence of sugars such as fructose provokes a response in insects to 
feed, presumably via sensory organs on the mouthparts of the insect. DMDP 
has the same shape and stereochemistry as fructose and this drug will prevent 
locusts from feeding, even if it is present in only trace quantities. 
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Figure 1.04. 
The similarity between fructose and DMDP. 
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The fructose analogue reversibly blocks the receptor sites which 
determine the presence of food, whilst it remains non-toxic to the insect. 
Other pests could, in theory, be controlled using natural plant alkaloids or 
synthetic derivatives, but again it is a matter of trial and error. 
, The plant alkaloids have other therapeutic properties which have 
perhaps not received as much attention due to the interest in HIV inhibition. 
For instance, castanospermine and swainsonine both have various effects on 
cancer cells. StudieS23 have shown that specific glycoproteins show increased 
branching of P-1,6 linked sugars during metastasis (the invasion of healthy 
tissue by cancer cells). If cancerous cells are incubated with swainsonine, the 
P-1,6 linked branched residues are reduced and a loss of metastasis is seen to 
occur. 
Likewise, swainsonine has also been reported to influence the effect 
natural killer cells have on cancerous celIS24. Once again by altering the type 
of N-linked asparagine oligosaccharide present on the turnour cell, the 
susceptibility towards lysis by killer cells was increased in vitro . Normal cells 
would presumably suffer a similar fate, but cancer cells are often characterised 
by unrestrained multiplication and would be a prime target. 
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Mechanism(s) of glycosidase hydrolysis 
Being inhibitors of a range of glycosidases from a variety of sources, the 
many plant alkaloids are useful tools for exploring the active site(s) of this 
class of enzyme. Furthermore, to gain more information on the 
structure/ activity relationship of various compounds, a model for the 
inhibition mechanism is required2l. At this moment though, no one theory 
can satisfactorily explain the range of data available, but this can be overcome 
by increasing the volume of information for a given enzyme and its 
inhibitors. 
On examination, many inhibitors are active against those enzymes that 
hydrolyse a substrate of similar size and stereochemistry. Thus, 1- 
deoxynojirimycin, related to glucose, inhibits the activity of several 
glucosidases1l. Likewise, castanospermine, which can be thought of as an N- 
alkylated deoxynojirimycin, inhibits various glucosidases as well25. However, 
swainsonine, which is a potent inhibitor of mannosidase enzymes, bears no 
resemblance to the pyranose structure of mannose, although the pyrrolidine 
ring does contain aspects of the mannose stereochemistry. The synthetic 
pyrrolidine (1) also inhibits several mannosidaseS26, suggesting that it is the 
five membered ring within the structure that is responsible for the activity of 
the inhibitor27. fig 1.05 
Figure 1.05 
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The inhibition by these alkaloids is competitive and reversible and it 
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has been assumed that a glycopyranosyl cation is involved by protonation of 
the basic amine group (pKa-6)28. The natural substrate of the enzyme is 
likewise protonated at the glycosidic oxygen by what has been suggested to be 
an aspartate residue within the active site29,30, fig 1.06 
Figure 1.06 
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A half-chair oxonium ion species is then formed (possibly transient or 
covalently linked to another carboxylate group) which can then collapse on 
hydration. The stereochemistry at the anomeric carbon is retained at the end 
of this process, fig 1.07. 
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oxonium ion species, fig 1.08. 
Figure 1.08 
A Yr.. 
0 
:%: % %* . It* : ** ). ---*,., .. ly 
coo- H 
HOCH I 2 
. ". I-'H N+ 0 H 'o, ýo 
HO 
coo- 
However, this hypothesis does not circumvent the problem that 
swainsonine bears little resemblance to mannose, or the fact that 6-epi- 
castanospermine resembles mannopyranose, yet is a poor inhibitor of 
mannosidaseS31, fig 1.09 
Figure 1.09 
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Literature modelling studies have been undertaken for a number of 
32,33 
alkaloid inhibitors and their relationship to the mannopyranosyl cation 
Our results for computer aided minimisation of swainsonine and the 
mannose cation using the CHARMm program are presented in figure 1.10, 
where reasonable overlap between the two was acheived. 
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Figure 1.10 
Two views of the minimised structures for swainsonine and the 
mannopyranosyl cation. 
superimposition of swainsonine and mannose cation 
swainsonine ca ion mannopyranosyl cation 
SCALE: 10.00mm/A 
If the ring heteroatoms in each molecule are superimposed, the C2 and C3 
hydroxyl groups of the mannose cation line up with the two hydroxyl groups 
in the 5-membered ring of swainsonine. In previous work, the C6 hydroxyl of 
the mannose cation had also shown good overlap with the 6-membered ring 
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hydroxyl group of swainsonine. In our studies, however, they were not 
particularly close. The literature results also suggested that the C4 hydroxyl 
group of the mannose cation did not overlap with any atoms in swainsonine 
and this was confirmed in our studies as well. 
It is interesting to note that previous computer aided minimisation of 
the mannose cation structure had resulted in a "flap up" half chair 
conformation. In this case, two of the C2, C3 and C4 hydroxyl groups are axial. 
Our minimisation resulted in the "flap down" conformation for the 
mannose cation, with one of the C2, C3 and C4 hydroxyl groups being axial. In 
either case, the C2 and C3 hydroxyl groups cannot be aligned exactly to those 
found in the 5-membered ring of swainsonine. 
1-deoxymannojirimycin can be aligned via the hydroxyl groups with 
the mannopyranosyl cation, but in this case the ring heteroatoms do not lie in 
the same region of space. This mismatch may account for the lower activity of 
1-deoxymannojirimycin compared to that of swainsonine. Likewise, 6-epi- 
castanospermine shows poor superimposition and poor inhibition. 
Recently, a similar study was undertaken on glucosidase inhibitors 
(both natural and synthetic) and similar conclusions were reached with an 
extra provis034. Inhibitors could bind in either substrate-like or transition 
state (half-chair) forms and inhibition was noted for both types, although the 
latter was more potent. Hence, 1-deoxynojirimycin in a protonated form does 
not show close stereochemical similarity to glucopyranoSyl cation and the 
positive charge on the nitrogen is not spread over the carbon and oxygen 
atoms as it is for the natural substrate (see fig, 1.11). Yet, 1-deoxynojirimycin is 
a potent inhibitor of cc- and P-glucosidases (Ki =1.8 x 10-5 M 
for sweet almond 
0-glucosidase), almost as potent as the amidine, (2), (Ki=8.0 x 10-6 M,, same 
enzyme 34/f ig, 1.12. 
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Figure 1.11. 
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The amidine in the half-chair conformation has a similar charge 
distribution to the glucopyranosyl cation and the two structures can be 
superimposed very weI134. - 
Figure 1.12. 
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In a case like this the stereochemistry of the hydroxyl groups do not 
seem to play such an important role as the electrostatic interaction between 
the positive charge and the carboxylate group in the active site. For instance, 
(2) is as active against jackbean (x-mannosidase and bovine P-galactosidase as 
against P-glucosidase35. The orientation of the hydroxyl groups is important 
for the recognition and binding of inhibitors which are more chair-like in 
character (1-deoxynojirimycin is only a weak inhibitor of jackbean cc- 
mannosidase and shows no inhibition of P-galactosidase). 34 
Before this molecular modelling work had been published, Fleet 
proposed an alternative explanation that even now cannot be ruled oUt26. 
Instead of protonation occurring at the glycosidic oxygen, he suggested the 
oxygen heteroatom was protonated which then underwent cleavage to give 
an acyclic oxonium species, scheme 1.01 
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Scheme 1.01 
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This acyclic species could then be attacked by water to complete the 
hydrolysis. Protonated amine inhibitors would thus assume more of the 
shape of the intermediate protonated glucoside. It is possible that in some 
enzyme systems one process occurs instead of the other, or that the two are in 
competition. 
Part of the problem with a glucopyranosyl cation is that the precise 
nature of the intermediate should be different for (x- and P-glucosides. u. - 
Glucosides should hydrolyse via the ground state chair conformation because 
the lone pair on the acetal oxygen, being anti-periplanar to the departing 
aglycon unit, can assist in oxonium ion formation. A P-glucoside would need 
to assume a boat conformation in order to fulfil this stereoelectronic 
requirement36, scheme 1.02 
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The two processes show different activation energies in model systems 
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and presumably the same applies to enzymatic hydrolyses. I- 
Deoxynojirimycin, however,, inhibits sweet almond P-glucosidase (Ki = 1.8 x 
10-5M) to an almost equal extent as brewers yeast cc-glucosidase (Ki = 8.7 x 10- 
6M). 
It is possible in Fleet's hypothesis, that a lone pair on the anomeric 
oxygen can assist in ring cleavage if both oc-and P-glucosides are in a chair 
conformation, fig, 
Figure 1.13 
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Chemical syntheses of plant alkaloids 
Since the first chemical synthesis of nojlrlmycin and its 1-deoxy 
analogue in 19682, there has been great interest in synthesising these and 
other alkaloids over the last ten years. It is interesting to examine the 
development in synthetic methodology over this period to the stage today 
where very efficient, short routes to 1-deoxynojirimycin are known. 
Retrosynthetic analysis of the construction of the piperidine ring can give 
clues as to possible biosynthetic routes, although often the biosynthesis of a 
particular compound can help in chemical synthesis via a biomimetic 
approach. A favoured strategy, and perhaps the most sensible, has been to use 
the "chiral poollf of available sugar derivatives 37,38,39,40. This has the 
advantage of being cheap, and most importantly, a number of chiral centres 
can be introduced without resorting to specialist reactions. This is particularly 
applicable to the plant alkaloids, though, which have close similiarities to a 
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number of natural sugars. Other, non-carbohydrate strategies have also been 
employed, most recently the synthesis of nojirimycin and 1-deoxvnojirimycin 
I 
starting from diethyl tartrate4l. 
Perhaps the biggest contribution to the synthesis of plant alkaloids and 
their analogues has been from the research group of Fleet40,37,42. His strategies 
illustrate the choices available and the flexibility which can be gained from 
using carbohydrate precursors. 
Essentially, two approaches are adopted for producing a piperidine ring 
from a starting hexose and examples will be given from both these classeS42 
For examPle, to synthesise 1-deoxymannojirimycin, glucose could be cyclised 
via a nitrogen link between C2 and C6 (with inversion of configuration at C2). 
This would provide all the necessary chiral centres and the synthetic problem 
then becomes one of protecting the sugar in the correct way to introduce the 
nitrogen functionality at C2 whilst also allowing oxidation at C6. By oxidising 
C6 to an aldehyde and using a reductive amination technique the 1-deoxy 
derivative would be produced, scheme 1.03. 
Scheme 1.03. 
CHO CH20H 
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Alternatively, mannose could be the starting hexose, but this time cyclisation 
via the nitrogen functionality would need to be via CI and C5, scheme 1.04. 
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Scheme 1.04. 
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This time the nitrogen atom needs to be introduced with retention of 
configuration at C5. In either case, amination could be at one or other carbon 
centre, the only difference being that a different intermediate is involved in 
producing the 1-deoxy compound. 
At first glance, the C2/C6 route as shown above seems complicated 
synthetically, i. e. the C6 carbon needs to be oxidised to the aldehyde and the 
C1 carbon needs to reduced to the primary alcohol. In practice, these 
complications are not apparent because the anomeric position is often in the 
form of an acetal and therefore protected for many synthetic steps. 
Furthermore, a reductive amination has been illustrated here, but equally the 
amine group on C2 could displace a good leaving group on C6 via an SN2 type 
mechanism, leading to the 1-deoxy compound directly. This would avoid any 
possible complications in oxidising the C6 primary alcohol to the aldehyde 
stage. 
The very first synthesis of 1-deoxynojirimycin2 used the Cl/C5 route 
with reductive arnination, as below. Diacetone-D-glucose served as the chiral 
hexose, which has the advantage of being cheap whilst also being partially 
protected with the acetonide moiety. Protecting groups obviously have the 
purpose of allowing a particular functional group to be manipulated, but in 
this and subsequent examples, they have the additional benefit of making 
water soluble precursors soluble in organic solvents. 
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The first chemical synthesis of nojirimycin. 
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So nojirimycin was synthesised in eight steps. The 1-deoxy derivative 
can be made in one step from nojirimycin using a reductive amination 
reaction (Pt/H2 in AcOH/H20). However, many sequences in this synthesis 
are protection/ deprotection steps to manipulate the required functional 
groups and furthermore step v suffers from the disadvantage that 
diastereoisomers are produced. It would be an advantage to have a common 
intermediate from which several alkaloids could be made and also a synthesis 
that avoided complicated separations. To this end Fleet used the intermediate 
(3) to make many different alkaloids by simply modifying various steps37,40. In 
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contrast to the previous example, C2/C6 cyclisation with inversion of 
configuration at C2 proved to be the most profitable route, often with the 
nitrogen functionality being introduced by SN2 displacement of triflate with 
azide anion, scheme 1.05 and scheme 1.06. 
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Scheme 1.06. 
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I-Deoxymannojirimycin (DMJ) is the obvious alkaloid to be obtained 
from hydrolysis and reduction of intermediate (3), but by inverting the 
hydroxyl stereochernistry at what was originally C5 in the glucose, or 
removing it altogether, 1-deoxynojirimycin (DNJ) or fagomine can be 
produced. Similarly, another amino group can be introduced with either 
stereochernistry at C2 in the nojirimycin ring leading to the alkaloid 
equivalent of N-acetylglucosamine (4). This synthetic derivative has been 
shown to be a potent and specific inhibitor of N-acetylglucosaminidases. 
Other piperidines are also possible, for instance, oxidation at CI gives a 
bicyclic lactone which can be hydrolysed to the corresponding pipecolic acid 
derivative. 
All the above transformations have the stereochemistry at C3, C4 and 
C5 in common, yet the flexibility of Fleet's methodology is evident when it is 
apparent that it can also be used to construct furanose sugar analogues. To 
achieve this, a C2/C5 cyclisation is required (step iii). An obvious target in this 
case is DMDP, although the synthetic strategy is by no means limited to this 
stereochemistry. 
The synthesis of DMDP. 
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PhCH20COCI /ether/ NaHC03 iv. triflic acid/H20, NaBH4/EtOH/H20 v. 
Pd(OH)2/H2/EtOH 
To reach DMDP, the stereochernistry at C5 needs to be retained so steps 
i-iii are concerned with introducing an epoxide function of opposite 
configuration so that in the cyclisation, a double inversion would have 
effectively taken place at C5. 
Enzymatic syntheses 
Recently, synthetic strategies have emerged whereby whole cells or 
isolated enzymes have been used to oxidise selectively a particular hydroxyl 
group, or couple together two simpler units to give the sugar 
derivative43,44,38,45. Despite being versatile, Fleet's methodology still requires 
significant protection/ deprotection steps, yet using enzyme systems, this is 
kept to a minimum. 
A well exploited transformation is the oxidation of the central hydroxyl 
group in D-erthyro configurated compounds by bacteria of the genus 
Gluconobacter , scheme 1.07. 
Scheme 1.07. 
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By using glucose itself, a short synthesis of 1-deoxynojirimycin can 
be 
accomplished 
38. 
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Enzymatic synthesis of 1-deoxynojirimycin. 
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(no 1,5-dideoxy-1,5-imino-L-iditol was observed in step iii) 
Following reductive amination of the glucopyranose ring, a C1 /C5 
cyclisation is effected after regioselective oxidation of the C5 hydroxyl group. 
A different approach, and one which has produced many synthetic 
derivatives of 1-deoxynojirimycin, uses an aldolase enzyme. Previous work 
had shown that fructose-1,6-diphosphate aldolase was very specific for 
dihydroxyacetone phosphate, but a wide variety of aldehydes were 
accepted44,45 scheme 1.08. 
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Scheme 1.08. 
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Both azide diastereoisomers resulting from the aldol reaction above 
were reduced to the corresponding piperidine after removal of the phosphate 
group by an phosphatase. 1-Deoxynojirimycin and 1-deoxymannojirimycin 
were obtained in a ratio of about 1: 4, and these could be separated by ion 
exchange chromatography. The elegance of this synthesis is its simplicity and 
the only limit is the number of aldehydes that can be accepted by the aldolase 
enzyme. For instance, fluorinated azido-aldehyde gave the corresponding 
fluorinated 1-deoxymannojirimycin exclusively34, scheme 1.09. 
Scheme 1.09. 
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Biosynthetic considerations 
Although a wide range of secondary metabolites have been discovered, 
very often they are derived from a few simple units which themselves 
originate from primary metabolic pathways essential for the organism's 
survival46. Such pathways might include glycolysis and amino acid 
metabolism, for instance. Before looking in detail at 1-deoxynojirimycin 
biosynthesis., it is worthwhile to examine why an organism would produce 
this alkaloid in the first place and any possible selection advantage that might 
be gained from it. 
The biosynthesis of 1-deoxynojirimycin follows a very typical time 
course in that the alkaloid is produced only after the initial growth and 
replication steps have occurred (see chapter 2). The most important criterion 
for any living system is to grow and then reproduce and this takes precedence 
over any other process. The fact that secondary metabolism often takes place 
when nutrient supplies are low and this normal growth pattern is disrupted, 
has led many authors to suggest that secondary metabolism is an overflow 
procesS47,48,46. Intermediates from primary metabolism increase and these can 
then be used as substrates for producing secondary metabolites. In this way, 
enzymes that normally catalyse reactions essential for survival can be used in 
secondary metabolism as a means to keep these enzymes functioning until 
circumstances are right again for renewed primary metabolism. Natural 
selection then takes over and organisms that produce "useful" secondary 
metabolites are favoured over those that synthesise redundant ones. The vast 
number of soil organisms that produce antibiotics and the many plants that 
make toxic or unpalatable metabolites must be seen as acquired rather than 
pre-designed systems. 
Although nojirimycin exhibits antibiotic properties, glucosidase 
inhibition could provide a microorganism with a mechanism to inhibit other 
organisms' glucosidase enzymes. This might be important when nutrient 
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supplies were low, although the process relies on the producing 
microorganism being immune to its own alkaloid inhibitors. In addition, a 
plant could benefit from the insect anti-feedant properties of certain 
compounds., not to mention the inhibition of glycohydrolases essential to the 
digestive system of an insect. In the mulberry tree, 1-deoxynojirimycin is 
located in the rootS4 so either it is produced there or else translocated from 
another region and stored. It is in a place where no useful benefit is apparent, 
but is it coincidence that several Streptomyces species which produce this 
compound are also soil dwelling bacteria . 
47 A possible link could be that 
originally one organism produced the alkaloid and then through infection, 
for instance, the other obtained the enzymes for its biosynthesis. 
Usually, a good indication of the biosynthetic precursor(s) to a 
secondary metabolite can be gleaned from its structure, and also to a lesser 
extent, its source. There is a danger in this approach of assuming that 
compounds with similar structures are formed by similar metabolic 
pathways. Coniine, one of the hemlock alkaloids, has a similar structure to 
halosaline, yet the former is derived from acetate whilst the latter originates 
from lysine49, fig 1.14. 
Figure 1.14. 
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The extensive research into the chemical synthesis of 1-deoxynojirimycin 
suggests a carbohydrate as one of the main contenders for the biosynthetic 
source. Since glucose has all the required stereochemical centres, the simplest 
route might involve a C1/C5 cyclisation, yet as mentioned earlier, amination 
at either centre might then occur. The actual cyclisation mechanism might 
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also be different to the one shown here. 
A proposed biosynthetic route for 1-deoxynojirimycin 
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Essentially, this is a biochemical version of the chemical route 
previously described in the first synthesis of nojirimycin. 
The oxidation and 
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reduction steps might involve NAD+/NADH, and one possible method of 
reductive amination uses the co-enzyme pyridoxamine phosphate. 
Reductive amination with pyridoxamine phosphate. 
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A number of amino sugars are found as components of the polyene 
macrolide antibiotics, and two in particular, mycosamine and perosamine, 
illustrate similar biosynthetic steps to those proposed for I- 
deoxynojirimycin. 50 
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The proposed biosynthesis of mycosamine and perosamine. 
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It is important to emphasise that all the transformations are carried out 
using an intact glucose ring structure, and although an amino sugar and not 
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an alkaloid is produced, it is a simple step to cyclise the amine function with 
the aldehyde (rather than a hydroxyl group) to produce a nitrogen heterocycle. 
The thymidine diphosphate serves to activate the sugar ring for attachment 
to the macrolide in the final stages of biosynthesis. 
A glance at the studies already undertaken on alkaloid biosynthesis 
reveal that the vast majority of compounds are derived from the metabolism 
of amino acids, and thus in many cases from carbohydrate sources via the 
citric acid cycle5l. Particularly, the aliphatic amino acids, (L)-ornithine and (L)- 
lysine have been implicated in a number of biosynthetic schemes towards 
pyrrolidine and piperidine alkaloids respectively (e. g. cocaine and anabasine 
52,53 biosynthesis 
The construction of the ring system in 1-deoxynojirimycin could 
possibly originate in the same fashion from lysine, but a number of hydroxyl 
groups are present which presents a problem on how these might be 
introduced into an essentially unreactive ring, scheme 1.10 
Scheme 1.10. 
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However, the biosynthesis of the indolizidine alkaloids swainsonine and 
slaframine in Rhizoctonia leguminicola both involve lysine and 
functionalisation of a saturated carbon centre54. 
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The biosynthesis of swainsonine and slaframine in Rhizoctonia 
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The first stage involves the formation of pipecolic acid from (L)-lysine. 
The pipecolic acid, presumably as a thioester, then reacts with malonyl CoA 
35 
before reductive cyclisation affords the indolizidine ring structure. The two 
pathways then split and hydroxyl and amine groups are introduced, the exact 
timing of which still remains uncertain. Swainsonine, in particular, is 
hydroxylated at C2 and slaframine has its amine moiety introduced via a keto 
group at C6, in both cases at "unreactive" carbon centres. The origin of the 
hydroxyl at C4 is ambiguous as there is the possibility it could arise from 
double bond migration followed by epoxidation and ring opening, scheme 
1.11. 
Scheme 1.11. 
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These hydroxylations and oxidations of unreactive, saturated carbon 
atoms are presumably carried out by an oxygenase enzyme, using molecular 
oxygen and FADH2 as the co-enzyme55. 
substate--H + 02 + FADH2 --*-- substrate--OH + H20 + FAD 
However, it seems unlikely that three hydroxyl groups would be introduced 
successively into the basic piperidine ring structure to give I- 
deoxynojirimycin and the carbohydrate route therefore looked the more 
plausible one before this work was undertaken. 
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CHAPTER TWO 
Biosynthesis of nojirimycins in S. subrutilus. 
Nojirimycin (NJ) and 1-deoxynojirimycin (DNJ) have been isolated 
from a wide range of microorganisms, and these cultures lend themselves to 
biosynthetic study by using isotopically labelled precursors. A few of the 
Streptomyces and Bacillus strains which produce nojirimycins are listed 
below. 
Microorganisms which produce nojirimycins. 
Nojirimycin producers DNJ producers 
S. roseochromogenes S. lavendulae SF 425 
S. lavendulae SF 425 S. subrutilus 
S. nofiriensis B. subtilis 
S. subrutilus 445 B. amylolique aciens 
Although several piperidine alkaloids have been isolated from plants, 
including DNJ, microorganisms offer a number of advantages over plants for 
biosynthetic studies. Usually it is a simple matter to feed the labelled 
precursor to the liquid medium from which the microorganism feeds, and 
this can be accommodated on virtually any scale of production. At the end of 
the fermentation, it is usually straightforward to remove the microorganism 
before final purification. In biosynthetic experiments involving plants, 
labelled precursors need to be introduced by means of a wick or by injection. 
The study is limited by the number of plants and in some cases by seasonal 
variations if the secondary metabolite of interest is produced in a 
fruit, for 
example. Usually mechanical methods are then required to extract the 
compound(s) from the leaves or roots before further purification can take 
place. 
In this thesis., the production of four alkaloids, DNJ, NJ, 1- 
deoxymannojirimycin (DMJ) and mannojirimycin (Mj) has been evaluated in 
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S. subrutilus and B. subtilis var niger. This involved the synthesis of 
isotopically labelled precursors which are described in chapter 3. 
The stereochemical relationship between NJ, DNJ, MJ and DMJ. 
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The influence of nutrients and culture conditions on the yield of DNJ 
in S. subrutilus and the development of the trehalase assay for time course 
6 studies was work carried out by S. J. Trew at Warwick University' . 
Fermentation medium 
The complex medium used in all biosynthetic studies involving S. 
subrutilus is given below. This organism showed slightly higher titres of DNJ 
in a soyabean medium with starch as the carbon source when compared to 
the patented producer, S. lavendulae ATCC 31434. 
Fermentation medium for S. subrutilus. 
% W/V 
Glucose 0.4 
KCI 0.05 
MgS04.7H20 0.05 
NaCl 0.5 
NaN03 0.2 
CaC03 0.35 
Sovabean meal 1 
DNJ 
OH 
HO AOH 
N CH20H 
H 
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The medium was made up to 500mL with distilled water and then split 
into 30mL aliquots before being autoclaved. After inoculation with S. 
subrutilus, the flasks were then incubated at 28-30'C/200 r. p. m for 7 days. 
The distribution of the medium to several shake flasks improved the 
yield of DNJ compared to when a bulk reaction vessel was used. This was 
presumably because of improved aeration, so all subsequent fermentations 
were carried out in this manner, including those for B. subtilis. It was hoped 
that a defined medium could be used for the biosynthetic studies, in which 
the soyabean meal was replaced by a series of amino acids in known 
concentrations. However, S. subrutilus showed poor production of DNJ in 
this type of system so a complex medium as above was used as a base. 
This complex medium was based on work by Ezure et a14 who had 
investigated several carbon and nitrogen sources and the effect these had on 
the production of DNJ. They had found that soluble starch (2% w/v) was the 
best carbon source, giving a DNJ titre of 263gg ml-1 based on a sucrase assay. A 
carbohydrate biosynthetic route would originate from the starch whilst an 
amino acid pathway would utilise lysine from the soyabean meal. 
To test this., the starch in the original medium needed to be replaced 
with an alternative carbohydrate source that could be easily labelled with an 
isotope. Glucose was found to be a good substitute, although mixtures of 
glucose and starch, which had been reported earlier5, needed to be avoided. 
This was because the glucose might be used up rapidly in the growth of the 
cells and the reserve of starch might then contribute to secondary 
metabolism. 
Extensive work by TreW56 had revealed that the highest yield of DNJ 
was produced with 0.6% w/v glucose in the medium (65ýtg mL-1 DNJ). In 
terms of alkaloid produced per weight of glucose fed, the medium with 0.2% 
w/v carbon source proved to be more efficient (15.8gg mL-1 DNJ g-1 glucose) as 
shown below. 
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The relationship between glucose concentration and DNJ production56. 
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A compromise was reached between efficiency of production and the 
quantity of fermentation medium that needed to be prepared in order to 
produce an isolable amount of alkaloid. This level was set at 0.4%w/v glucose 
which meant that with a 500mL fermentation, approximately 30mg of DNJ 
would be produced in total. Despite numerous experiments varying different 
nutrients and culture conditions, the basic medium of Ezure4, without the 
starch, was utilised. 
This yield of DNJ might appear to be low given that various strains in 
different species have been reported to produce very high levels of DNJ. 
Ezure has described UV mutant strains of S. lavendulae capable of producing 
up to 900 ýig mL-1 of alkaloid. Similarly, a laboratory strain57 of B. subtilis can 
produce DNJ from many different carbon sources up to a value of 1000 ýIg 
mL-1- In both these cases, the inhibition of sucrase was used as an assay 
method, although this enzyme is inhibited by both DNJ and NJ, with Ki 
values of 2.2 x 10-8 M and 1.2 x 10-7 M respectively58. Hence, a sucrase assay 
may give optimistic concentrations of DNJ if appreciable amounts of NJ are 
40 
present, which is possible in the case of S. lavendulae. Ezure has described an 
HPLC method of analysis but no comparison of the two techniques was made. 
Studies towards a high producing medium for B. subtilis var niger 
were not carried out in such detail and as a result a much lower titre of DNJ 
was obtained using this organism (25ýtg mL-1 DNJ, 8ýtg mL-1 g-1 glucose). Our 
initial studies with B. subtilis ATCC 33234 using a minimal salts medium 
intended for B. subtilis DSM 70457 had given poor yields of DNJ. Other 
organisms of the Bacillus species had been reported to produce the alkaloid59 
and so research concentrated on B. subtilis var niger ATCC 9372, a readily 
available species. Using various media, the following was found to be the 
most productive and was based on that for B. amyloliquefaciens, a patented 
producer of DNj60. 
Fermentation medium for B. subtilis var niger. 
B. amyloliquefaciens B. subtilis var niger 
Glycerol(3%) Glucose(O. 4%) 
CaC03(3%) CaC03 (0.2%) 
Soyabean meal(3%) Soyabean meal(l%) 
Diluted with tap water Diluted with tap water pH=6.8 
To compensate for the lower concentration of DNJ in this organism 
compared to S. subrutilus , most experiments were carried out using 75OmL of 
fermentation medium, producing typically 10-12mg of DNJ. 
Assay techniques. 
Two methods were used to quantify DNJ and NJ during the 
fermentation and purification processes. 
Trehalase assay 
DNJ and NJ both inhibit pig kidney trehalase (EC 3.2.1.28), an enzyme 
that hydrolyses trehalose into glucose, scheme 2.01. 
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Scheme 2.01 
OH 
HO OH OH OH 
HOCH' 0 018181 2 OH 
0 
CH20H 
trehalose 
OH 
HO, 
HO 0 -40 
OH 
H20H 
glucose 
The amount of glucose released can be determined by a standard blood 
glucose assay using the enzyme glucose oxidase. 
glucose oxidase glucose + 02 + H20 imm- gluconate + H202 
The assay comes in a kit form (Boehringer-Mannheim GmbH, 
Peridochrom@), where the hydrogen peroxide produced in the above reaction 
is used to oxidise phenol to benzoquinone. This reacts with 4- 
aminophenazone to give the red imino derivative which can be detected 
s pectropho tome trically. The presence of NJ or DNJ inhibits trehalase and 
therefore the formation of glucose, so a weaker absorption was noted when 
these two alkaloids were present. Like sucrase, which has already been 
described, trehalase was affected by NJ and DNJ (Ki = 2.6 x 10-5 M and 3.4 x 10-6 
M respectively)56. Although NJ was the weaker inhibitor, to get an accurate 
estimation of the concentration of DNJ, the former needed to be removed. 
This was conveniently done using a heat/acid treatment first described by 
Ishidal. The product(s) from this decomposition have been characterised by 
Inouye2. 
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The decomposition of NJ under heat/acid conditions. 
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The inhibition by DNJ was not affected by this treatment, as demonstrated 
belOW56. 
Inhibition of trehalase by DNJ and NJ after incubation with an equal volume 
of 6M HCI at 90'C-56. 
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By preparing standard solutions of NJ and DNJ, an estimation of the amount 
of each alkaloid in a fermentation could be made following heat/acid 
treatment. The disadvantage with this method was that there was always the 
possibility that other compounds were present in the culture medium which 
inhibited this enzyme (see results for B. subtilis below). To ascertain whether 
the enzyme assay was correct, gas chromatography was also used for 
quantitation. This method was first described in 1986 for a range of 
polyhydroxyalkaloids and only necessitated derivatisation to the 
trimethylsilyl derivative6l. By using an internal standard of methylglucoside 
and a standard calibration curve, the amount of DNJ in the fermentation 
could be determined. The disadvantage with this method was that NJ 
decomposed after silylation (or on the column) so only an estimate of the 1- 
deoxy derivative could be obtained. 
With S. subrutilus, the two techniques gave identical results for the 
quantity of DNJ. Neither technique was faster than the other, as the GC 
sample needed to be lyophilised prior to derivatisation, whilst the trehalase 
assay involved a heat/acid step. The enzyme assay did give extra information, 
however, in the form of the NJ concentration. 
In the fermentations involving B. subtilis var niger, the agreement 
between the GC result and that from the trehalase assay was not good. The 
enzyme was inhibited to a higher degree after heat/acid treatment than could 
be accounted for by DNJ alone. After 7 days fermentation, a typical heat 
treated culture medium showed 70% inhibition of trehalase, corresponding to 
0.05mg mL-1 DNJ- The GC assay consistently gave values of 0.025mg mL-1 for 
the same fermentation at the same point in time. One reason for the apparent 
low titre for DNJ might be the presence of an impurity co-eluting with the 
internal standard and therefore giving a larger area for this component. 
When the chromatogram was run without internal standard, no such 
impurity was found, so Presumably at least one further inhibitor was present 
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which was not identified in this project. 
From the GC chromatogram another alkaloid was seen to be present 
other than the DNJ in the S. subrutilus fermentation. This was always 
present in smaller amounts and later proved to be the manno epimer of DNJ, 
1- deoxymannojirimycin (DMJ). 
Gas chromatogram of the S. subrutilus fermentation after partial 
purification. 
10 
minutes 
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DMJ had not been reported in S. subrutilus before, although it had been 
isolated in 1988 from S. lavendulae GC-148, which also produced DNJ. 
Isolation of the two alkaloids confirmed the gas chromatography results that 
the level of DNJ was 21/2 times higher than that of DNJ. Fortunately, DMJ 
was shown to have no effect on trehalase., even at concentrations up to 0-5mg 
mL-1, well exceeding that found in the fermentation. 
Time course studies by TreW56 using S. subrutilus gave some 
indication of the interaction between nojirimycin and DNJ over the 
fermentation period, although DMJ had yet to be discovered in this organism 
at this time. 
Time course studies on the production of DNJ and NJ in S. subrutilus. 56 
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The biosynthesis of DNJ and NJ followed a typical path in that they were not 
produced until the glucose concentration had fallen to about 25% of its initial 
concentration. Growth of the organism before this time was the dominant 
factor. The amounts of NJ and DNJ produced then both increased together 
after 75h, with NJ showing a particularly large increase at this time. 
At all 
points until the end of the fermentation, the level of NJ was 
higher than that 
46 
of DNJ. The time course studies only indicated that the two alkaloids were 
present in the fermentation at the same time and did not prove whether NJ 
was a precursor to DNJ, although this was a plausible hypothesis. 
Time course studies with B. subtilis var niger appeared to follow a 
different pattern. Percentage inhibition of trehalase, although not an accurate 
method for estimating DNJ in this organism, can be used to detect the 
presence of NJ qualitatively. No decrease in inhibition, however, could be 
detected in heat/acid treated samples compared to the crude fermentation 
during 7 days incubation. This suggested that either NJ was not being 
produced or that it was at a much lower level compared to that in S 
subrutilus and the enzyme assay was not sufficiently sensitive to detect it. 
Another interesting difference between the two organisms was that B. 
subtilis var niger did not produce DMJ. Earlier work with B. subtilis ATCC 
33234 had suggested that DMJ was not present after 7 days fermentation, but 
this could be because the compound was a precursor to DNJ itself. A gas 
chromatography study revealed that DMJ was not produced at any stage 
throughout the fermentation, although DNJ was produced after 48h (not 
quantified) rising steadily thereafter to give a final concentration of 0.02mg 
mL-1. These observations were to have important consequences for the 
biosynthetic pathway in B. subtilis var niger and will be discussed later. 
As more evidence emerged from labelling studies, an assay was 
required which could detect mannonojirimycin NJ). Already it had been 
shown that the mannose analogue of DNJ was present in S. subrutilus, and 
investigations indicated that it was likely the manno epimer of NJ was there 
too. The inhibition of jack bean a-D-mannosidase (EC 3.2.1.24) was the basis 
for an enzyme assay, scheme 2.02. 
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Scheme 2.02. 
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Normally, the hydrolysis of p- ni trophenylm anno side gives mannose 
and p-nitrophenol, but in the presence of a mannosidase inhibitor, the 
concentration of the latter is reduced. Conversion to the yellow 
nitrophenolate anion allows the hydrolysis reaction to be monitored 
spectrophotometrically. As with the trehalase assay, inhibition of the enzyme 
decreases the absorbance due to nitrophenolate anion. 
The compound of interest, Mj, was reported to lose its inhibitory 
properties after treatment at pH 5.5 and 50oC62 (compare the heat/acid 
treatment of NJ). At this pH and temperature, the loss of inhibitory activity 
had a half life of ~4h so a test for Mj was feasible by comparing inhibition 
before and after 24h heat treatment. Unlike the NJ assay, where an authentic 
standard was available, a sample of Mj was not available and so the assay 
remained a qualitative rather than a quantitative one. 
The importance of pH in inhibition studies using mannosidases. 
The state of ionisation of the alkaloid inhibitor, i. e. whether it is 
protonated or not, and the degree of ionisation of carboxylate groups within 
the active site of the enzyme, are two important factors governing the 
effectiveness of inhibition. Ambiguities between the two can arise from 
experimental data63. For instance, an increase in inhibition with increasing 
pH can arise either because the inhibitor binds in an unprotonated form and 
subsequently protonates within the active site, or because there is more 
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ionisation of carboxylate groups to bind the protonated form of the alkaloid. 
Examples are known of both types of enzyme system63. 
It is important therefore to find a pH for the enzyme being used which 
maximises the inhibition, thereby making the assay as sensitive as possible. 
For trehalase, maximum inhibition was at pH 6.0 (pKa of DNJ = 6.4)64 and 
fortunately this was also at the optimum pH value for hydrolysis 65 
The mannosidase assay presented a dilemma. The inhibition of jack 
bean cc-D-mannosidase by DMJ was reported to be higher at pH 5.5 than at pH 
4.5 by a factor of 5.8, figure 2.0162. Studies by Li et al on the optimum 
hydrolytic pH for this enzyme gave a value of 4.2 as the ideal66' with 75% of 
the activity of the enzyme being retained at the higher pH value of 5.5. 
However, in our studies, no inhibition occurred at pH 4.5, even using a 
standard concentration of 2.0 x 10-4 M DMJ. The IC50 of this alkaloid at this pH 
using jack bean (x-D-mannosidase was reported to be 1.5 x 104M, So 
approximately 50% inhibition of the enzyme should have taken place67,68. At 
pH 5.5, despite a slower hydrolysis rate, inhibition was observed and the 
experimental IC50 value of 4.5 x 10-4 M agreed with the literature value of 4.0 
X 10-4 M at this pH32. This pH value was then used in our subsequent 
inhibition studies. 
From the graph overleaf, it can be seen that jack bean cc-D-mannosidase 
was also inhibited by DNJ. 
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The inhibition of crjack bean mannosidase by DNJ and DMJ. 
Inhibition 
This contrasted with trehalase which was not inhibited by DMJ even at quite 
high levels (page 46). The difference between the two enzymes in terms of 
inhibition was also quite marked, with DNJ showing stronger inhibition of 
trehalase than DMJ with the mannosidase (DMJ Ki =6.8 x 10-5M jack bean (X- 
D-mannosidase, DNJ Ki =3.4 x 10-6M pig kidney trehalase). 
DNJ was present in the S. subrutilus fermentation at a level which 
would effect the mannosidase assay if DNq was being quantified, but since the 
assay was really designed for MJ , this was not a great setback. The level of 
DMJ can be determined accurately using GC if required. 
DMJ was not affected by the heat treatment already outlined so the 
decrease in inhibition following this step gave a direct means of establishing 
the presence MJ. More worrying was the fact that NJ also inhibited jack bean 
cc-D-mannosidase, although 500 times less effectively than MJ (Ki = 5.0 x 10- 
4M and 1.2 x 10-6M respectively). To circumvent this problem, the 
concentration of NJ in the fermentation could be assessed using the trehalase 
assay. Since NJ was available as a standard, the effect of this alkaloid on jack 
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bean cc-D-mannosidase could then be determined. 
It was fortunate in this study that Mj was a stronger inhibitor of 
mannosidase than DMJ (contrast NJ and DNJ with trehalase) and that a 
relatively large difference in NJ and MJ inhibition existed for the 
mannosidase enzyme,, especially at pH 5.5. The figure 2.01 summarises the 
inhibition constants for Mj, DMJ and Nj62. 
Figure 2.01 
The inhibition constants (Ki) for DMJ,, MJ and NJ at pH 4.5 and 5.562. 
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All Ki values are in gM for jack bean cc-D-mannosidase. 
Purification of DNJ and DMJ from the fermentation medium 
Nojlrlmycin was difficult to isolate from the fermentation. Inouye 
states, " isolation of nojirimycin in a pure state proved a difficult task owing 
to the instability of the antibiotic under neutral and acidic conditions, as 
indicated by a rapid decrease of the biopotency at room temperature". A 
widely used technique to semi-purify the crude culture medium was to pass 
the filtered or centrifuged fermentation liquor down a strongly acidic cation 
exchange resin. Protonated alkaloids adsorb to the column whilst neutral 
sugars and glycolytic byproducts pass through. This immediately presents a 
problem for NJ separation as the pH of the filtrate eluting from the column 
drops to about 2. This technique has been used to isolate NJ, although only 
from large scale fermentationsi. 
DNJ and DMJ are not acid sensitive and can be easily adsorbed onto 
Dowex 50 (H+ form). Scheme 2.03 outlines the remaining steps to purify DNJ 
and DMJ from S. subrutilus and B. subtilis.. 
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Scheme 2.03 
The isolation of DNJ and DMJ from S. subrutilus and B. subtilis. 
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After adsorption to the cation exchange resin, the alkaloids were 
removed by eluting with 2M ammonia. Other workers had used 0.5M 
ammonia solution5, but this was found to only remove some of the DNJ (e. g. 
4mg out of 15mg). The eluate was then concentrated and taken up in 70% 
aqueous ethanol. At this stage the aqueous ethanol solution was a dark brown 
and not all the solid dissolved leaving suspended polymeric impurities. The 
alumina column removed most, but not all, of this dark coloration leaving a 
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very pale yellow solution. It was possible at this stage to separate DNJ from 
DMJ (in the free base forms) by careful chromatography on alumina, but there 
was considerable overlap of the two alkaloids and only a small amount of 
each could be obtained in a pure form. TLC (Si02) of the alumina column 
filtrate indicated one main spot with weak impurities present. DNJ and DMJ 
standards likewise co-eluted on a silica TLC plate. 
The best way to separate the two epimers was by flash chromatography 
of the peracetyl derivatives. Using the solvent system in scheme 2.03, it was 
possible to separate most of each alkaloid, although there was some overlap 
between the two. To speed the purification process up, this was the only point 
where careful chromatography was carried out; the ion exchange and 
alumina columns essentially became filtration processes where fractions were 
not collected. The isolated peracetyl DNJ and DMJ were identical with the 
authentic acetylated alkaloids. 
Unfortunately for NMR purposes, the peracetyl DNJ proved to be 
fluxional about the carbon/nitrogen amide bond, showing significant 
broadening in the 1H NMR spectrum at room temperature. This made 
assignment of the signals impossible, although by warming the compound to 
90'C in pyridine, the peaks in the spectrum coalesced so that the various 
proton positions could be identified. Peracetyl DMJ exhibited the same 
phenomenon, but this time the two rotamers about the carbon/nitrogen 
amide bond could be easily distinguished in the 1H NMR spectrum. Under 
the same conditions as above, the peaks in this spectrum also coalesced, 
although some proton resonances remained slightly broadened. 
There is a difference in the ease of deacetylation of peracetyl DNJ and 
DMJ. Treatment of peracetyl DMJ with concentrated methanolic ammonia 
removed all the 0-acetyl and N-acetyl groups, whereas only the 0-acetyl 
groups were removed from peracetyl DNJ under the same conditions. This 
contrasts to the observations of Inouye et al who claimed that all the acetyl 
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groups were removed by concentrated methanolic ammonia on the basis of 
IR evidence2. 
An attempt was made to remove the N-acetyl group in the peracetyl 
DNJ using Meerwein's salt, which had been reported69 to hydrolyse the N- 
acetyl group in preference to the 0-acetyl in peracetyl glucosamine, scheme 
2.04. However, only N-acetyl DNJ could be recovered from the reaction. 
Scheme 2.04. 
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The fully acetylated alkaloids and the N-acetyl DNJ were used to 
analyse the amount and position of various labels during biosynthetic 
studies. Occasionally, the DNJ/DMJ from S. subrutilus was analysed as a 
mixture directly after the alumina column without derivatisation, but this 
could only be carried out where labelled protons were not overlapped by 
other resonances. The assignment of proton and 13C peaks for different 
derivatives are given later in this chapter and in the experimental section. 
The recovery of DNJ (and DMJ where relevant) differed slightly 
between the two organisms studied. S. subrutilus was investigated first when 
the methods of isolation were being refined, and with practice it became 
routine to work with smaller quantities of alkaloid in larger volumes of 
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culture medium, as with B. subtilis. var niger. 
The recovery of peracetyl DNJ and DMJ from S. subrutilus and B. subtilis. 
S. subrutilus B. subtilis var niger 
Production (after 7 days) 
Recovery (peracetyl) 
30mg in 35OmL 
12mg (DNJ) 
12mg in55OmI. 
14mg 
Most of the labelling studies have been carried out using deuterium 
labelled precursors, although in certain cases, 13C enriched compounds were 
employed. Both these isotopes have the advantage that the position of the 
label can be detected by NMR spectroscopy, although for 2H NMR problems 
can arise if insufficient compound is used. The deuterium spectra were 
typically run in a 5mm tube in the lock channel of the spectrometer (i. e. the 
magnet was not locked). This limited the number of scans that could be taken, 
depending on the drift in the magnetic field. However, the lowest 
enrichment detected using 12mg of peracetyl DNJ was approximately 5 atom 
% D, and in virtually all cases, well resolved spectra were obtained. Usually, 
the 2H NMR experiments were run at 50'C or higher as this was found to 
sharpen the signals significantly. 2H has a quadrupole moment and 
intrinsically broadened peaks in the 2H NMR spectrum at room temperature. 
Enrichment of precursors with tritium was less attractive, despite the fact that 
much lower levels could be detected, because the DNJ or acetyl derivatives 
resisted crystallisation. Furthermore, since only a small quantity of alkaloid 
was recovered, any degradation to locate the site of labelling would probably 
have presented practical difficulties. 
In practice, some experiments using deuterium isotopes showed a high 
enough level of enrichment for the site of the label to be determined using 1H 
NMR. The reduced integral height of labelled positions enabled the 
percentage enrichment to be compared with that obtained from mass 
spectrometry. 
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Mass spectrometry. 
In conjunction with NMR studies, mass spectrometry not only 
revealed how much of a given isotope was present in the DNJ/DMJ, but also 
to a limited extent, where it was located. Spectra had been obtained for the 
free base for both DNJ and DMj70,5, but in this project the fully acetylated 
material was used. To minimise random errors, quantification of a particular 
isotope involved 5 scans of the isolated peracetyl alkaloid over two or three 
separate days. Natural abundance material was also analysed under identical 
conditions so that the contribution of natural abundance isotopes could be 
determined. Using ammonia chemical ionisation mass spectrometry,, 
peracetyl DNJ gave an (M + H)+ peak at m/z 374. After the contribution of the 
natural abundance isotopes to ((M + H)+l)+ had been subtracted, the 
percentage enrichment of a given isotope could be expressed as a percentage 
of the unlabelled material. Hence using the absolute intensity of each peak, 
the percentage enrichment was given by the following: 
MH+11+ (corrected) x 100% 
MH+11+ (corrected) + MHI+ 
Figure 2.02 shows part of the mass spectrum for natural abundance 
peracetyl DNJ and a synthetic derivative, 6,6-dideuteroperacetyl DNJ. The 
molecular ion in each case can be seen at m/z 374 and m/z 376 respectively 
(m/z 393 is (M + NH4)+). 
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Figure 2.02 
The partial mass spectrum for peracetyl DNJ and 6,6-dideuteroperacetyl DNJ. 
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100 374 
The fragmentation is dominated by the loss of acetic acid (Mr 60) and 
ketene (Mr 42), both of which are common fragments for acetylated sugar 
71,72 derivatives 
The ions arising from the fragmentation of peracetyl DNJ by Cl mass 
spectrometry. 
Fragment (m/z) Assignment 
374 MHI+ 
332 MHI+ - CH2CO 
314 MHI+ - CH3COOH 
272 m/z 314 - CH2CO or m/z 332-AcOH 
254 m/z 314 - CH3COOH 
240 m/z 314 - CH3CO- OCH3 
Comparing the two spectra it can be seen that nearly all the fragments 
for the synthetic dideuterated DNJ are two mass units higher than for the 
corresponding natural abundance sample. The only peak which was common 
to both was m/z 240, indicating that the deuterium had been lost. This was 
probably the loss of methyl acetate from m/z 314, whereby the isotopic label 
remained in the neutral fragment, scheme 2.05. 
Scheme 2.05 
AcO OAc + 
AcO 
OAc + 
H 
ol am + CH3CO- OCD2H 
N 
N CD20Ac Ac 
Ac 
(5) 
(It is likely that protonation of an ester carbonyl occurs first, followed by the 
loss of acetic acid to give a charged fragment such as (5) shown in scheme 2.05 
above). 
If the elimination occurred as in scheme 2.05, then peracetyl DNJ 
labelled at H4 with deuterium should also show peaks one mass unit higher 
than natural abundance material, although again m/z 240 should be found as 
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this label will be retained in methyl acetate. Experimentally, this was found to 
be the case. 
Figure 2.03 shows the complete mass spectrum for peracetyl DNJ 
labelled at H4 with deuterium. Inset is the partial spectrum for the same 
compound labelled at H1 (m/z 200-260) These samples were run using a 
tandem mass spectrometer under FAB conditions where it was possible to 
select m/z 375 preferentially over m/z 374 ( the derivatives were not 100 atom 
% D). All the fragments are one mass unit higher than the natural abundance 
material due to the retention of deuterium, including m/z 241 for H1 labelled 
peracetyl DNJ. The isotope at this position cannot be eliminated in methyl 
acetate, in contrast to when H4 is labelled. 
59 
Figure 2.03 
The tandem mass spectrum of peracetyl DNJ labefled at H4 with deuterium 
(FAB ionisation). 
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The lower mass fragments cannot be used as reliable evidence in this 
case because significant fragmentation of the parent molecule has taken place. 
By selecting m/z 375 in the spectrometer, the majority of the peak intensity is 
due to DNJ labelled with deuterium, but a proportion is also due to 13C 
isotopes in DNJ without deuterium. Unfortunately, this natural abundance 
13C is randomised throughout the molecule. At lower masses where several 
neutral fragments have been lost, there will inevitably be loss of natural 
abundance 13C and the appearance of ions normally seen in the natural 
abundance spectrum. 
The type of elimination shown in scheme 2.05 was not unexpected as 
the common fragments acetic acid and ketene both involve the same process 
of hydrogen migration, scheme 2.06. 
Scheme 2.06 
0 #, OR ao» ROH 
CH2CO 
AcO OAC 
+ OAc + 
H N CH HN CH20Ac Ac 20Ac Ac 
I 
m/z 314 m/z 254 
Isotope labelling studies. 
+ AcOH 
The first two labelling experiments used glucose labelled separately at 
H1 and H2 with deuterium. When the DNJ and DMJ were isolated from the 
fermentation medium it was found that the H6 protons were enriched, but to 
very different levels according to which labelled sugar was used. 
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Furthermore, it was apparent that when 1-[2H]-D-glucose was the carbon 
source, one of the prochiral protons was labelled exclusively, whereas with 2- 
[2H]-D-glucose the other one was enriched. Figure 2.04 summarises the 
percentage enrichment of the added glucoses and the isolated alkaloids. 
Figure 2.04 
The 2H enrichment found in peracetyl DNJ and DMJ after feeding 1-[2H]- 
glucose and 2-[2H]-glucose to S. subrutilus. 
Peracetyl DNJ Peracetyl DMJ 
1-[2H]-glucose (33 atom % D) 
2-[2H]-glucose (25 atom % D) 
21.7 ± 2.4 atom %D 
1 5.8 ± 0.3 atom %D1 
21.9 1.7 atom %D 
6.5 0.3 atom %D 
2H NMR of the fully acetylated DNJ and DMJ and comparable shifts in the 1H 
NMR spectrum (in brackets) are summarised below, figure 2.05. 
Figure 2.05. 
IH and 2H NMR chemical shift values for peracetyl DNJ and DMJ after 
feeding 1-[2H]-D-glucose and 2-[2H]-D-glucose to S. subrutilus. 
Peracetyl DNJ/ppm Peracetyl DMJ/ppm 
1-[2H]-D-glucose 
2-[2H]-D-glucose 
4.49(4.50), H6a 
4.61(4.63), H6b 
4.47(4-50), H6a 
4.79(4-81), H6b 
-j 
(All spectra were run in pyridine at 900C, referenced to the a proton of 
pyridine at 8 8.70ppm. Full spectroscopic assignments are given in the 
experimental section). 
The first conclusion was that glucose was a precursor to DNJ and DMJ 
in this fermentation. However,, it was perplexing that both labelled glucoses 
should lead to alkaloids labelled exclusively at H6 when they were originally 
attached to two different carbon atoms. The deuterium 
NMR gave one peak 
for each epimer in the two labelling experiments, showing that 
randomisation of the label did not occur. Further confirmatory evidence was 
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required, as the chemical shift difference between a methylene adjacent to 0- 
acetate (H6) and a methylene adjacent to N-acetate (H1) was not particularly 
large; for instance., CH3CH20. COR 8 3.83 ppm and CH3CH2NH COR 8 2.97 
PPM 73. The splitting pattern of both H1 and H6 protons might be similar - 
both would show a large geminal coupling as well as a much smaller vicinal 
coupling to either H5 (in the case of HO or H2 (in the case of H1 protons). If 
the alkaloids had been isolated as the free base then it would have been 
straightforward to assign which proton was enriched with deuterium. The 
presence of the acetyl group s changed the shape of the pyranose ring and it is 
possible that the close proximity of an acetyl group might effect the chemical 
shift of Hl and/or H6. 
Confirmatory evidence came from mass spectrometry. If deuterium 
was located at H6,, then the fragment due to the loss of methyl acetate, m/z 
240, should display an M+1/M isotope ratio equal to that found in the natural 
abundance sample. figure 2.06. 
Figure 2.06. 
The M+1/M ratio of three ions in the mass spectrum of peracetyl DNJ and 
DMJ after feeding 1-[2H]-glucose and 2-[2H]-glucose. 
m/z 374 m/z 314 m/z 240 
AcDNJ(ex. l-[2H]-glucose) 45.8 ± 2.8 42.1 ± 6.5 13.5 ±3.9 
AcDNJ(ex. 2- [2H] -glucose) 21.4 ± 3.8 19.0 15.4 2.9 
AcDNJ natural abundance 17.5 ± 2.0 16.8 ± 4.6 14.3 4.0 
Calculated 18.4 16.1 12.7 
(All values correspond to the M+1/M ratio of the particular ion in percent). 
The peracetyl DNJ isolated from both labelling experiments had a very 
similar M+1/M ratio for m/z 240 compared to that from the natural 
abundance sample, indicating that the label was located at H6. This was 
particularly noticeable for the l-[2H]-D-glucose experiment, where the M+I/M 
ratio was large in m/z 374 and m/z 314, but much smaller in m/z 240. Since 
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the two protons in question coupled to each other in the 1H NMR spectrum, 
their assignment from mass spectrometry after feeding 1-[2H]-D-glucose 
confirmed the more ambiguous data from 2-[2H]-D-glucose. 
Further experiments were undertaken with 1-[13C]-D-glucose where the 
movement of isotopic label was not expected, unlike the case with deuterium. 
Partial purification of the DNJ indicated that inversion of the glucose 
molecule had taken place and that C6 at 8 61-91ppm was enriched, figure 2.07. 
Figure 2.07. 
The 13C chemical shift values of DNJ after feeding 1-[13C]-D-glucose to S. 
subrutilus. 
Assignment cl C5 C6 C2 C3/4 C3/4 
Partially purified DNJ 49.23 61-20 61-91* 71.43 72.05 78.92 
DNJ ex. Sigma 1 49.07 61.02 61.72 71.22 71.86 78-81 
Since the proton positions in DNJ can be easily assigned and are documented 
in the literature, it was possible to assign the carbon NMR spectrum from 
heteronuclear COSY experiments. 
It was noticeable in both the 13C and 2H experiments that the 
enrichment of the original glucose added to the fermentation was higher 
than that isolated in the alkaloids. 1-[13C]-D-glucose had been added at a level 
of 50 atom % 13C, but the isolated DNJ contained 33 ±3 atom % 13C. It was 
later discovered that the reason for this was because DNJ and DMJ could be 
produced in trace amounts even if glucose was not present in the medium. 
Either another glucose source, such as starch, was present in the soyabean 
medium, or less likely, another non-carbohydrate precursor was being 
utilised. The amount of DNJ produced without added glucose represented 
one third of the total when glucose was present (0.02mg mL-1 compared to 
0.06mg mL-1). This agreed with the values of enrichment when 1-[13C]-D- 
glucose and 1-[2H]-D-glucose were used as carbon sources. 
Using these 
precursors, approximately two thirds of the 
initial enrichment was recovered 
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in the isolated alkaloids, whereas with 2-[2H]-D-glucose the level of 
enrichment was much lower than might have been expected (two thirds of 
25% = 16%). As the mechanism of biosynthesis became apparent, this could be 
explained. 
The glucose/fructose isomerisation. 
The inversion of the glucose molecule so that label introduced at C1 
finished at C6 suggested the first step in the biosynthesis was the 
isornerisation of glucose to fructose,, scheme 2.07. 
Scheme 2.07 
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The reaction is reversible and two enzymes are known to catalyse the 
process, namely glucose-6-phosphate isomerase74 and glucose isomerase75 - At 
this stage in our experiments no inference was made as to whether the 
glucose was phosphorylated or not. This isomerisation meant that 2H or 13C 
at C1 of glucose would result in C6 of DNJ being labelled if cyclisation 
occurred between C2 and C6. This immediately ruled out the first possibility 
of a C1/C5 cyclisation which has already been outlined in the introduction, 
whereby the stereochernistry of DNJ was inherently present in the glucose 
molecule. A C2/C6 cyclisation gives a carbon backbone which does not 
contain the complete stereochemistry of DNJ and two chiral centres need to 
be inverted. 
The mechanism of isomerisation catalysed by glucose-6-phosphate 
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isomerase has been studied in detai176 and involves abstraction of H2 by a 
basic site (B in scheme 2.07) within the enzyme to form a cis ene diol. The 
involvement of a trans ene diol was discarded from evaluation of the 
radioactivity present in glyoxylate after isomerisation experiments with 1- 
[3H]-D-glucose-6-phosphate77. More recently, deuterium NMR was used to 
evaluate the position of labelling in glycidyl acetate, which had been 
synthesised from glycerol following the glucose/ fructose isomerisation78. 
Collapse of the ene diol and replacement of the original abstracted 
proton in a "windscreen wiper" type mechanism leads to fructose. Deuterium 
introduced at C2 in glucose finishes at the pro-R position in the 
hydroxymethyl of fructose. Deuterium introduced at CI of glucose does not 
move during the isomerisation and finishes at the pro-S position in the 
hydroxymethyl of fructose, scheme 2.08. 
Scheme 2.08 
Stereochemistry of the glucose/fructose isomerisation 
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This mechanism satisfies why 2H at H1 and H2 of glucose finishes at 
H6 in both cases. The lower enrichment of label when using 242HI-D-glucose 
could arise from two possibilities. First, exchange of the deuterium from the 
abstracting base with solvent water, so that when the ene diol collapses, 
protium is replaced at C1 to give fructose. This has been shown to occur 
by 
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Rose et al, with glucose-6-phosphate isomerase and triose phosphate 
isomerase both catalysing the incorporation of tritium into the respective 
substrates from tritiated water. A second explanation is that a primary kinetic 
isotope effect operates and unlabelled glucose isomerises preferentially. In the 
current study, a fermentation with S. subrutilus carried out in deuterium 
oxide with unlabelled glucose showed that no isotope label was incorporated 
into the peracetyl DNJ or DMJ, so it seems likely that the isotope effect is 
operating. It is interesting to note at this stage that under equilibrium 
conditions, deuterium and tritium were incorporated from solvent using 
glucose-6-phosphate isomerase79,76, yet under the same conditions at pH 7.0, 
essentially no deuterium was incorporated into glucose using glucose 
isomerase75. This highlights the difference between the two enzymes. 
Different prochiral protons at H6 in DNJ and DMJ were labelled 
depending on which deutero-glucose was used in the fermentation. Without 
synthesising DNJ and DNU labelled at Pro-R and pro-S with deuterium, it is 
impossible to be absolutely certain which proton is which. However, an 
analogy can be drawn with glucose, in which the H6 protons have been 
labelled stereospecifically with deuteriUM80. It should be added that this 
treatment is not intended as a proof of the labelling. 
Figure 2.08 shows part of the 40ON4Hz 1H NMR spectrum of DNJ, N- 
acetyl DNJ and glucose respectively. The H6 protons can be clearly seen in the 
first two spectra as two double doublets coupling to each other. The same can 
be seen in the spectrum of glucose, but there is also the added complication of 
the minor anomer, which can just be discerned as two smaller double 
doublets between the main signals. 
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Figure 2.08 
The 1H NMR spectrum of N-acetyl DNJ, glucose and DNJ in the region of the 
H6 protons. 
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N-acetyl DNJ adopts a very similar chair conformation to glucose and 
DNJ as can be seen from the coupling constants of the ring protons. When 1- 
[2H]-D-glucose was used in the fermentation, the isolated N-acetyl DNJ was 
labelled at H6 which was at highest frequency (5 3.82 ppm). Conversely, using 
242HI-D-glucose, H6 at lowest frequency (8 3-68ppm) was labelled. 
The chemical shifts and coupling constants for, the three compounds 
are very similar, figure 2.09. 
Figure 2.09 
The 1H NMR chemical shift values and coupling constants for the H6 protons 
in glucose, N-acetyl DNJ and DNJ. 
Chemical shift Coupling constant(Hz) 
Glucose 3.60 _ 12.3,5.7 
3.78 12-3,2.2 
N-acetyl DNJ 3.68 12.4,5.6 
3.82 12.4,3-0 
DNJ 3.56 11-7,6.2 
I 7r, 
0.1, / 11.7,3.0 
In glucose the H6 proton at highest frequency has been shown to be the 
pro-S proton, whilst the lower frequency signal is the pro-R. If an analogy can 
be drawn between glucose and N-acetyl DNJ, the label from feeding 1-[2H]-D- 
glucose would be at the pro-S position whilst that from 2-[2H]-D-glucose, 
would be at the pro-R. This is in agreement with the glucose/ fructose 
isomerisation, since the migrating H2 proton is replaced in the pro-R position 
of the hydroxymethyl group of fructose, whilst H1 from the original glucose 
molecule, finishes up as pro-S. 
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Labelling at H5 and H6 of glucose 
If a C2/C6 cyclisation is taking place to produce DNJ, the 
stereochernistry at the original C2 and C5 of glucose needs to be altered. If 
fructose, or a phosphorylated derivative, is the first intermediate in the 
biosynthesis, then amination of the ketone would need to give the R 
configuration at this centre, figure 2.10 
Figure 2.10 
The stereochemical relationship between glucose, fructose, DNJ and DMJ. 
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Since DMJ was also produced in the fermentation and originated from 
fructose in the same way as DNJ, it was likely that the two alkaloids shared a 
common biosynthetic pathway. DMJ only needs to have one stereochernical 
centre altered, i. e. C2 of the original glucose. 
The transamination reaction already outlined (page 32) allows an 
amine function to be introduced either side of the prochiral ketone in 
fructose. The epimerisation at the original C5 of glucose was then thought to 
involve a process similar to that occurring at Cl/C2, scheme 2.09. 
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Oxidation of C5 of fructose leads either to a dicarbonyl hexose (6), or if 
the fructose is already aminated, to the keto amine (7). The oxidation of 
sugars with a D-erthyro configuration has been described in Chapter 1, and 
for instance, fructose is oxidised by Gluconobacter suboxydans to the 5-keto 
fructose (6)81. Although (6) was symmetrical and labelling experiments 
indicated at this stage that no randomisation of enriched isotope occurred, it 
was still possible that (6) was bound to the active site of the enzyme, thereby 
removing the symmetry of the molecule. This would prevent the molecule 
from dissociating, rotating through 180'C and then rebinding the opposite 
way round so that any introduced label finished at C1 and C6. Other 
possibilities existed to remove the symmetry of the intermediate, such as the 
presence of a phosphate at C6. 
The order of amination and oxidation was not certain, but it was 
hypothesised that after oxidation at C5, an ene diol species could then form. 
This might be a cis or trans isomer depending on which prochiral methylene 
proton of C6 was removed, but on collapse of the ene diol intermediate, a 
proton could be replaced on the re or si face of C5 producing the desired 
epimerisation at this centre. The system was analogous to glucose and 
mannose isomerase. Following isomerisation, MJ and NJ (shown here in 
their acylic form) would dehydrate and be reduced to the corresponding 1- 
deoxy derivative. 
At this stage, the amination of C6 of fructose instead of C2 could not be 
discounted. So long as the stereochemistry at C2 (of the original fructose) was 
in the R configuration after dehydration and reduction, an amine group at C6 
could lead to the 1-deoxy compound directly. Compare the structure of the 
cyclised keto amine to that of the pyranose form of fructose, scheme 2.10. 
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Scheme 2.10 
Arnination of fructose at C6 to produce DMJ directly. 
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To test the hypothesis in scheme 2.09, glucose with both H6 protons 
labelled with deuterium was used in a fermentation. Deuterium was expected 
at H1 (the non-migrating proton) and also at H2 (the migrating proton) in 
DNJ. The fermentation in deuterium oxide had shown that deuterium was 
not incorporated into any part of the DNJ/DMJ molecule, so it was expected 
that transfer of label would occur rather than exchange with the solvent. 
The results indicated that both DNJ and DMJ only had one deuterium 
label located at M(equatorial) in both cases. No evidence of even slight 
enrichment by dideuterated material could be detected by mass spectrometry. 
Figure 2.11 summarises the mass spectrometric data for the two alkaloids. 
Fia-ure 2.11 
Peracetyl DNJ Peracetyl DMJ 
6,6-[2H]-D-glucose 43% (monodeuterated) 41 % (monodeuterated) 
70 atom %D per H61 I I 
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Each C6 methylene proton in the glucose was enriched to 70 atom %D and 
the isolated alkaloids contained deuterium to 42 atom %D This suggested 
that the removal of one of the deuterium atoms was probably not influenced 
by a substantial kinetic isotope effect, unlike that found for 2- [2H] -D- glucose. 
Dilution of 70 atom %D by one third would lead to the values of enrichment 
found in the DNJ/DMJ. 
Figure 2.12 shows the deuterium NMR spectra for a mixture of DNJ 
and DMJ, illustrating how temperature can effect the resolution obtained. The 
partial 1H NMR spectrum has been included for reference and to illustrate the 
assignment of the Hl protons for each compound. 
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Figure 2.12 
The 2H NMR spectra for a mixture of DNJ and DMJ isolated from S. 
subrutilus after adding 6,6-[2H2]-D-glucose. 
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From the 400 MHz NMR spectrum of DNJ in the region of Hl, it was 
possible to distinguish Hl(equatorial) and Hl(axial). Hl(axiai) shows two large 
axial coupling constants and appears as a large double doublet (almost a 
triplet) at 5 2.38 ppm, whilst M(equatorial) shows a large axial coupling along 
with a much smaller equatorial one. This proton appears as a double doublet 
with coupling constants of 12.3 and 5.1 Hz. 
The assignment for DMJ was not so simple, since both Hi protons 
would be expected to show a large and then a small coupling to H1 and H2 
respectively, figure 2.13. 
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From the Karplus curve82, the angle between both HI protons and H2 
in DMJ is only 60', giving coupling constants of approximately 2.4 Hz. To 
distinguish between equatorial and axial protons, n-O-e studies were 
undertaken. Irradiation of the signal due to one proton at C1 (8 2.65ppm) 
caused enhancements to the signals at 5 3.92 (7.9%, H2) and 5 3.50 (5.3%, H3), 
while irradiation of the signal due to the other proton at C1 (8 2.90ppm) 
caused enhancement of the signal due to H2 only (7.7%). Computer assisted 
molecular modelling of DMJ in its energy minimised conformation, gave the 
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approximate distances H3-Hl(eq. ) as 3-8Aand H3-Hl(ax. ) as 2-7A, suggesting 
that the proton at lower frequency (5 2.65 ppm) was the axial one. The IH 
NMR spectrum of the hydrochloride salt of DMJ has been fully assigned in 
the literature70 and this places the axial proton at lower frequency to the 
equatorial one as well. Protonation of the amine should not in theory alter 
the relative positions of Hl(eq. ) and Hl(ax. ), although it does increase their 
chemical shift value compared to the free base. 
The evidence so far suggested that oxidation did not occur at C5, but at 
C6 and that a possible method of epimerisation at C5 might still involve a 
similar mechanism to the fructose/ glucose isomerisation, scheme 2.12. 
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Enolisation of the aldehyde could occur, but instead of isomerising to the 5- 
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keto derivative,, the aldehyde reforms with the proton replaced to give the 
epimer at C5. An enzyme might be responsible for replacing the proton at this 
position, or the mechanism was possibly non-enzymatic. 
To test the hypothesis in scheme 2.11., 5-[2H]-D-glucose was used as a 
carbon source and the results are outlined below. 
Figure 2.14 
Enrichment of 2H in peracetyl DNJ and DMJ after feeding 542HI-D-glucose. 
Peracetyl DMJ I Peracetyl DNJ 
1542HI-D-glucose (75 atom% D) 122.7 ± 1.7% DI none I 
The 2H NMR spectrum indicated that DMJ was labelled at H2 whilst DNJ was 
not enriched in deuterium at all. If the epimerisation was proceeding as in 
scheme 2.11, deuterium would be expected at H2 in DNJ as well. It could be 
argued that the first precursor formed in scheme 2.11 had the correct 
stereochernistry for DMJ. The DMJ formed in the fermentation would result 
from the precursor remaining untouched by an epimerising enzyme. DNJ 
would have to originate from an epimerisation at this centre and a kinetic 
isotope effect would select for the natural abundance intermediate over the 
enriched one. This would explain the loss of deuterium in DNJ if the kinetic 
isotope effect was large enough to discriminate completely between labelled 
from unlabelled material. However, given the high enrichment of the 
glucose at the start of the fermentation, it is very unlikely that no deuterium 
would be found in the DNJ if the mechanism in scheme 2.11 was operating. 
It was more plausible that the epimerisation occurred by a direct 
oxidation at C5 followed by reduction as in the biosynthesis of mycosamine 
and perosamine50, (page 33). 
Two possibilities existed (scheme 2.12). Oxidation at the C2 position of 
Mj (route 0 or DMJ (route ii) would produce a keto intermediate (in the case 
of Mj this may or may not be cyclic). 
Reduction of this derivative by NADH 
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would give the NJ or DNJ alkaloid respectively. The deuterium would be 
retained in the Mj and DMJ if the rate at which the equilibrium between the 
two epimers was established was not fast. If the two diastereoisomers inter- 
converted rapidly in either route i or route ii, the deuterium would probably 
be lost. 
Scheme 2.12 
CH20H 
H2N 
HO- 
- OH 
D--OH 
CH20H 
oxidatiw 
CH20H 
H2N- 
HO- 
OH 
D- OH 
CHO 
OH 
HO 
D,. 
, %OH 
IOSS Of 2H 
route i 
HO N CH20H 
H 
mannonojirimycin 
dehydration 
HO 
D, 
OH 
%OH 
N CH20H 
reduction 
I 
OH 
HQ 
H, 
, %OH 
HO N CH20H 
H 
nojirimycin 
IOSS Of 2H 
DNU 
route 
80 
OH 
%OH 
HO N CH20H 
H 
A 
oxidation reduction 
ehydration 
reduction 
DNJ 
From the studies undertaken with 6,6-[2H2]-D-glucose, the reduction of the 
unsaturated ring to produce label at M(equatorial) in DNJ and DMJ must occur 
from the underside ((x face) in both cases. A common intermediate for this 
reduction would seem sensible to give the same labelling pattern. On this 
basis, route ii was attractive because the intermediate (8) was the precursor to 
both DNJ and DMJ, scheme 2.13. 
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In route i this reduction step would need to be carried out on two 
different diastereoisomers. 
It had been reported83 thatDNJ could be epimerised to DMJ by a strain 
of the Agrobacterium sp . After 24h incubation with the microorganism, DNJ 
was nearly completely converted to DMJ. It was thought that this reaction 
occurred by oxidation to a cyclic 2-keto compound followed by reduction to 
give the epimeric derivative. A similar process had been observed with 1- 
deoxy-D-glucose 83, which could be epimerised in the same way to give 1- 
deoxy-D-mannose. 
The problem with route ii (epimerisation at the 1-deoxy level) was that 
it was difficult to see how nojirimycin could be produced. NJ was present in 
the fermentation , but its 
involvement in the biosynthesis of DNJ had yet to 
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be proved. 
The presence of mannojirimycin was suggested at this time from 
qualitative evidence using the mannosidase assay. At the end of the 
fermentation period, the level of NJ was estimated by the trehalase assay, and 
it was shown to be present at a concentration of 0-05mg mL-1. This agreed well 
with previous time course studies. The effect of MJ on trehalase was not 
known, although DMJ had shown no inhibition of the enzyme at 
concentrations up to twenty times that present in the fermentation. 
Nonetheless, the decrease in inhibition of trehalase following heat/acid 
treatment was attributed entirely to the presence of NJ, even though it was 
possible that MJ might be partly responsible. The value of 0.05mg mL-1 was a 
maximum value for the NJ concentration. 
The effect of NJ on jack bean cc-D-mannosidase was assessed next. 
Using a standard concentration twice that of the maximum present in the 
fermentation, the extent of the inhibition of the mannosidase was 31/2 times 
less than had been observed previously in the culture medium. The level of 
NJ was not sufficient to account for the observed decrease in inhibition of the 
mannosidase following heat treatment of the fermentation sample. Since the 
experiments concentrated on the difference in inhibition before and after 
heat/acid treatment, the DNJ and DMJ present would not effect these 
conclusions. Although Mj has not been isolated from S. subrutilus, it has 
been found in S. lavendulae, a closely related specieS84,85 
At the time these studies were carried out, a gas chromatography assay 
also indicated that DMJ was produced before any DNJ. Forty eight hours after 
inoculating a fermentation, DMJ was easily detected in the culture broth (not 
quantified), whereas only a trace of DNJ was present. This agreed with the 
time course studies of DNJ production. After a further 26h, the same 
fermentation contained 21/2 times the amount of DNJ as DMJ, a value that 
was consistently found in all the fermentations and which remained after the 
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full time course had been completed. This did not prove that DNJ was formed 
from DMJ, since if Mj was the common intermediate, dehydration and 
reduction need only occur to produce DMJ. With DNJ, an additional 
epimerisation step needed, to be included and this possibly slowed the 
production of this alkaloid. 
The investigations so far had not proved whether NJ was a precursor 
to DNJ or not. The addition of aliquots of unlabelled NJ to the fermentation 
at different time intervals was carried out to investigate whether the yield of 
DNJ increased. Using the trehalase assay, no significant change in the yield of 
DNJ was noted. NJ was present at a higher concentration than DNJ until the 
end of the fermentation, and it was possible that only a proportion of the NJ 
was finally converted to the DNJ. The latter,, for instance, might inhibit the 
enzyme responsible for its manufacture from NJ. Labelled NJ needed to be 
introduced into the fermentation to see if it was incorporated into DNJ. The 
reported instability of NJ meant that initial studies concentrated on labelling 
with a tritium isotope at H6. This was in a position which was away from any 
possible dehydration and reduction processes and the tritium could still be 
detected even if the incorporation of NJ into DNJ was low. 
Problems arose with this approach as it was found that if [3H] labelled 
NJ was added to a fermentation just before sterilisation and purification, the 
isolated DNJ contained radioactivity. Impurities from nojirimycin 
decomposition appeared to be contaminating the DNJ, despite various 
attempts to purify or remove them. 
NJ was then synthesised with two deuterium labels at H6 and when 
this was added to the fermentation after 70h and 119h, the DNJ and DMJ 
showed the following enrichment, figure 2.15. 
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Figure 2.15 
The 2H enrichment in peracetyl DNJ and DMJ after feeding 6.6-[2H]- 
nojirimycin to S. subrutilus. 
Peracetyl DNJ Peracetyl DMJ 
NJ (99 atom %D per H6) 
(29mg added overall) 
10.9 ± 2.9 % 
(dideuterated) 
4.4 ± 2.0 % 
(dideuterated) 
Figure 2.16 shows the 2H NMR spectrum of the peracetyl DNJ and DNff - 
In each case, the natural abundance 2H of the pyridine solvent can be seen 
between 8 7.00-9.00 ppm in addition to the H6 2H resonance of the alkaloid. 
RA 
%l-X 
Figure 2.16 
The 2H NMR spectrum of peracetyl DNJ and DMJ after adding 6,6-[2H2]- 
nojirýycin to S. subrutilus. 
85 
Pr" 
rpm 
From the mass spectrometric data., only a small fraction of the DNJ and 
DMJ was enriched with deuterium considering that the maximum 
concentration of NJ in the fermentation at any stage was under 0.07mg mL-1 
(600mL fermentation = 42mg). For the amount added, if all the labelled NJ 
aad been incorporated, the total enrichment of DNJ and DMJ combined 
would be nearer 40%. Our 1H NMR studies on the stability of NJ had shown 
that the compound was stable at pD 7.0 for at least 1 week, but this was not 
representative of the fermentation conditions. 
The fact that the 2H label was also found in the DMJ shows the 
epimerisation reaction in operation. The level of enrichment in the DNJ was 
nearly 21/2 times that of the DMJ, which was the same ratio in which the two 
alkaloids were found in S. subrutilus cultures. The addition of deuterated NJ 
presumably upsets the equilibrium between NJ and MJ (or DNJ and DMJ if 
the NJ was converted to the deoxy derivative first). The restoration of this 
equilibrium was then reflected in the percentage enrichment of the two 
alkaloids. 
The confirmation that NJ was a precursor to DNJ eliminated 
amination at C6 of fructose as this mechanism did not produce NJ as an 
intermediate, scheme 2.14. 
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Scheme 2.14 
The formation of DNJ and DMJ by amination at C6 of fructose. 
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Confirmation of epimerisation. 
The timing of the epimerisation of the two alkaloids was still 
uncertain. NJ had been shown to be a precursor for DMJ, but this could be via 
Mj or DNJ (route i or route ii in scheme 2.12). DNJ labelled at H6 was fed to 
the fermentation after 96h and after a further 67h, the DNJ and DMJ were 
isolated. The results are summarised below, figure 2.17. 
Figure 2.17. 
The 2H enrichment in peracetyl DNJ and DMJ after feeding 6,6-[2H2]-l- 
deoxynojirimycin to S. subrutilus. 
Peracetyl DNJ Peracetyl DMJ 
DNJ(99 atom %D per HO 15.9 ± 1.3 %D1.6 ± 0.7 %D 
10mýy, added overall (dideuterated) (dideuterated) 
These results indicated that little or no epimerisation occurred at the 1- 
deoxy level (route ii was excluded). Although DMJ would be converted into 
DNJ in route ii, the epimerisation was an equilibrium process since labelled 
NJ was a precursor to DMJ. From this, the addition of labelled DNJ would 
shift the equilibrium to DMJ and label should be found in this alkaloid if 
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route ii was in operation. 
The experiment with labelled NJ had only shown a small enrichment 
(4.5%) of DMJ with deuterium, but the relative values between the DNJ and 
DMJ were important. With introduced labelled DNJ, there was a large 
difference in the enrichment of the two alkaloids when compared to the 
labelled NJ studies. Epimerisation at the DNJ level cannot be completely 
excluded as there was some evidence for slight enrichment of deuterium in 
DMJ, but this was certainly not the major route. 
The use of dideuterated precursors was an advantage in this study as 
the M+2/M ratio of the molecular ion of peracetyl DNJ/DMJ was only 3.4% 
0.7% (calculated = 3.3%). 
Assume that peracetyl DNJ or DMJ has 5% enrichment of the mono or 
dideuterated substrate and the intensity of the natural abundance molecular 
ion was 95 units: 
a. If 5% monodeuterated, the intensity of M+1 will be (0.18 x 95) + 5. 
- b. If 
5% dideuterated, the intensity of M+2 will be (0.034 x 95) + 5. 
For natural abundance peracetyl DNJ, M+1 /M = 18% and M+2 /M = 3.4% 
In case a, the enrichment only represents 22% of the total abundance at that 
mass, whereas in case b, the enrichment is nearly 61% of the M+2 abundance. 
It should be easier to detect the isotopic label in case b to case a. 
The addition of labelled DNJ to the fermentation also allowed an 
estimate of the native DNJ concentration to be made by the isotope dilution 
method. Since 10mg of dideuterated DNJ was added to the fermentation,, the 
observed enrichment of 16% in the isolated alkaloid indicated that 62mg of 
DNJ was present at the end. Gas chromatography analysis of the fermentation 
after the first purification step (cation exchange chromatography) showed that 
52mg of DNJ was present. This did not take into account that, a) some labelled 
DNJ was perhaps epimerised to DMJ, or metabolised in some other way, or b) 
that some DNJ was lost during the first purification step. In retrospect,, it was a 
88 
mistake not to analyse the fermentation directly by GC as this would have 
perhaps confirmed the slight enrichment found in the DMJ. 
A summary of the proposed biosynthesis is as follows, scheme 2.15. 
This was analogous to Fleet's synthesis of DNJ and DMJ, involving C2/C6 
cyclisation and nitrogen introduced at C2 with inversion of configuration 
(page 23) 
89 
Scheme 2.15 
The proposed biosynthesis of MJ, NJ, DNJ and DMJ in S. subrutilus. 
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Other experiments. 
3- [2H] -D- glucose was also fed to S. subrutilus to confirm the dilution of 
isotope label to two thirds of that originally introduced. In the proposed 
biosynthetic pathway, deuterium at C3 was not involved in any step and like 
1-[2H]-D-glucose and 1-[13C]-D-glucose, it should be retained throughout 
DNJ/DMJ production, figure 2.18. 
Figure 2.18 
he I T 2H enrichment in peracetyl DNJ after feeding 3-[2H]-D-glucose to S. 
subrutilus. 
Peracetyl DNJ 
13-[2H]-D-glucose (35 atom % D) 123.6 ± 2.6 atom% DI 
2H NMR confirmed that the H4 position of peracetyl DNJ was labelled, as 
would be expected from the proposed inversion of the glucose molecule. The 
enrichment found was consistent with previous results in that 67% 
of the introduced isotope was retained in the final product. 
The biosynthesis of DNJ and DMJ in B. subtilis var niger. 
The biosynthesis of DNJ in this organism aroused interest for a 
number of reasons. It was perplexing that NJ could not be detected at any stage 
during the fermentation using the trehalase assay (page 47), and yet in S. 
subrutilus it had been shown to be a precursor to DNJ. Other Streptomycetes 
produced NJ, although not necessarily at the same time as S. subrutilus The 
following graph shows the relationship between DNJ and NJ in S. lavendulae 
56, figure 2.19. 
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Figure 2.19 
The production of NJ and DNJ in S. lavendulae 56 
6o- 
50- 
1 
4o- 
30 - 
20- 
10- 
0 
0 100 
time/h 
30 
20 
E 
NJ mg1mL 
E 
-3 
DNJ mg1ml 
z 
lo 0 
-f- 0 
200 
Unlike S. subrutilus , the production of NJ starts before that of DNJ and 
than rises to a maximum after about 100h. By the end of the fermentation, NJ 
can no longer be detected in the medium, presumably because it has all been 
converted to the 1-deoxy derivative. A pathway to DNJ without using NJ as a 
precursor has already been highlighted upon (page 73) if amination occurs at 
C6 of fructose. 
Two other peculiarities existed which in themselves did not discount 
the biosynthesis as described for S. subrutilus.. DMJ was not produced in the 
medium at any stage and it was apparent that another inhibitor of trehalase 
was being produced other than DNJ (page 44 and 47). This was also recognised 
for the mannosidase assay as well. Using jack bean (x-D-mannosidase, it was 
discovered that very high levels of inhibition occurred prior to heat 
treatment, but this decreased by a minimum of one third following heat/acid 
treatment, figure 2.20. The level of DNJ throughout the 7 day fermentation 
period did not increase above 0.02mg mL-1 which was insufficient to account 
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for the post heat/acid stage. DNJ only starts to inhibit this mannosidase at a 
concentration of 0.06mg mL-1 (3% inhibition). Again this suggested that an 
unidentified inhibitor(s) was(were) present making enzyme assays unreliable. 
Figure 2.20 
Inhibition of jack bean a-D-mannosidase by the filtrate from a B. subtilis 
fermentation before and after heat/acid treatment. 
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These results indicated that Mj was present,, but it was difficult to 
reconcile the existence of this alkaloid with the production of DNJ. Without 
DMJ or NJ, how might MJ be processed into DNJ using the proposed S- 
subrutilus biosynthetic route? Route i and route ii in scheme 2.12 both went 
via these intermediates. Clearly, either another biosynthetic scheme (or a 
variation of the S. subrutilus pathway) was in operation, or else the level of 
the intermediates was misleading. 
1-[13C]-D-glucose studies. 
The results of feeding 1-[13C]-D-glucose to B. subtilis are summarised 
below, figure 2.21. 
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Figure 2.21 
The 13C enrichment in peracetyl DNJ after feeding 1-[13C]-D-glucose to B. 
subtilis var niger. 
Peracetyl DNJ 
I l-[13C]-D-glucose (16 atom % 13C) 116.2 ± 1.2 atom % 13C I 
The 13C NMR indicated that C6 was labelled (as previously), but also there 
was slight enrichment at C1 (approximately a 3: 1 ratio between the two), 
figure 2.22. This was further confirmed by the mass spectrum in which m/z 
240 showed isotopic enrichment of its M+l ion (6.3 %±3.3%). 
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Figure 2.22 
The 13C NMR spectrum of natural abundance 13C N-acetyl DNJ from S. 
subrutilus and that isolated from a fermentation using 1-[13C]-D-glucose with 
B. subtilis var niger. Authentic N-acetyl DNJ is presented as a comparison. 
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In this instance, the enrichment of the glucose was reflected in the 
enrichment of the isolated peracetyl DNJ. Contrast this with S. subrutilus 
where a two thirds dilution occurred. In this case, DNJ was not coming from 
an alternative source, although a fermentation without glucose was not tried. 
This result suggested that a different biosynthetic mechanism was 
operating. Since 13C label was present at both ends of the molecule, a 
symmetrical intermediate was a likely candidate. The labelling was not 
equally distributed between the two atoms., but this could be due to a limited 
dissociation from the active site of the enzyme. A route whereby some 
molecules underwent a C2/C6 cyclisation (to give the 13C label at CO, whilst 
others underwent a C1/C5 cyclisation (13C at Cl) was unattractive. Essentially 
two sets of enzymes would need to be involved to process the various 
intermediates. As the majority of labelling finished at C6, an inversion of the 
glucose molecule was still taking place. This led back to 5-keto fructose, first 
postulated for S. subrutilus. This had the required symmetry and also the 
molecule contained a 2-keto function which could be involved in 
epimerisation to the DNJ stereochemistry. 
Before any labelling studies were undertaken, gas chromatography was 
used to see if any 5-keto fructose (5KF) could be detected in the fermentation. 
In this investigation, no silylated 5KF could be found over a7 day period, 
although the analysis was made difficult by the fact that the silylated 
compound existed in at least four different forms by GC. The silylation was 
carried out in pyridine and the 13C NMR spectrum in this solvent showed 
evidence for more than one species, including the acyclic form from a 13C 
resonance at 206ppm. Previous studies on the hexose sugar in deuterium 
oxide indicated that the pyranose form was present predominantly86. 
Further experiments in which glucose and 5KF were added part way 
through a fermentation did not show any increase in the production of DNJ, 
in either case, when compared to a control. 
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To determine whether a symmetrical intermediate was involved, 6,6- 
[2H21-D-glucose was used as a carbon source The following results were 
obtained, figure 2.23. 
Figure 2.23 
The 2H enrichment found in peracetyl DNJ after adding 6,6-[2H2]-D-glucose to 
B. subtilis var niger. 
Peracetyl DNJ 
6,6-[2H2]-D-glucose 48.4 ± 0.9 atom %D 
(90 atom% D per H6) (mono de uterated) 
The 2H NMR and IH NMR integrals indicated that Hl(eq. ) only was labelled 
in the recovered DNJ. This labelling pattern was identical to that for S. 
subrutilus , except that a lower enrichment of the isotope was found in B. 
subtilis These results ruled out a 5KF symmetrical intermediate, since if 
oxidation at C5 occurred first, deuterium should be found at C1 and C6, 
analogous to the 13 C experiment, scheme 2.16. 
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If oxidation at C6 (scheme 2.17) was the initial step, again deuterium 
should be found at both ends of the DNJ. A kinetic isotope effect would 
favour protio glucose at this stage, which was before the molecule became 
symmetrical. The 13C studies had also shown that only one quarter of the 
label introduced had swapped to the other end of the molecule, so these 
effects might successively dilute any label at H6 in the DNJ. However, the 
alkaloid was enriched by 50% in deuterium upon isolation and so any 
randomisation as observed by the 13C experiment would be easily detectable. 
Scheme 2.17. 
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As the 1-[13C]-D-glucose and 6,6-[2H2]-D-glucose experiments 
contradicted each other in the results they gave., it was decided to work from 
the other end of the biosynthetic pathway. A fermentation was set up in 
which unlabelled NJ was added 58h after inoculation with the 
microorganism. After 6 days, GC assay indicated three times as much DNJ was 
present compared to the normal culture medium (0.06mg mL-1 compared to 
0.02mg mL-1). S. subrutilus had shown no such increase in an identical 
investigation. Labelled NJ was added in a further experiment at the same 
time and gave the following results, figure 2.24. 
Figure 2.24 
The 2H enrichment in peracetyl DNJ after feeding 6,6-[2H2]-nojirimycin to B. 
subtilis var niger. 
Peracetyl DNJ 
6,6-[2H2]-nojirimycin 9.8 ± 1.8 atom %D 
(2.5mg 99 atom %D per H atom) (dideuterated) 
The deuterium NMR spectrum of the isolated DNJ showed that both H6 
protons were labelled as expected. 
This result indicated that NJ was being produced and then siphoned off 
to DNJ so that its concentration remained low. In the natural abundance NJ 
experiment with B. subtilis , less alkaloid was added than that for the 
analogous S. subrutilus fermentation, yet the former showed a definite 
increase in DNJ production whilst the latter did not. If all the labelled NJ, as 
above, had been incorporated into DNJ, the expected enrichment would have 
been approximately 18% (based on 12mg of alkaloid per 600mL). The 
experimental result was lower than this, but there may be other fates for this 
intermediate. 
The evidence so far pointed to a similar mechanism to that of S. 
subrutilus. Inversion of the glucose molecule was taking place to give 
ultimately mannojirimycin. This did not undergo dehydration and reduction 
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to give DMJ as had previously been the case, but the epimerisation step to NJ 
was presumably the same. The latter underwent dehydration and reduction 
to finally produce DNJ. The one anomaly at this stage was the 1-[13C]-D- 
glucose result, where enrichment at C1 was seen. The "top" and "bottom" 
part of the glucose molecule appeared to behave differently, and this lead to 
the hypothesis that glucose split into two C3 fragments within the 
biosynthetic pathway. 
The aldolase-catalysed reaction, whereby fructose- 1,6-diphosphate is 
split into dihydroxyacetone and glyceraldehyde-3-phosphate, has been 
extensively studied as it is fundamental to energy production via 
glyColySiS87,88. The two C3 fragments can inter-convert, a reaction catalysed by 
triose phosphate isomerase, scheme 2.18. 
Scheme 2.18 
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At equilibrium, 96% of the triose phosphate is dihydroxyacetone 
phosphate87, but the reaction proceeds to glyceraldehyde-3-phosphate because 
the latter is efficiently removed to continue in glycolysis. The formation of 
glyceraldehyde-3-phosphate leads to its immediate removal as it is processed 
into other C3 metabolites, whereas the dihydroxya ce tone essentially acts as a 
reserve for more glyceraldehyde-3-phosphate. 
When the 13C label is at C1 of glucose, this will become C1 of 
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d ihydr oxyace tone phosphate and consequently C3 of glyceraldehyde-3- 
phosphate. The latter will mostly continue into other C3 metabolites, but 
since the aldol reaction is reversible, it is possible that 13C label will find its 
way into C6 of fructose-1,6-diphosphate. During the biosynthesis, if the 
"normal" C2/C6 cyclisation occurs from this intermediate to give DNJ, 13C 
enrichment of C1 and C6 will be found. If the fructose derivative remains 
intact, label will be found at C6 only. 
A number of assumptions are made here which need to be qualified. If 
dihydroxya ce tone was produced then it is possible to find enrichment at four 
carbon atoms, Cl, C3, C4 and C6 of fructose, scheme 2.19. 
Scheme 2.19 
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It is likely that the phosphorylated form is utilised to remove the symmetry 
of the dihydroxya ce tone and this is the usual substrate in glycolysis in any 
case. 
In the experiment with 6,6-[2H2]-D-glucose, it might be expected that 
glyceraldehyde-3-phosphate labelled at C3 with deuterium would be 
produced. From the isomerisation to dihydroxyace tone phosphate, it is 
plausible that the aldol equilibrium would lead to deuterium at C1 of 
fructose- 1 . 6-diphosphate, eventually 
leading to the H6 protons of DNJ being 
labelled. DNJ isolated from this experiment did not show any deuterium at 
H6 which would arise from such a process. The reason was probably because 
the label from 1-[13C]-D-glucose and 6,642H21-D-glucose lay in two different 
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intermediates following the aldol cleavage, and these suffered completely 
different fates. Although the triose phosphate equilibrium is mainly on the 
side of dihydroxyace tone phosphate, the reaction is very fast and significant 
randomisation of the label from dihydroxyace tone phosphate to 
glyceraldehyde-3-phosphate can occur. The same randomisation process 
occurs for glyceraldehyde-3-phosphate, but as it is present in very much 
smaller quantities, this isotope randomisation does not express itself to any 
significant extent in the dihydroxyacetone phosphate. Also, the main 
direction of the aldol cleavage is not to produce a C6 hexose, but the C3 trioses 
and it is very likely that randomisation of C6 deuterium cannot be detected. 
Presumably as the initial growth phase of the microorganism slowed and 
intermediates from glycolysis increased, the reverse of the aldol cleavage to 
produce fructose-1,6-diphosphate was encouraged. 
To investigate whether this fragmentation of fructose-1,6-diphosphate 
followed by isomerisation and then recombination of the C3 trioses occurred 
in DNJ biosynthesis, glyceraldehyde labelled at C1 with 13C was used. This was 
fed to B. subtilis in one portion 24h after inoculation with the 
microorganism. The 13C NMR spectrum indicated that C3 or C4 of the DNJ 
was enriched, but only to a slight extent over the natural abundance sample, 
f igure 2.25. 
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Figure 2.25. 
The 13C NMR spectrum for N-acetyl DNJ isolated from B. subtilis after 
adding 1-[13C]-DL-glyceraldehyde. 
-j- 
so so 
70 60 50 40 30 20 "M 
N-acetyl DNJ after feeding 1413CI-D, Ljoyceraldehyde to B. subtilis 
PPM 
natural abund a 13C N-acetyl DNJ 
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Mass spectrometry suggested slightly more enrichment than was 
evident from the 13C NMR spectrum, figure 2.26. 
Figure 2.26. 
The 13C enrichment of peracetyl DNJ after feeding 1-[13C]-D, L-glyceraldehyde 
to B. subtilis var niger. 
Peracetyl DNJ 
1-[13C]-D., L-glyceraldehyde (50 atom % 13C) 6.4 ± 0.7 atom % 13C 
(1.2g per 750 mL of soyabean medium) I I 
Assignment of 13C NMR peaks was by 1H/13C COSY spectroscopy, 
although it was not possible to differentiate between C3 and C4 since the H3 
and H4 protons overlapped significantly in the IH NMR spectrum. By 
analogy with glucose, where the C3 carbon appears at higher frequency 
(76.48(p), 73.26(a) ppm) to the C4 (70.20,70-16 ppm),, the C3 of N-acetyl DNJ 
would appear to be labelled (77.80 compared to 69.97ppm). These results are 
consistent with the aldol reaction with dihydroxyacetone phosphate to 
produce fructose- 1,6-diphosphate enriched at C4 with 13C. The proposed 
inversion via C2/C6 cyclisation of this intermediate produces DNJ labelled at 
C3, scheme 2.20. 
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Other studies with B. subtilis had found that DNJ was produced on C3 
carbon sources such as glycerol, but at approximately 1/50th of the 
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concentration when C6 sugars were used, such as fructose, glucose and 
sorbitO157. In hindsight, it would have been better to use a glucose labelled in 
two positions (e. g. C1 and C6) and to measure the ratio of the two labels in 
the glucose and in the isolated DNJ. There is always the danger in adding an 
intermediate such as glyceraldehyde that the equilibrium of a particular 
reaction is disturbed. The excess of glyceraldehyde may have pushed the 
reaction towards fructose- 1,6-diphosphate thereby producing a false result. 
The high dilution of label from that introduced confirmed that this was not a 
major part of the biosynthetic route. 
Similar labelling patterns have been observed in the biosynthesis of 
various 6-deoxy hexose sugarS89,90,91. The antibiotic hygromycin A, produced 
by S. hygroscopicus, contains the deoxy sugar, 5-keto-6-deoxy-D-arabohexose. 
Biosynthetic studies have shown that the carbon backbone of this molecule 
originates from glucose. figure 2.27. 
Figure 2.27 
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Labelling experiments with 1-[14C]-D-glucose showed that 87% of the 
total radioactivity was located at C1 in the isolated hexose, whilst the 
remaining 13% was at C6. With 6-[14C]-D-glucose, 95% of the radioactivity was 
at C6 whilst only 3% was at C1. Although there was no inversion of the 
glucose molecule, there was some randomisation of the label between the two 
ends of the molecule. 
Studies on the biosynthesis of L-fucose by Aerobacter aerogenes 
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showed that glucose was a precursor. Again using 1-[14C]-D-glucose, 63% of 
the total radioactivity of the isolated L-fucose was at C1 with 22% at C6. 
Similar results were also obtained with glucose enriched at C6 with 14C. In 
this investigation the glucose was also re-isolated and shown to have the 
following isotope distribution, figure 2.28. 
Figure 2.28 
The location of 14C in glucose re-isolated from Aerobacter aerogenes 
cl C6 
1-[14C]-D-glucose 
6-[14C]-D-iy, lucose 
1 
68% 
13% 
23% 
94% 
It was likely that the glucose molecule was incorporated intact into L-fucose (a 
possible mechanism for 5-keto-6-deoxyarabohexose is described below) and 
that the randomisation of the label occurred via a phosphorylated fructose 
intermediate. A mechanism in which the glucose could split into two halves 
which were in equilibrium with one another was postulated at the time, 
although no reference was made to the specific C3 trioses. 
Scheme 2.21 
The proposed biosynthesis of 5-keto-6-deoxy-D-arabohexose. 
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Given the similarity between the two hexoses, L-fucose might be 
derived from the reduction of the keto group. 
In B. subtilis , isotopic label introduced into the top 
half of the 
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molecule should be slightly randomised in the production of DNJ by the 
minor pathway operating in scheme 2.18.2-[2H]-D-glucose was therefore 
investigated as a carbon source, in which the deuterium should be placed at 
H1 of fructose. Any randomisation of the label would be identifiable from 
enrichment at C1 as well as the expected C6. 
After adding 2-[2H]-D-glucose (39 atom % D) to a B. subtilis 
fermentation, the isolated peracetyl DNJ contained deuterium at H6 only (15 
atom % D), a result identical with that from S. subrutilus . No evidence for 
randomisation of the deuterium existed and this was possibly because 
oxidation to Mj had involved the removal of the labelled proton, scheme 
2.22. 
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This oxidation was most likely to be stereospecific, removing only one 
of the prochiral methylene protons to give Mj. If the deuterium had been 
removed in this step, then feeding 1-[2H]-D-glucose should result in the other 
prochiral proton being labelled with deuterium, and this time the oxidation 
would remove a proton instead. Unfortunately., time constraints did not 
permit this investigation. 
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Conclusion. 
In this project, the biosynthetic pathway to four different piperidine 
alkaloids in S. subrutilus has been discussed. Glucose was identified as the 
source of these secondary metabolites, and it is suggested that this 
carbohydrate is incorporated intact into the alkaloid structure with a novel 
head to tail inversion. Before this work was undertaken, DNJ and NJ were 
already known to be produced by S. subrutilus. Our studies identified DMJ as 
a further constituent of the fermentation medium and it is now believed that 
MJ is the common intermediate to the other three derivatives. 
A similar biosynthetic route operates in B. subtilis var niger with only 
minor differences. DNJ was already known to be present in the culture 
medium and our investigations showed that NJ was a precursor to this 
alkaloid. This microorganism does not, however., contain the enzymes 
capable of producing DMJ from W, whose presence has been postulated from 
enzyme inhibition studies. 
In both organisms the head to tail inversion of the glucose molecule 
means that DNJ and NJ biosynthesis requires alteration of two of the original 
stereochernical centres in the glucose. This appears to be an inefficient route 
when both alkaloids could be produced by oxidation and reductive amination 
of glucose itself. Epimerisation of one centre in each case would then provide 
DMJ and MJ. 
Further work arising from this project might include the isolation of 
the enzymes or intermediates involved in the biosynthesis of these alkaloids. 
This would be of possible benefit to any commercial production of these 
compounds and might confirm the results already presented in this thesis. 
Other directions of research might include an investigation into the 
biosynthesis of the more complicated bicyclic polyhydroxylated alkaloids, or a 
screen for novel alkaloid enzyme inhibitors in existing fermentation cultures. 
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CHAPTER THREE 
The synthesis of isotopically enriched precursors for biosynthetic 
experiments. 
Introduction 
To investigate the biosynthesis of DNJ and related alkaloids, glucose 
labelled specifically with 2H or 13C at various positions was required. The 
penalty for using spin active nuclei in this study was that high enrichment of 
the biosynthetic precursors was a necessity. Deuterated glucoses ideally 
needed to be prepared on a gram scale as the fermentations used 2g of glucose 
per 500mL of culture medium (3g/75OmL for B. subtilis ). A limited number 
of [2H]- and [13C]- enriched glucoses were available commercially, and some of 
these have been used in this investigation. However, even some of the 
cheaper isotopically enriched glucoses were expensive on the scale required. 
Previous fermentation studieS4,57 had used high levels of glucose, 
typically 2% w/v and yet our studies with S. subrutilus had shown that a 
decrease in DNJ Production occurred with increasing glucose concentration. 
The smaller glucose concentrations used in this study (0.4%w/v) meant that 
2H or 13C could be used as a label without synthesising large amounts of 
isotopically enriched precursors. 
Synthetic routes were available for glucoses enriched at every carbon 
atom with deuterium, and these were based mainly on reductive methods 
using, for instance, metal hydrides. Another method of isotope incorporation 
which has also been used in this project is exchange of a proton with 
deuterium from solvent. This was the case in the synthesis of 2-[2H]-D- 
glucose using deuterium oxide. 
In the work described below, a new chemical route to 2-[2H]-D-glucose 
has been developed, which complements the enzymatic synthesis from the 
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literature which is also described. A new strategy towards 5-[2H]-D-glucose is 
presented which is superior to the two literature syntheses in that unwanted 
stereoisomers are avoided. Other isotopically enriched glucoses have been 
prepared according to the literature routes with little or no modification. Both 
NJ and DNJ have been prepared with deuterium enrichment by modifying 
two literature syntheses of these alkaloids, and the method has then been 
extended to include tritium labelling as well. In respect to the synthesis of 
glucose analogues for fermentation studies, a number of literature routes to 
these compounds have been examined, and the preferred methods, or new 
ones, have been outlined. 
Synthetic methods. 
1-[2H]-D-glucose and 1-[13CI-D-glucose. 
These two labelled precursors were the only ones purchased from a 
commercial supplier (Aldrich). 
242HI-D-glucose 
Since glucose can exist in an acyclic form in aqueous solution with H2 
cc to the aldehyde carbonyl, it might be expected that base exchange of this 
labile proton in deuterium oxide would lead to incorporation of label at the 
required position. Glucose, in the presence of alkali, had been reported92 to 
produce fructose, mannose and various other intermediates from this proton 
abstraction and subsequent enolisation. Early studies, however, had not 
detected any incorporation of deuterium into the glucose molecule after 
reaction in alkaline deuterium oxide93 - This was consistent with our studies 
where deuterium had not been incorporated into glucose in either acid or 
alkaline deuterium oxide by 1H NMR. In contrast to this, other literature 
work suggested that a small incorporation of label did occur and that this 
varied depending on the intermediate isolated (-1 atom %D for glucose)93,94. 
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Scheme 3.01 
The isomerisation of glucose under alkaline conditions. 
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As only a small incorporation of deuterium was observed (presumably 
not detected by 1H NMR in our experiment) and that several compounds 
were produced in the reaction, this synthetic route became impractical. 
An alternative was based on a synthesis of deuterated arabinose95. By 
making the 2-0-benzyl ether of arabinose, the conversion to the 
corresponding ketose as above was precluded. In alkaline deuterium oxide, 
two C2 epimers of 2-0-benzylarabinose were produced, each with H2 enriched 
with deuterium. The desired arabino diastereoisomer was then recovered by 
re-crystallisation from ethyl acetate. 
The corresponding 2-0-benzyl-cc-D-glucose had already been 
ill 
synthesised in 4 steps from glucose pentaacetate96,97, although the H2 
deuterated derivative had not been reported. It seemed unnecessary to spend 
several steps synthesising glucose protected solely at C2 with the benzyl ether 
when the deuterium exchange should work equally well on the fully 
benzylated glucose. To this end, 2,3,4,6-tetrabenzyl-(x-D-glucose was 
synthesised in only two stepS98, scheme 3.02. 
Scheme 3.02 
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The hydrolysis of the methyl glucoside in step ii meant that (10) could 
exist in the acyclic form and hence deuterium exchange was possible The 
previous synthesis of 2-[2H]-2-0-benzylarabinose had then carried out this 
exchange in deuterium oxide/NaOD in which (10) was not soluble. By 
carrying out this reaction in a mixture of deuterium oxide /NaOD / dioxan 
(anhydrous) instead, the C2 epimers of 2,3,4,6-0-tetrabenzyl-(X-D-glucose 
deuterated at C2 could be produced as a 1: 1 mixture. The desired gluco epimer 
was then obtained by recrystallisation from methanol. In theory, the filtrate 
containing the manno epimer and some gluco could be re-equilibrated in 
NaOD/deuterium oxide/dioxan, although this was not carried out in practice. 
It was straightforward to determine the amounts of each 
diastereoisomer after the deuterium exchange as the two anomeric proton 
signals were at different chemical shift values in the 1H NMR spectrum 
(gluco 8 5.25 manno 5 5.31). In the protio-derivative, the anomeric proton of 
the a gluco diastereoisomer appeared as a doublet of 4.41-1z, whereas the 
deuterated analogue appeared just as a singlet. 
The last remaining step was to deprotect the benzylated glucose by 
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hydrogenolysis, scheme 3.03. 
Scheme 3.03 
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From a cheap starting material, the synthesis involved 4 steps (16% 
overall) and utilised a cheap source of deuterium towards the end of the 
reaction sequence. The lowest yield was the hydrolysis of the methylglucoside 
prior to exchange (33%), although no attempts were made to optimise this. 
Enzymatic synthesis 
An enzyme based method from the literature75,79,99 was also employed. 
Incubation of either glucose or fructose-6-phosphate in deuterium oxide with 
glucose-6-phosphate isomerase led to a 9: 1 mixture of 2-[2H]-D-glucose-6- 
phosphate and 1-[2H]-D-fructose-6-phosphate, scheme 3.04. 
Scheme 3.04. 
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The reaction takes place under equilibrium conditions and the 
incorporation of isotope is via exchange of H2 with solvent water during the 
glucose /fructose isomerisation (scheme 2.07 and 2.08). Alkaline phosphatase 
was then used to hydrolyse the phosphate esters followed by ion exchange 
chromatography to remove inorganic impurities. The synthesis was shorter 
than in scheme 3.02 and 3.03 and produced the 2-[2H]-D-glucose in higher 
yield (60% overall). The stereospecificity of the enzyme mechanism meant 
that only the required stereoisomer was produced and hence this avoided any 
separation and wastage of labelled material. 
Both methods were used to prepare 2-[2H]-D-glucose for fermentation 
studies. The enzymatic route was preferred, although this had the 
disadvantage that traces of fructose were present in the recovered glucose. 
Attempts were made to purify the glucose by either recrystallisation or 
derivatisation followed by chromatography, but satisfactory results were not 
obtained. Mass spectrometry confirmed that the glucose was enriched to >98 
atom % D. 
114 
3-[2H]-D-glucose. 
342HI-D-glucose was synthesised according to Koch and PerlinlOO. 
The synthesis of 3-[2H]-D-glucose 
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One modification was made. The literature route used DMSO/AC20 for 
the oxidation in step i, yet the analogous Swern oxidationlOl produced the 
ketone and other unidentified impurities by 1H NMR and TLC. The best 
method of oxidation was with pyridinium dichromate in CH202 with the 
presence of powdered molecular sieves. This gave the ketone and the 
hydrated ketone in high yield without the need for chromatographic 
purification. 
From the reaction sequence, the first two steps were concerned with 
introducing the deuterium label, whilst the remainder of the synthesis 
inverted the stereochemistry at C3. The hydride reduction with NaBH4 was 
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highly stereospecific and led entirely to the 1.2.5,6-0-diisopropylidene-(X-D- 
allo-hexofuranose by 1H NMR analysis102- The corresponding reduction with 
LiAlH4 gave a 7: 3 allolgluco mixture103. Previous studies had shown that the 
allo stereochernistry was produced from isolation of D-allose on hydrolysis 
after the reduction step. However, it was easy to distinguish the two epimers 
in the IH NMR spectrum by the chemical shift values of H1 and H2 and the 
corresponding coupling constants. H2 in 1,2,5,6-0-diisopropylidene-oc-D- 
glucose appeared as a doublet (4.2Hz) by virtue of coupling to HI only; 
coupling to H3 was not apparent presumably because the dihedral angle 
between H2 and H3 is very close to 90'. Contrast this with the allo epimer, 
where H2 appeared as a double doublet (4.2,4.3Hz) from coupling to H1 and 
H3, where the dihedral angle is much less than 90' between H2 and H3. 
The relationship between H1, H2 and H3 for the two C3 epimers of 1,2,5,6-0- 
diisopropylidene-D-glucose 
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gluco stereochemistry alto stereochemistry 
This stereospecificity in reduction was also observed in synthesising 5-[2H]-D- 
glucose. 
, 5-[2H1-D-gIucose 
Previous syntheses of this deuterated glucose had not given satisfactory 
yields and/or s tere ospecifi city' 04,105. One route involved the reduction of D- 
xylo-5-hexulosonic acid, produced from D-glucose using Gluconobacter 
suboxydatis, scheme 3.05106. Repeating this procedure confirmed that an 
equimolar mixture of D-gluconic and L-idonic acids was produced107. 
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Following lactonisation, reduction using boric acid/NaBH41 08 gave only trace 
quantities of 5-[2H]-D-glucose, a result also reported in the literature 
preparation. 
Scheme 3.05 
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Another method had employed 1,2-0-isopropylidene-a-D-6,3- 
glucuronolactone, scheme 3.06. Oxidation at C5 using chromium trioxide had 
given the keto lactone in only 17% yield, which was subsequently reduced 
with NaBH4 to give the gluco and ido lactones in a 2: 1 ratio. 
Scheme 3.06 
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Reagents D acetone/H+ ii) Cr03/AcOH iii). NaBD4/EtOH 
Various attempts to improve the oxidation at C5 were unsuccessful. It 
had been reported'09 that Swern oxidation produced the keto lactone 
conveniently in 90% yield, although this could not be repeated. TLC of the 
reaction indicated that oxidation appeared to be taking place, but on warming 
to room temperature and subsequent aqueous work up, decomposition 
occurred. 
The synthesis then developed was as follows, scheme 3.07. 
Scheme 3.07 
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The protected alcohol (18) had been synthesised by Inouye in 3 steps 
from 1,2,5,6-0-diisopropylidene-cc-D-glucose2. The ketone could be produced 
using Ac20/DMSO, although this gave unwanted impurities which were 
avoided with the Swern oxidation Reduction of the ketone with NaBH4 led 
to the gluco diastereoisomer only by 1H NMR, although traces of a lower Rf 
component could just be detected by TLC. This was presumed to be the 
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a ternative C5 epimer. Replacement of the NaBH4 with NaBD4 allowed easy 
incorporation of deuterium. 
Attempted hydrogenolysis of the trityl and benzyl groups failed, a 
problem that also occurred when synthesising deoxyglucose analogues. The 
four phenyl groups possibly prevent the molecule from orienting correctly on 
the catalyst surface for reduction to take place. Dissolving metal reduction 
using lithium in liquid ammonia gave consistently high yields of the 
partially protected sugar. 
The stereospecificity observed in synthesising 3-[2H]-D-glucose and 5- 
[2H]-D-glucose can be attributed to attack of hydride from the least hindered 
side of the carbonyl in each case. Figure 3.01 shows the energy minimised 
conformation for 1.2,5,6-0-diisopropylidene-a-D-ribo-hexofurano-3-ulose- It 
would be easier in this molecule for hydride to approach the ketone from 
above the carbonyl rather than underneath, where the 1,2-0-isopropylidene 
and furanose ring oxygen's are in the way. This would give the required allo 
stereochemistry. 
Similarly, the minimised conformation for (18) shows that one side of 
the carbonyl group at C5 is hindered by the benzyl group at C3. Reduction 
from the least hindered face of the carbonyl group then gives the desired 
gluco stereochemistry. 
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Figure 3.01 
Tile energy mininlised coil f ormations for a) 1,2,5,6-0-diisopropylidene-cc-D- 
ribo-liewfurailo-3-ulose and b) 3-0-benzyl-6-0-triphenylmetliyl-1,2-0- 
isopropylidene-cc-D-xi/lo -hexofuranos-5-ulose. 
a) J, 
b 
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1H and 13C NMR confirmed the position of the label in the isolated 
glucose (no C5 epimer could be detected) and the mass spectrum of the 
peracetate showed an enrichment of 92 atom % D. 
6,6-[2H2]-D-Glucose 
1/2-0-isopropylidene-6,6-[2H2]-(x-D-glucose was synthesised according to 
Lemieux and Stevens95 and subsequently hydrolysed to the deuterated 
hexose. Modifications were carried out to the purification stages only. 
Scheme 3.08 
6,6-[2H]-D-Glucose synthesis 
H o', 
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HO 0 0 OH 00H 
(22) 
0, OH 
[2 D 6,6- HI-D-glucose D 
00 OH 
(23) OH 
Reagents 0 acetone/H-'ý ii) LiAID4/THF then NaBD4/EtOHiii) H2SO4/H20 
6,6-[2H2]-nojirimycin and 6,6-[2H2]-l-deoxynojirimycin 
Various syntheses of NJ were available, but a route was needed 
whereby deuterium could be introduced towards the end of the synthesis in a 
position that was remote from any biosynthetic process. The most suitable 
synthesis to achieve this aim involved oxidation at C5 of 1,2-0- 
is o propyli den e-6,3-glucuro no la c tone 109. The ketone functionality was then 
converted to the amine and deuterium could be introduced at H6 as above for 
6,6-[2H2]-D-glucose. The difficulties already encountered with oxidising the 
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lactone at C5 meant that an alternative route to the amine at C5 was required. 
Fleet'10,111 had synthesised the azido lactone (27) in 5 steps from 6,3- 
glucuronolactone and in our studies this was hydrogenated to the 
corresponding amine and protected as the BOC derivative. The original route 
of Anzevenol09 with minor modifications 
converted to DNJ by the method of Inouye2 
Scheme 3.09 
then gave NJ which could be 
6,6-[2H2]-nojirimycin and 6,6 -[2H2] -1-deoxynojirimycin synthesis. 
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Reagents 0 CF3COO-Nal/MeOH ii) (CF3SO2)20/CH2CI2/pyridine iii) NaN3/DMFiv) 
H2/Pd on C/EtOAc v) BOC anhydride/EtOAc vi) LiAID4/THF then 
NaBD4 / EtOH /deuterium oxide vii) S02/H20/35-45'C viii) Dowex lx8(OH form) ix) 
H2/PtO2/AcOH/H20 
The reduction of the lactone (29) to glycol was slow even with excess 
LiAID4. Typically the lactone would be reduced rapidly to a mixture of the 
lactol and glycol, but thereafter complete reduction to the latter took several 
hours, despite refluxing in THE A faster procedure was to isolate the mixture 
of lactol and glycol and then complete the reduction with NaBD4 in EtOH. 
Using this method, the reduction of the lactol had completely taken place 
after 20 minutes at room temperature. Usually deuterium oxide was added to 
the EtOH as appreciable exchange of deuterium had been reported to occur 
with just NaBD4 in alcohol solvents112- 
To introduce tritium into NJ or DNJ at C6, the reduction of the lactone 
was carried out using AlC13/NaBT4 in diglyme at room temperature. In both 
cases the NJ was recovered as the bisulphite adduct (33) as this allowed long 
term storage of the alkaloid (stable for at least several months at -10'C). It was 
straightforward to convert this derivative to NJ or DNJ as required. 
Figure 3.02. 
OH 
HO, f. . %%OH 
e*( H03S%e* N CT20H 
H 
(33) 
1-[13C]-D, L-glyceraldehyde. 
Racemic glyceraldehyde was synthesised with 13C enrichment at Cl (50 
atom % 13C) by the method of Serianni et al'13,114,115. 
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1-[13C]-D, L-Glyceraldehyde synthesis 
HOCH i o- HOCH 2CHO + NaCN - 2CH(OH)CN 
HOCH 
CHO 
2CH(OH)CN 30. n --- 
1 
nr-"OH (34) 1 
CH20H 
Reagents i) NaCN/H20/pH 8 ii) H2/Pd on C/H20/pH 1.7 
Detailed experimental procedures and 13C NMR spectra were given. 
Synthesis of glucose and DNJ analogues. 
The aim of this section of the investigation was to synthesise analogues 
of glucose which could then replace the glucose in the usual fermentation 
medium. It was hoped that the corresponding DNJ analogue would be 
produced if subtle changes to the glucose molecule did not upset the 
biosynthesis mechanism. Recent interest had focused on analogues of those 
alkaloids normally found naturally, and this research effort had already 
revealed interesting results. For instance, the improvement in inhibition of 
HIV by acylating C6 of castanospermine has already been alluded to (page 9). 
In contrast, the removal of a hydroxyl at C1 destroyed the u. -glucosidase 
activity when compared to the parent compound'16. 
The discovery that a particular analogue shows weaker inhibition of an 
enzyme, or a class of enzymes, is not in itself a setback as the relationship 
between inhibition and structure is not clear. At the time of starting this study 
with DNJ, some knowledge of the relationship between structure and 
inhibition was known from natural alkaloid derivatives. Fagomine, the 2- 
deoxy analogue of DNJ, figure 3.03, failed to inhibit (x- and P-glucosidases, (x- 
mannosidase, (x- and P-galactosidases and (x-fucosidasell7. DNJ and DMJ, in 
contrast., were known inhibitors of a number of these enzymes. 
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Figure 3.03 
OH 
NK, CH20H 
H 
fagomine 
The presence of a hydroxyl at C2 would therefore appear to be essential 
for a number of glycosidase enzymes, although the stereochemistry at this 
position is apparently less important. DNJ will inhibit (x-mannosidase, 
although not as well as DMJ. 
Three glucose analogues were synthesised and investigated to see if 
they could act as substrates in the biosynthetic pathway. They were 3-deoxy-D- 
glucose, 3-0-methyl-D-glucose and 5-deoxyglucose. These were chosen 
because all three were substrates for the glucose-fructose isomerisation 
reaction75 (the first step in the biosynthesis) and the modified centre was in a 
position where it would not in theory interfere with any stage of the 
biosynthetic mechanism. If the analogues were substrates for metabolism, the 
first two derivatives would give 1,4-dideoxy NJ and 4-0-methyl DNJ 
respectively, whilst 5-deoxy-D-glucose would give fagomine. Although 
fagomine was a natural alkaloid, 5-deoxy-D-glucose was one of the best 
substrates for the fructose /glucose isomerisation. The lack of a hydroxyl at C5 
meant that the normal epimerisation reaction in the biosynthesis would be 
avoided. 
3-0-Methyl-D-glucose 
3-0-Methyl-D-glucose was synthesised as below, scheme 3.10. 
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Scheme 3.10 
Synthesis of 3-0-methyl-D-glucose. 
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When this glucose analogue was fed to S. subrutilus, glucose was also 
included in the fermentation medium as the microorganism needed an 
energy source for growth. It is unlikely that the 3-0-methyl-D-glucose would 
be able to fulfil this role. The final concentration was 2g of glucose and 2g of 3- 
O-methyl-D-glucose in 500ml, of soyabean medium. After partial purification 
of the fermentation, mass spectrometry and gas chromatography indicated 
that DNJ and DMJ were present. No indication of the molecular ion (m/z 346) 
for the 4-0-methyl derivative could be found in the mass spectrum. Later 
work resulted in the synthesis of 3-0-methyl DNJ which gave the required 
peak in the mass spectrum. This confirmed that the molecular ion was not 
unstable for this derivative and it was likely the same applied to 4-0-methyl 
DNJ. 
To test whether the glucose was being used preferentially for the 
biosynthesis, a second fermentation was tried which just contained 3-0- 
methyl-D-glucose (4g/5OOmL). Again DNJ and DMJ could be detected by GC 
and also as their peracetyl derivatives in the mass spectrum. These two 
alkaloids presumably originated from the carbon source that had been causing 
the dilution in the labelling studies. It was interesting that the ratio of DNJ to 
DMJ in these two fermentations was unlike that observed for fermentations 
in the biosynthetic studies. In previous work, DNJ was always found in excess 
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to DMJ (typically 21/2 times as much). In both experiments with 3-0-methyl- 
D-glucose, DMJ was found in excess. For the 1: 1 mixture of carbon sources, the 
DNJ/DMJ ratio was 0.78 (13mg of DNJ). Complete replacement of the glucose 
gave a DNJ/DMJ ratio of 0.49. The increased carbon source concentration was 
a possible cause for this disturbance in the ratio of the two alkaloids, although 
when 4g/5OOmL of glucose was substituted into the medium, the usual ratio 
was again observed. It seems likely that the glucose analogue is inhibiting one 
(or more) of the biosynthetic pathways leading to a decrease in the amount of 
DNJ. The fermentation with 2g of both glucose and 3-0-methyl-D-glucose had 
shown a lower titre of DNJ than when either 2g or 4g/5OOmL of glucose only 
was used. The unusual ratio observed was therefore due to less DNJ rather 
than more DMJ. 
3-deoxy-D-glucose. 
3-deoxy-D-glucose was synthesised by two different literature 
routes 118,119,120,121. The best method was found to be as follows. 
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Synthesis of 3-deoxy-D-glucose 
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The method above was based on the Barton deoxygenation procedure 
for secondary alcohols. The radical deoxygenation in step ii proceeded in 75- 
85% yield, giving in addition minor amounts of the characterised impurity 
(39). This had not been described in previous work, although the yield of 3- 
deoxy-1,2,5,6-0-diisopropylidene-oc-D-ribo-hexofuranose was identical. Barton 
had found similar byproducts with aliphatic O-alkyl thioesters and the 
mechanism can be formulated as in scheme 3.11. 
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The radicals produced can be quenched by more Bu3SnH to produce the 
compounds found in the reaction. 
When the glucose in the fermentation medium of S. subrutijus was 
replaced by 3-deoxy-D-glucose, the evidence for the product of 1,4-dideoxy NJ 
was inconclusive. The mass spectrum showed that DNJ and DMJ were 
present and a peak at m/z 316, corresponding possibly to the dideoxy 
derivative, was also found. This was very much weaker than the parent ion 
for DNJ and DMJ. 
GC analysis of the fermentation indicated that DNJ was present at a 
concentration of 0.02mg/mL (400 mL) and that the usual ratio between DNJ 
and DMJ also existed. 
, 5-deoxyglucose. 
Several literature routes existed for this hexosel22,123,124,125,126,127, but in 
this project a short synthesis was developed based on the strategy of 3-deoxy- 
D-glucose, scheme 3.12. 
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Scheme 3.12 
Synthesis of 5-deoxyglucose 
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This strategy had the advantage that unwanted side products were not 
produced, which had been the case with some of the literature routes. The 
radical deoxygenation proceeded in almost quantitative yield without any 
other radical side reactions as noted for 3-deoxy-D-glucose. 
On feeding the 5-deoxyglucose (100%) to S. subrutilus, no fagornine 
could be detected by GC analysis using a standard sample. Furthermore, only 
traces of DNJ were present in the fermentation in contrast to the other two 
fermentation studies. 
Chemical syntheses of DNJ analogues 
As biochemical modification of the DNJ structure had been 
unsuccessful, chemical routes were also investigated. At the time this work 
was started, the synthesis of 3-0-methyl-l-deoxynojirimycin and 1,3- 
dideoxynojirimycin had not been published, yet the synthesis of 3-0-methyl- 
D-glucose and 3-deoxy-D-glucose meant that precursors to the desired 
alkaloids were available. Using methodology developed by Inouye2,3-0- 
methyl-l-deoxynojirimycin was synthesised as follows, scheme 3.13. 
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Scheme 3.13 
Synthesis of 3-0-methyl-l-deoxynojirimycin. 
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Two diastereoisomers were formed in step v in a ratio of 7: 1. These 
could be separated by flash chromatography, although at this stage it was not 
possible to distinguish the gluco isomer from the ido isomer by 1H NMR. The 
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main fraction was used to synthesise the bisulphite adduct (51) and this was 
shown to be the gluco derivative from the following spectroscopic evidence. 
H5 coupled to both H6 protons with coupling constants of 4.5 and 2.9 Hz 
respectively. These values were also repeated in the signals for the two H6 
protons along with a larger geminal coupling. The third coupling shown by 
H5, which can only be to H4, indicated a diaxial relationship for these two 
protons (J=11.3Hz). Had this main fraction been the ido isomer then the 
coupling constant would have been smaller because of an axial/ equatorial 
relationship between these two protons. In synthesising NJ, Inouye2had also 
assigned the major diastereoisomer to that of the gluco configuration on the 
basis of CD measurements. 
Inhibition of (x-glucosidase (trehalase) was weaker with 3-0-methyl-1- 
deoxynojirimycin, which only showed 20% of the inhibition of this enzyme 
compared to a DNJ control. This suggested that a hydroxyl at C3 was 
important., although the size of the 0-methyl group may have caused the 
poor inhibition. 
An attempt was then made to synthesise 1,3-dideoxynojirimycin by the 
same route using 3-deoxy-D-glucose. The strategy worked well up to the point 
of forming the bisulphite adduct. Saturating with S02 had been successful in 
other reactions, although in this case the sulphonic acid could not be 
produced. The reaction was not investigated further as recent resUltS128 
summarised which groups were necessary around the piperidine ring to 
produce inhibition. It was found that at C2, C3 and C4 a hydroxyl group was 
needed for inhibition of (x-glucosidase. It was not essential to have OH at C1 
or C6, although the C5/C6 linkage needed to be in place for effective 
inhibition. These studies had concentrated on (x-glucosidase because two (x- 
glucosidases were involved in glycoprotein processing (page 5). It was likely 
that inhibition of HIV by DNJ involved (x-glucosidase I., as the potent 
inhibitor N-butylDNJ was specific for this enzyme only. 
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Experimental 
General conditions 
1H NMR spectra were recorded at 220,250, or 400 MHz using a Perkin 
Elmer R34, a Bruker ACF 250 or a Bruker WH 400 spectrometer respectively. 
2H NMR spectra were recorded at 38-398 (ACF 250) or 61.424 MHz(WH 400). 
13C NMR spectra were recorded at 61.424 (ACF 250) or 100.623 MHz (WH400). 
In addition to TMS, the following reference signals were used for 1H and 2H 
NMR: HDO 8 4.75, pyridine (x-H 8 8.70, CHC13 8 7.23 ppm. All coupling 
constants are given in Hz. 
Mass spectra were recorded on a Kratos MS80 spectrometer. Chemical 
ionisation (CI) mass spectra used ammonia as reagent gas. Peracetyl DNJ and 
DMJ were used in all analyses to determine isotopic content and typically the 
mean was taken of 5 scans of a compound obtained over a period of two or 
three days. For the analysis of fermentations carried out in D20, a Kratos 
concept four sector mass spectrometer was used with methane as the reagent 
gas for CI mass spectrometry. All other experiments with this instrument 
used FAB ionisation with a glycerol matrix. 
Deuterated glucoses were analysed for deuterium enrichment by first 
acetylating the sugar (excess pyridine/AC20) followed by mass spectroscopy. 
Comparison was with authentic glucose pentaacetate (Aldrich) in the same 
manner as described in chapter 2. 
IR spectra were recorded using a Perkin Elmer 1720X FT spectrometer. 
UV spectra were recorded using a Philips PU 8720 scanning 
spectrophotometer. 
Liquid scintillation counting used Optiphase Safe@ (10 mL., LKB) as 
scintillant and radioactivity was measured with a Packard 2000CA TriCarb 
liquid scintillation analyser. 
GLC analysis was performed on a Carlo Erba Fractovap with an FID 
detector using a 30 m quartz J&W DB5/0.25ýtm column. The flow rate of the 
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carrier gas (N2) was 2mL min-1 with a gas split ratio of 30: 1. The 
in)ector/ detector temperature was 250'C and the column temperature was 
1900C 
Anhydrous solvents were obtained by distillation from the following: 
THF, dioxan and toluene (Na/benzophenone); CH2C12 (CaH2); pyridine 
(KOH); acetone (B203). DMSO and DMF were stored over freshly activated 4A 
molecular sieves. Anhydrous MeOH and diglyme were purchased from 
Aldrich and CH3CN was HPLC grade. 
TLC was performed using glass backed Si02 TLC plates (Merck Kieselgel 
60F-254) and compounds were visualised with either 10% H2SO4 (conc. ) in 
EtOH for sugar derivatives or ninhydrin. (0.1% w/v in n-butanol) for amines. 
In each case the TLC plate was heated with a hot air gun following spraying. 
Merck silica gel 60 (230-400 mesh ASTM) was used for flash chromatography. 
Maintenance of microorganisms. 
S. subrutilus ATCC 27467 and B. subtilis ATCC 9372 were first grown 
in nutrient broth upon receipt. The microorganisms were sub-cultured 2 or 3 
times and then stored as follows. 
S. subrutilus -a 100gl aliquot of the nutrient broth culture was 
transferred under sterile conditions to an oatmeal agar petri dish. After 
spreading across the agar, the microorganisms were incubated at 37'C for 
several days. On appearance of a white crust of spores, a sterile loop was used 
to scrape the spores into a small volume of sterile distilled water (2-3mL). 
This suspension was sterile filtered through cotton wool, whirlimixed and 
then centrifuged (30OOrpm/20min. ). The supernatant was discarded and the 
pellet was taken up in 20% aqueous glycerol (1000ýtQ. To test for 
contamination and to quantify the viable spores, a 100[tL aliquot was taken 
from this stock solution and diluted in a serial fashion. Contamination 
usually took the form of light coloured, soft colonies. 
Streptomyces colonies 
were pale brown, hard and appeared sub-divided. 
Serial dilution analysis 
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indicated typically 106-107 colonies per 10%tL. The stock glycerol solution was 
then kept at -10'C. 
B. subtilis - after sub-culturing, a 100gL aliquot of the nutrient broth 
culture was spread over a nutrient agar petri-dish. After incubation for 24h at 
37'C, the B. subtilis colonies could be identified as soft, light brown spheres. 
Colonies that were not contaminated were transferred using a flamed loop to 
sterile nutrient broth and incubated for a further 24h at 30'C. During this 
time, the clear nutrient broth solution became turbid. A 500ýtl, aliquot was 
removed and transferred to glycerol solution (500ýtl,, 66%) for storage at -10'C. 
Inoculation of Streptomyces fermentations was with 50-100ýtl, of the stored 
spore suspension. Growth was monitored by the formation of mycelia under 
the phase contrast microscope. For B. subtilis 100ýtl, of the stored bacterial 
suspension was transferred to 50mL of sterile nutrient broth and incubated 
for 24h at 30'C. Inoculation of the main fermentation medium was with 
300ýtl, of this broth. 
Media 
Oatmeal agar 
Oatmeal, finely ground, 30g 
Yeast extract., 1g 
Agar #1,15g 
Distilled water, 1L 
The oats and yeast extract were boiled together for 3h. The agar was then 
added followed by vigorous stirring. The solution was then autoclaved and 
poured. 
Nutrient broth (Oxoid) Bg L-1 Autoclaved (120'C/20 min. ) 
Nutrient agar (Oxoid) 28g L-1 Autoclaved (1201C/20 min. ) 
Fermentation conditions, isolation and characterisation of metabolites. 
The constituents of the fermentation media are described in chapter 2. 
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In all feeding experiments, labelled glucoses were diluted with unlabelled D- 
glucose before use. Aliquots of media (30mL in a 250mL conical flask) were 
inoculated with the required microorganism and then shaken at 28-30'C for 
7d at 200rpm- The concentration of DNJ was monitored during this period by 
either GC or with the trehalase assay. The medium was then autoclaved at 
120'C for 20 min., centrifuged at 50OOrpm for 30 min. and the supernatant 
added to a column of Dowex 50 ion exchange resin (H+ form, 15mL per 100mL 
supernatant). The column was washed with distilled water (2 bed vol. ) and 
then eluted with aqueous ammonia (2M, 2 bed vol. ). This eluate was 
Iyophilised or concentrated to 50mL for further GC analysis as required. The 
Iyophilised residue was taken up in the minimum volume of 70% aqueous 
EtOH, filtered and applied to a column of A1203 (neutral, Brockmann grade D. 
This column was eluted with 70% aqueous EtOH (3 bed vol. ) and 
concentrated in vacuo. The residue was dissolved in pyridine and treated 
with an excess of acetic anhydride in the presence of DMAP. The acylation 
mixture was evaporated to dryness in vacuo and the peracetylated alkaloid(s) 
were purified by flash chromatography on silica (elution with EtOAc : CH202" 
30% v/v). 
To deacetylate peracetyl DNJ or DMJ, the alkaloid was stirred with 
concentrated NH3 (5mL., d 0.880) and methanol (5mL) overnight at room 
temperature. Evaporation of the reaction gave either N-acetyl DNJ or free 
DMJ in approx. 70% conversion. 
Gas chromatography 
For analysis of the fermentation culture directly, a 1mL aliquot was 
removed and centrifuged to remove suspended solids. This was then whirli- 
mixed with (x-methylglucoside internal standard (100gL, 0.8 mg mL-1) and 
Iyophilised. Sigma SiIA (100ýtl, ) was added and the reaction was set aside for 
30 min. at 601C. Aliquots (1[tL) of this mixture were analysed by GLC for DNJ 
and DMJ. 
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Trehalase assay for NJ and DNJ129 
To a solution of trehalase (Sigma Chemical Co., 20ýtL, 0.005ggmL-1, 
0.385 U mL-1) in maleate buffer (pH 6.0) was added inhibitor solution (20 ýIQ 
and the mixture was incubated at 37'C for 15 min. Trehalose (20[tL, 56 mM) in 
0.1M maleate buffer (pH 6.0) was added and the reaction was incubated for a 
further 60 min. at 37'C. The reaction was stopped by the addition of GOD-PAP 
(Boehringer) glucose assay solution (1 mL) containing tris buffer and after a 
further incubation of 30 min., the absorbance at 510 nm was then determined. 
To eliminate interference by NJ, an equal volume of 6M HCl was added to the 
fermentation sample which was then heated in a boiling water bath for 6h. 
The solution was Iyophilised, re-suspended to the original volume in 
maleate buffer (pH 6.0) and assayed as above. 
Mannosidase assay for MJ and DMj130 
The inhibitor solution (150gL) was incubated with jack bean (x-D- 
mannosidase (Sigma Chemical Co., 50ýtL, 0.02 mg mL-1,20U mg-1) and 
sodium acetate buffer (250 gL, pH 5.5) at 25'C for 15 min. 4-Nitrophenyl-cc-D- 
mannoside (200 ýxL, 30 mM) was added and the mixture was incubated at 25'C 
for 15 min. The reaction was stopped by the addition of glycine buffer (2 mL, 
0.1 M, pH 10.7) and the absorbance of the solution at 400 nm was read 
immediately. As with the trehalase assay, determinations were carried out in 
triplicate against the appropriate blank reactions. 
Spectroscopic data for isolated metabolites. 
Peracetyl DNJ. 1H NMR (400 MHz, C5D5N, 90') 5 2.01 (3H, s, Me), 2.04 (6H, s, 
Me), 2.05 (3H, s, Me), 2.19 (3H, s, Me), 3.60-3.80 (1H, br. s, H1), 3.99-4.05 (2H, br. s, 
H1 & H5), 4.50 (1H, dd, H6,11.5,5-9)t 4.63 (1H, dd, H6,11.6,7.8), 5.11 (1H, m, 
H2), 5.32 (1H, t, H4,3.8,4.3), 5.39 (1H, t, H3,3.9,3.4); MS (CI): found m/z 
374.1450,, calc. for C16H24NO9 m/z 374-1451 (M + H)+. 
N-Acetyl DNJ. 1H NMR (40OMHz, D20) 8 1.84 (3H, s, Me), 2.73 (1H, t, Hlax., 
12.0), 2.90 (1H., br. t,, H5)., 3.30 (1H, dd, Hleq.,, 12.4,5-1), 3.34-3-44 (2H, m, H3 & 
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H4), 3.60 (1H, ddd, H2,5.2,8.8), 3.71 (1H, dd, H6,12.4,5.6), 3.82 (1H, dd, H6,12.4, 
3-0); 13C NMR (100.6 MHz, D20) 8 47.9 (Cl), 60.2 (C6), 60.8 (C5)., 69.6 (C2), 70.4 
(C3 or CQ, 78.0 (C3 or C4). 
Peracetyl DMJ 1H NMR (400 MHz, C5D5N, 90'Q 8 1.96 (3H, s, Me), 2.01 (3H, s, 
Me), 2.03 (3H, s, Me), 2.13 (3H, s, Me), 2.22 (3H, s, Me), 3.46 (1H, br. s, Hl), 3.85 
(2H, br. s, Hl & H5), 4.50 (1H, dd, H6,11.4,6.1), 4.81 (1H, br-dd, H6), 5.36 (2H, m. 
H3 or H4. H2)., 5.70 (1H., t., H3 or H4,3.3); MS (CI): found m/z 374.1450, calc. for 
C16H24NO9 m/Z 374.1451.13C NMR (61.42 MHz, CDC13,25'C) Two rotamers 
existed 5 20.6-21.7 (several peaks, Me), 34.40 (Cl), 40-15 (Cl), 49.96,55.46,59-96 
(CO, 60.12 (CO, 64.83,65.76,66-90,67.08,67-63,68.41,168.8-170.7 (several peaks, 
CO) 
DMJ 1H NMR (400 MHz, D20) 8 2.85 (1H, m, H5), 3.00 (1H, dd, Hl, 13.9,1.3), 
3.20 (1H, dd, Hl, 13.9,2.9), 3.58 (1H, dd, H3,9.6,3.1), 3.71 OH, dd, H4,10.0,9.3), 
3.75 (1 H, dd, H6,12.1,6.0), 3.85 (1 H, dd, H6,12.4,3.2), 4.10 (1 H, M, H2). 13 C 
NMR (100.6 MHz, D20) 8 48.3 (Cl), 59.5,61.0,67.1,67.5,73.7ppm 
Chemical syntheses. 
242HI-D-Glucose 
2., 3., 4,, 6-Te tra-0-benzyl-D-glucopyrano side (10) was synthesised in two 
steps (30% overall yield) according to the method of Tate and Bishop98. 
a-Methyl-2,3,4,6-tetra-0-benzyl-D-glucopyranoside (9). 1H NMR (220 MHz, 
CDC13) 8 3.40 (3H, s, OMe), 3.55-4-10 (6H, m, H2-H6), 4.45-5.05 (9H, m, 4xCH2., 
H1), 7.20-7.50 (20H, m, aromatic H). MS (CI) m/z 572 (M + NH4)+. 
2,3,4,6-Tetra-0-benzyl-D-glucopyranose (10). IH NMR (220 MHz, CDC13) 8 3.50- 
4.10 (6H, m, H2-H6), 4.46-5.00 (8H, m, CH2), 5.25 (1H, d,, Hl,, 4.4),, 7.10-7.50 
(20H,, 
m, aromatic H). MS (CI) m/z 558 (M + NH4)+, 540 
(M + NH4 - H20)+- 
2,, 3,, 4,, 6-Tetra-0-benzyl-2-[2H]-D-glucopyranose (11). 
Sodium (1g, 0.04 mol) was dissolved in deuterium oxide (54 mL) under 
N2. This solution was then added to a solution of 2,3,4,6-tetra-0-benzyl-D- 
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glucopyranose (7.2g, 0.013 mol) in dry dioxan (235 mQ and the mixture was 
stirred under N2 for three days at room temperature. The dioxan was 
evaporated in vacuo and the residual solid was dissolved in CH202- This 
solution was washed with water (3 x 50 mQ until the aqueous layer was 
neutral. The organic layer was dried (MgS04) and the solvent was removed in 
vacuo to yield a tan solid (8 g). 1H NMR showed this to be an approximately 
equal mixture of gluco- and manno-isomers. Recrystallisation of this solid 
from methanol gave pure 2-[2H]-2,3,4,6-tetra-0-benzyl-D-glucose (3 g, 83% of 
the available gluco-isomer). M. N. 136-138'C, lit98.150-151'C (protio- 
derivative). [a]23D -= +57.5' (c = 0.06 CHC13) lit. value98 +20.7'. 1H NMR (220 
MHz, CDC13) 8 3.50-4.10 (5H, m, H3-H6), 4.46-5.00 (8H, m, CH2), 5.25 (1H, s, 
Hl), 7.10-7.45 (20H, m, aromatic H). MS (CI) found 559.2920 calc. for 
C34H39DN06 m/z 559.2919 (M + NH4)+. 
242HI-D-Glucose (12). 
To palladium black (11 mg) suspended in glacial HOAc (250 mQ was 
added 2-[2H]-2,3,4,6-tetra-0-benzyl-D-glucose (2.45 g, 4.4 mmol) and the 
mixture was stirred under hydrogen (1 atm) for 24h after which time 455 mL 
of hydrogen was taken up. TLC (BuOH : AcOH : H20: EtOAc) showed that a 
mixture of glucose and acetylated derivatives were present. Water (20 mL) 
was added and the catalyst was removed by filtration through Celite. The 
filtrate was evaporated to dryness in vacuo and the residue was dissolved in 
MeOH to which a few drops of ammonium hydroxide (d 0.880) had been 
added. After 2h the solution was evaporated to dryness and the residue was 
dissolved in water (30 mL). The aqueous solution was extracted with CH202 
(2 x 10 mL) and then Iyophilised to yield 2-[2H]-D-glucose as a clear, colourless 
syrup (0.548 g, 65%). 1H NMR (400 MHz, D20) 8 4.11-4.18 (4H, m, H3p, H4p, 
H5p, H4, D), 4.24-4.31 (3H, m, 
H6ccp, H3(x), 4.31-4.36 OH, m, H6(Xp, H5(x), 4.66 (1H" 
s, Hlp), 4.91 (1H, s, H1c). The spectrum compared well to that of authentic 
D- 
glucose,, except that both H1 protons, normally seen as doublets, 
had collapsed 
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to two singlets. The lowest frequency signal in D-glucose (H2P, 8.0 Hz) was 
missing in the deuterated derivative. 13C NMR (100.6 MHz, D20) 8 96.42 
(Clp), 92.61 (Clu), 76-48., 76.25 (C3P, C5P), 73-26 (CRO, 71-97 (C5(x), 70-20" 70.16 
(C4(xp), 61.31,61.15 (C6(xp). Where cc and P refer to the two anomers of 
glucosel3l. Authentic D-glucose had signals at 8 74.6 (H20) and 71.9 (H2(X), 
whereas the deuterated compound displayed two weak triplets at 8 74.24 and 
71-61. MS (CI) m/z 409 (M + NH4)+., 391 (M + H)+. Compared to authentic 
glucose pentaacetate,, the level of deuterium enrichment was >97 atom % D. 
2H NMR (61.4, D20) 8 3.13,3.50 ppm. Authentic D-glucose exhibits a doubled 
doublet in its 1H NMR spectrum due to H2P, 8 3.13 and H2(x 8 3.46 ppm. 
The method of Bock et a175 was followed in preparing 2-[2H]-D-glucose 
by the enzymatic route (60% overall yield). The 13C and 1H NMR spectra 
compared well to that of the 2-[2H]-D-glucose synthesised by the chemical 
route. 
3-[2H]-D-Glucose. 
This was synthesised according to Koch and PerlinlOO, except that the 
initial oxidation of 1,2,5,6-0-diisopropylidene-a-D-gluco-hexofuranose was 
carried out using pyridinium dichromate132 in 74% yield. 
1,, 2,, 5,. 6-0-diisopropylidene-a-D-ribo-hexofurano-3-ulose (13). 
CH202 (200 mL, dry) was stirred with Py2Cr2O7 (43.5 g, 0.12 mol) and 
powdered molecular sieve (5 g) for 5 min. under N2. The alcohol (15 g, 0.06 
mol) was then added to the orange solution in one portion and the mixture 
was stirred for 48h at room temperature. After this time, TLC (20% EtOAc : 
CH2CI2, A1203) indicated a slower moving component with no evidence of 
starting material. The reaction was filtered through Celite and the CH202 was 
evaporated in vacuo to give a crude brown oil. EtOAc (250 mL) was added 
and the suspension was sonicated for 5 min. Filtration through a Si02 Plug 
using 30% EtOAc : CH202 gave a colourless oil that solidified overnight at 
OOC. This solid was kept under vacuum until a constant mass was reached. 
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Yield 11.14 g (74%). The 1H NMR spectrum in CDC13 showed that a mixture of 
ketone and hydrated ketone were present (30% hydrated). 1H NMR (400 MHz, 
CDC13, hydrate) 8 1.33 (3H., s,, CH3),, 1.35 (3H, s, CHA, 1.46 (3H, s, CH3), 1.55 OH, 
s, CH3), 3.72 (1 H, br. s, OH), 3.88 (1 H, d, H4,6.6), 4.15 (1 H, br. s, OH), 4.24 (1 H, d, 
H2,3.8), 4.41 (1H, q, H5,6-3), 5.82 (1H, d, H1,3-8); (ketone) 8 1.31 (6H, s, CH3). 
1.41 QH, s, Me), 1.43 (3H, s, Me), 4.00-4.05 (2H, m), 4.32-4.35 (2H, m), 4.36 (1H' d, 
H2,4.5), 6.11 (1H, d, H1,4.5). MS (CI, CH4) m/z 259 (M + H)+. IR (film) 1) 3700- 
3100 cm-1 (OH, hydrate), 1776 (CO, strained), 1380 (doublet, gem dimethyl). 
1,2,5,6-0-diisopropylidene-3-[2H]-a-D-allo-hexofuranose (14). (95 %) IH NMR 
(220 MHz, CDC13) 8 1.20-1-60 (12H, 3s, isopropylidene), 2.70 (1H, br. s, OH), 3.85 
(1H, d, H4,4.7), 4.08 (2H, m, H6), 4.35 (1H, m, H5), 4.65 (1H, d, H2,4.2)"4.85 (1H, 
d, H1,4.2). MS (G) m/z 262 (M + H)+. 
1,2,5,6-0-diisopropylidene-a-D-allo-hexofuranose. I(X123D -",: +36.4' (c = 0.4 H20) 
lit. value102 +37.7'. 1H NMR (220 MHz, CDC13) 8 1.30-1.65 (12H, 4s, isopropyl), 
2.70 (1 H, d, OH, 9.2), 3.85 (1 H, dd, H4,9.1,4.5), 4.09 (3H, m, H3 & H6), 4.35 (1 H, 
m. H5), 4.65 (1H, dd, H2,4.2), 5.86 OH, d, H1,4.2). MS (CI) m/z 261 (M + H)+, 
245,220. 
3-Toluene-p-sulphonyl-1,2,5,6-0-diisopropylidene-3-[2H]-a-D-allo- 
hexofuranose (15). (88%) 1H NMR (220 MHz, CDC13) 5 1.30-1.60 (12H, 4s, 
isopropylidene), 2.49 (3H, s, Me), 3.85 (1H, m, H5), 4.00 (1H, dd, H4,6.5,6-2), 
4.70 (1H, d, H2,2,8), 5.80 (1H, d, Hlf 2-8), 7.35 (2H, d, aromatic, 9.7), 7.90-7.98 
(2H, d, aromatic, 7-3). 
3-Benzoyl-1,2,5,6-0-isopropylidene-3-[2H]-a-D-gluco-hexofuranose (16). (72%) 
1H NMR (220 MHz, CDC13) 8 1.28-1.57 (12H, s, isopropylidene), 4.10-4.20 (2H, 
m. H4-H6), 4.35-4.45 (2H, m, H4-H6), 4.68 (1H, d, H2,4-3), 6.00 (1H, d, Hl, 4-3), 
7.45-7.70 OH, m, aromatic H), 8.06-8.10 (2H, m, aromatic H), MS (CI) m/z 365 
(M + H)+, 349,307. 
1,2,5,6-0-diisopropylidene-3-[2H]-ct-D-gluco-hexofuranose (17). (60%) 1H NMR 
(220 MHz, CDC13) 8 1.20-1.51 (12H 4s isopropylidene), 2.78 (lH., br. s OH), 4.40 
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(4H, m, H4-H6), 4.58 OH, d, H2,4.3), 6.00 (1H, d, H1,4.3). MS (CI) m/z 262 (M + 
H)+, 246. Compared to authentic 1,2,5,6-0-diisopropylidene-ec-D-gluco- 
hexofuranose, the deuterated derivative was enriched to 97 atom % D. 
342HI-D-Glucose (100%) 1H NMR (400 MHz, D20) 8 3.12 (1H, d, H2P, 8.0), 3-26- 
3.31 (2H, m, HUcp), 3.36 (1H, ddd, H5P, 12.3,5.7,2.2),, 3.41 (1H., d., H2cc, 3.8), 3.61 
(1H, dd, H6P, 12.3,5.7), 3.64 (1H, dd, Hftc, 12.4,5.6), 3.70-3-75 (2H., m., H6a. ' 
H5oc), 3.78 (1H, dd, H6P, 12.3,2.2), 4.53 (1H, d, H1 P, 8-0), 5.11 (1H, d, H10C., 3-8). 
The spectrum compared well to that of authentic D-glucose. H2a and H2P had 
both collapsed to doublets, and H3(x and H3P (normally at 8 3.58 and 3.37 ppm 
respectively) were both absent. 2H NMR (61.4 MHz, D20) 8 3.36 and 3.58 ppm. 
The higher frequency signal was 2/3 the intensity of that at lower frequency. 
MS (CI) m/z 409 (M + NH4)+. Compared to authentic glucose pentaacetate, the 
deuterated derivative was enriched to 96 atom % D. 
542M-D-Glucose. 
3-0-benzyl-6-0-triphenylmethyl-1,2-0-isopropylidene-(x-D-gluco- 
hexofuranose (18) was prepared according to Gramera et a1122,123 in three 
steps, 35% yield overall. 
3-0-benzyl-1,2,5,6-0-diisopropylidene-a-D-gluco-hexofuranose. 1H NMR (400 
MHz, CDC13) 8 1.30 OH, s, Me), 1.37 OH, s, Me), 1.42 (3H, s, Me), 1.49 (3H, s, 
Me), 3.98-4.02 (2H, m, H2 & HQ, 4.09-4.15 (2H, dd, H6a & H6b, 8.6,6.2,3.1), 4.35 
(1H, m, H5), 4.57 (IH, d, H3,3.2), 4.62 (1H, d, CH2 benzyl, 11.8), 4.67 (1H, d, CH2 
benzyl, 11.8), 5.89 (1H, d, H1,3.7), 7.25-7.40 (5H, m, aromatic H). MS (CI) m/z 
351 (M + H)+,, 335,, 310 
3-0-benzyl-1,2-0-isopropylidene-a-D-gluco-hexofuranose. 1H NMR (220 MHz, 
CDC13) 8 1.33 (3H., s, Me), 1.50 (3H, s, Me), 2.20-2.90 (1H, br. s, OH), 3.72 (1H, dd, 
H2,12.1,5.4), 3.84 (1H, dd, H6,12.1t 4.1), 4.04 (1H, m, H5), 4.15 (2H, m, H3 & 
H4), 4.60 (1H, d, CH2 benzyl, 10.7), 4.66 (1H, d, H2,4.3), 4.78 (1H, d, CH2 benzyl, 
10,7), 5.98 (1H, d, Hl, 4.3), 7.40 OH, m, aromatic H). MS (CI) m/z 328 (M + 
NH4)+, 311 (M + H)+. 
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3-0-benzyl-6-0-triphenylmethyl-l,, 2-0-isopropylidene-a-D-gluco- 
hexofuranose 1H NMR (400 MHz, CDC13) 8 1.31 (3H, s, CH3),, 1.49 (3H, s, CH3)., 
2.67 (1H, br-d, OH, 7.0), 3.23 (1H, dd, H6,9.4,5.5), 3.42 (1H, dd, H6,9.4,5.5), 4.03 
(1 H, d, H3,3.1),, 4.17 (1 H,, m, H5)., 4.32 (1 H, dd., H4,7.6,3.1),, 4.45 (1 H, d, CH2 
benzyl, 11.6), 4.56 (1H, d, H2,3.8),, 4.61 (1H, d, CH2 benzyl, 11.6)., 5.91 (1H, d, Hl, 
3.8), 7.20-7.45 (20H, m, aromatic H). MS (CI) m/z 553 (M + H)+, 475"461. 
3-0-benzyl-6-0-triphenylmethyl-l,, 2-0-isopropylidene-a-D-xylo-hexofuranos- 
5-ulose (19). 
CH202 (50 mL,, dry) was added to a 250 mL round bottomed flask under 
N2. Oxalyl chloride (2 mL, 23 mmol, freshly distilled) was added next before 
cooling to -78'C. This was followed by the addition of DMSO (3.4 mL, 48 
mmol, dry) over 5 min. The two reagents were stirred together for 
approximately 10 min. before the alcohol (11.2 g, 20 mmol) in CH202 (20mL) 
was added dropwise. Immediately following the addition, the reaction was 
warmed to -30'C whereupon the previously cloudy solution cleared. The 
reaction was stirred at this temperature for a further 10 min. Et3N (14.6 mL, 
105 mmol, ex. CaH2) was added next and the reaction was allowed to warm to 
room temperature slowly. A slight yellow tinge was apparent at this stage. 
Water (50 mQ and CH202 (50 mQ were added and the organic layer was 
separated. This was washed with more water (2 x 50 mQ and saturated brine 
(50 mQ. The organic solution was dried (MgS04) and concentrated to yield 
7.82 g of the ketone (70%). TLC (10% Et20 : toluene) indicated that a higher Rf 
spot was present compared to the starting material. No alcohol was present by 
TLC. M. Pt. 160-162)C. Lit. 169-170oC2. [CC]23D = -9.7' (c = 0.12 CHC13) lit. value 
-181.1H NMR (400 MHz, CDC13) 8 1.28 (3H, s, Me), 1.45 (3H, s, Me), 4.03 (1H, d, 
CH2/ 18.2), 4.09 (1H, d, CH2., 18.2), 4.36-4.40 (2H, m, H3 or H4, H6), 4.47 (1H, d, 
H6,11.7), 4.50 (1H, d, H3 or H4,3-6), 4.85 (1H, d, H2,3.7), 5.92 (1H, d' H11 3-6)/ 
7.14-7.44 (20H, m, aromatic H). 13C NMR (100.6 MHz, CDC13) 8 26.3 (Me), 26.8 
(Me), 68.2,69.1,72.4,81.6,83.4,84.5,87.1,105.6,106.0,112.2,126-128,136.8,143.2/ 
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146.8,202.9 (CO). MS (CI) no molecular ion was seen m/z 307 (M +H- 
CHPh3)+ (base peak). Analysis : found; C 76-09, H 6.23% calc. for C35H3406; C 
76.34, H 6.22%. 
3-0-Benzyl-6-0-triphenylmethyl-l,, 2-0-isopropylidene-5-[2H]-D-gluco- 
hexofuranose (20). 
To a solution of 3-0-benzyl-6-0-triphenylmethyl-1,2-0-isopropylidene- 
cc-D-xylo-hexofuranos-5-ulose (7-76 g, 14 mmol) dissolved in CH202 (60 mL) 
was added NaBD4 (0.6 g, 14 mmol) dissolved in EtOH (75 mL). When TLC 
analysis (Si02, diethyl ether : toluene 10% v/v) showed that no starting 
material remained, the solvent was evaporated in vacuo and the residue was 
dissolved in CH202 (50 mL). This solution was washed with water (75 mL), 
dried (MgS04) and evaporated in vacuo to give the title compound 7.5 g, 
(96%). In identical experiments using NaBH4. only the gluco-isomer and no 
ido-isomer could be detected in the product by 1H NMR spectroscopy. 1H 
NMR (220 MHz, CDC13) 8 1.32 (3H, s, Me), 1.51 OH, s, Me), 2.69 (1H, s, OH), 
3.25 (1H, d, H6,9.3), 3.45 (1H, d, H6,9.3), 4.08 (1H, d, H3,3.1), 4.37 (1H, d, H4, 
3.3), 4.50 (1H, d, CH2., 11.8), 4.60 OH, d, H2,4-0), 4.65 (1H, d, CH2,4-0), 6.98 (1H, 
d, H1,4.0), 7.20-7.60 (20H, m, aromatic H). MS (CI) found m/z 476.219 calc. for 
C29H30DO6 m/z 476.2184 (M +H- C6H6)+. 
1,2-0-isopropylidene-5-[2H]-a-D-gluco-hexofuranose (21). 
This was prepared according to Inouye2 with modification to the 
purification step. 
Ammonia gas was condensed into a dry 250 mL round bottomed flask 
fitted with a NaOH drying tube. The total volume of the liquid was approx. 
100 mL. The alcohol (3.75 g, 6.8 mmol) was added in dry THF (10 mL) 
followed by Li metal (200 mg, 28 mmol). The reaction became difficult to stir 
so an additional 15 mL of THF was added. As the Li dissolved, the solution 
went a deep red. After 45 min., NH4CI (3.0 g, 56 mmol) was added in portions 
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and the ammonia was left to evaporate overnight. The remaining residue 
was washed several times with THF, filtered and concentrated to give an off 
white oil. This was washed with cyclohexane (2 x 40 mQ with the aqueous 
layer being retained. Lyophilisation gave 1.3 g of a white foam. TLC (30% 
EtClAc : CH202) showed one baseline component with no starting material 
present. The products from previous reactions were pooled and freeze dried 
with Si02. This was applied to a short column Of Si02 and this was then 
washed with 5% MeOH : Et0Ac- 3-0-Benzyl-6-0-triphenylmethyl-1,2-0- 
isopropylidene-5-[2H]-D-gluco-hexofuranose (7.5 g) gave the title compound 
as an amorphous solid (2.96 g, 97%). [a]23D = -4-3* (c = 0.09 H20). IH NMR (220 
MHz, D3-MeOH) 8 1.20 (3H, s, Me), 1.36 (3H, s, Me), 3.50 (1H, d, H6,11.8), 3-68 
(1H, d, H6,11-8), 3.94 (1H, d, H3 or H4), 4.14 (1H, d, H3 or H4), 4.40 (1H, d, H2), 
5.81 OH, d, H1). 
5-[2ffl-D-Glucose. 
1,2-0-isopropylidene-5-[2H]-cc-D-gluco-hexofuranose was dissolved in 
water (40 mQ and H2SO4 (conc. ) was added until the pH was less than 2.0 
(meter). The solution was then heated at 90'C for Ih after which time TLC 
(10% MeOH : EtOAc) showed that all the starting material had hydrolysed. 
The pH of the solution was adjusted to 6.6 (meter) with 1M NaOH and then 
the solution was applied to a short mixed bed ion-exchange column. After 
eluting with water, the recovered eluate was lyophilised to yield 1.54 g of the 
title compound as a clear colourless syrup. (64%). 1H NMR (400 MHz, D20) 8 
3.19 OH, t, H2P, 8-0), 3.35 (2H, m, H4cfl, 3.44 OH, t, H3P, 9-3), 3.48 (IH, dd, 
H2a, 9.6,3.8), 3.65 (1H, t, H3a, 9-6), 3.67 (IH, d, H6P, 12-3), 3.70 (IH, d, H6a, 
12.3), 3.79 OH, d, H6cc, 12.3), 3.84 OH, d, H6P, 12.3), 4.61 OH, d, HIP, 8-0), 5.18 
QH, d, Hla, 3.8). The spectrum compared well with that of authentic D- 
glucose. H6 (both anomers) existed as a doublet in the 1H NMR spectrum and 
H5 (both anomers) were missing. MS(CI) m/z 409 (M + H)+ 332 (M +H- 
AcOH)+. Compared to authentic glucose pentaacetate, the deuterated 
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derivative showed 92 atom % D. 
6,6-[2H2j-D-Glucose. 
1,2-0-isopropylidene-a-D-glucuronolactone (22). 
This was prepared in 70% yield by the method of Kitihara et a1133. Myt 
117.5-118.5'C. Lit 120.5-121.5'CllO [a]23D == +48.5' (c = 0.1 CHC13) lit. value134 
52.5'. 1H NMR (220 MHz, CDC13) 8 1.38 (3H, s, CH3)., 1.65 (3H, s, CH3), 3.00 (1 H, 
br-s, OH), 4.58 OH, d, H5,4.4), 4.90 (2H, m, H2 & H3), 5.00 (1H, dd, H4,3.3,2.7), 
6.05 (1H, d, Hl, 3.3). MS (CI) m/z 234 ((M + NH4)+,, 217 (M + H)+. 
6,6-[2H2]-1,2-0-isopropylidene-a-D-gluco-hexofuranose (23). 
This was prepared according to Lemieux and Stevens with certain 
modifications95. 
THF (dry, 50 mL) was added to a 250 mL round bottomed 3-necked 
flask. LiAlD4 (1g, 24 mmol) was added next followed by the dropwise addition 
of 1,2-0-isopropylidene-cc-D-glucuronolactone (5.44g, 25 mmol) in dry THF 
(50 mL). The rate of addition was such so as to keep the temperature below 
25'C. After all the lactone had been added, the mixture became gelatinous and 
a further 50 mL of THF was added. Stirring was continued overnight after 
which TLC (5% MeOH: EtOAc) showed mainly glycol with some lactol still 
remaining. No starting material was evident. The excess LiAlH4 was 
destroyed using a mixture of Na2SO4- 10 H20: Celite (1 : 1) followed by a drop 
of water. The suspension was then filtered through a pad of Celite to give a 
clear yellow solution which was concentrated. EtOH (40 mQ and NaBD4 (0.7g, 
17 mmol) was added to the crude yellow solid to complete the reduction. The 
reaction was left for 45 min. without stirring after which TLC showed just 
glycol. MeOH (- 40 mL aliquots) was continually added followed by 
distillation to remove borate. After 300 mL of MeOH had been evaporated, 
water (75 mQ was added followed by filtration to remove the precipitated 
aluminium hydroxide. The filtrate was clear and colourless (pH neutral) and 
this was Iyophilised to give 4.82g (86%) of the title compound as a white solid. 
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[(X]23 D= -4.0' (c = 0.15 H20)- 1H NMR (250 MHz, D20) 5 1.30 (3H, s, Me), 1.46 
(3H, s, Me), 3.92 (1H, d, H5), 4.10 (1H., dd., H4), 4.38 (IH, d,, H3)"4-75 (1H' d" H2), 
6.04 (1H, d, H1). 13C NMR (61.4 MHz, D20) 8 25.94 (Me)., 26.36 (Me), 69-06, 
74.38,80.54,85.22 (C2), 105.53 (Cl), 113.49 (3' Q. 8 signals (9 carbons, 1 
deuterated). 
6,6-[2H2]-D-Glucose. 
1.2-0-Isopropylidene-6,6-[2H2]-cc-D-gluco-hexofuranose (23) was 
hydrolysed as for 5-[2H]-D-glucose. After Iyophilisation, 2.80g of 6,, 6-[2H2]-D- 
glucose was obtained as a clear, colourless syrup (72%). TLC (BuOH : AcOH : 
H20 : EtOAc) showed only one sugar active component which co-eluted with 
authentic D-glucose. 1H NMR (400 MHz, D20) 8 3.18 (1H, t, H2P, 8.4), 3.31-3.45 
(4H, m, H5P, H3P, HUc, H4P), 3.46 (1H, H2(x, dd, 3.7,9.9), 3-65 (1H, t, H3cc, 9.5), 
3.75 (1H, d, H5cc, 10.1), 4.57 OH, d, Hlp, 7.9), 5.16 OH, d, Hlcc, 3.7). MS (CI) m/z 
410 (M + NH4)+, 409 (M + H)+. Compared to authentic glucose pentaacetate., 
the deuterated derivative was enriched to 99% (corresponding to the 
incorporation of 2 atoms of deuterium). 
Deuterated nojirimycins. 
1,2-0-Isopropylidene-(x-L-iduronolactone (25) was synthesised 
according to Bashyal et a1134 in 3 steps (59% yield overall). Data for 1,2-0- 
isopropylidene-u. -D-glucuronolactone has already been given. 
5-0-Trifluoromethanesulphonyl-1,2-0-isopropylidene-ot-D-glucuronolactone 
(24). 1H NMR (220 MHz, CDC13) 8 1.40 (3H, s, CH3)., 1.58 (3H, s, CH3), 4.95 (1H, 
d, H2,3.6), 5.02 (1H, d, H3,3.0), 5.15 (1H, dd, H4,2.8/ 4.3), 5.51 (1H, d, H5,4.4), 
6.16 UH, d, H1,3.6). MS (CI) m/z 366 (M + NH4)+,, 349 (M + H)+/ 333 (M +H- 
CH4)+. 
1,2-0-isopropylidene-a-L-iduronolactone (25). [(X]23D = +105.4' (c = 0.03 
acetone) lit. value134 1010.1H NMR (220 MHz,, CDC13 (sparingly soluble)) 
8 
1.38 (3H, s, Me), 1.54 (3H, s, Me), 3.35 (1H, br. s, OH), 4.38 (1H, s, H5), 4.83 
(1H, d, 
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H3,3.3), 4.89 (1H, d, H2,3.9), 5.10 (1H, d, H4,3.3), 6.00 OH, d, Hl, 3-9). MS (CI) 
m/z 234 (M + H)+, 201 (M +H- CH4)+- 
5-0-Trifluoromethanesulphonyl-1,2-0-isopropylidene-a-L-iduronolactonel34. 
(26) 
1,2-0-isopropylidene-a-L-iduronolactone (1g, 4.63 mmol) was stirred 
with CH202 (40 mL, dry) at -40'C. Not all the solid dissolved. Anhydrous 
pyridine (1 mL, 12 mmol) was added followed by the dropwise addition of 
triflic anhydride (0.93 mL, 5.5 mmol). The reaction was stirred at -40'C for 2h 
during which time all the lactone dissolved. TLC (30% EtOAc : CH2Cl2) 
indicated that no starting material remained after this time and that a faster 
moving component was present. The CH202 solution was extracted with HCI 
OM, 2x 25 mL) and then water (2 x 25 mL) . The organic solution was dried 
(NaS04) and concentrated to give a crude yellow solid (1.3g). Small quantities 
could be re-crystallised from EtOH, but larger amounts decomposed on 
heating to effect dissolution. The crude yellow solid was filtered through Si02 
using 20% EtOAc : CH202 to give the title compound as a white solid after 
concentrating in vacuo. Yield 1.30g (81%). The alcohol and the triflate ester 
were not stable at room temperature for more than 6 weeks-2months. 1H 
NMR (220 MHz, CDC13) 8 1.39 (3H, s, CH3)., 1.56 (3H, s, CH3), 4.92 (1H, d, H21 
3.6), 5.00 (1H, d, H3 or H4,3.6), 5.17 (1H, d, H3 or H4,3.3), 5.19 (1H, s, H5), 6.02 
(1H, d, H1,3.8). MS (CI) m/z 366 (M + NH4)+, 333 (M +H- CH4)+- 
5-Azido-5-deoxy-1,2-0-isopropylidene-a-D-glucuronolactonel34 (27). 5-0- 
Trifl uo rom e th ane s ulph onyl- 1,2-0-is op ropyli d ene -a-L-i durono lac tone (1g, 
4.63 mmol) was dissolved in dry DMF (10 mL). After cooling to -20'C, NaN3 
(180 mg, 2.8 mmol) was added in one portion . The reaction was stirred 
for a 
further 90 min. at -20'C and then it was poured into water (200 mL). The 
white emulsion was extracted with CH2CI2 (3 x 30 mL) and the combined 
organic extracts were back extracted with water (2 x 30 mL). The organic 
component was dried (Na2SO4) and concentrated to give the title compound 
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as a white solid, 0.59g (95%). 1H NMR (400 MHz, CDC13) 8 1.38 OH, s, Me), 1.55 
(3H, s, Me), 4.10 (1 H, d, H5,4.3), 4.81 (1 H, d, H2,3.8), 4.82 (1 H, d, H3,3.0), 4.99 
(1H, dd, H4,2.8,4.3), 5.98 (1H, d, H1,3.6). MS (CD m/z 259 (M + NH4)+,, 231 (M 
+ NH4 - N2)+,, 214 (M +H- N2)+- 
5-amino-5-deoxy-1,2-0-isopropylidene-cc-D-glucuronolactone (28). 
To 5-azido-5-deoxy-1,2-0-isopropylidene-oc-D-glucuronolactone (1.08g, 
4.5 mmol) in EtOAc (50 mQ was added 10% palladium on carbon (55 mg) and 
the mixture was hydrogenated at 2 atm for 4h after which time the mixture 
was filtered through Celite. TLC (20% EtOAc : CH2CI2)) indicated that no 
starting material remained Concentration in vacuo left the amine as a white 
foam, 0.96g (100%). 1H NMR (220 MHz, CDC13) 8 1.38 (3H, s, Me), 1.55 (3H, s, 
Me), 1.90-2.20 (1 H, br. s, NH2), 3.78 (1 H, d, H5,4.6), 4.85 (1 H, d, H3,3.1), 4.88 (1 H, 
d, H2,3.8), 4.98 (1H, dd, H4,3.1,4.8), 6.02 (1H, d, H1,3.7). IR (nujol mull) u 3381 
cm-1 (br., OH), 3326 (d., 1' amine), 1780 (CO, lactone). 
The reaction was repeated using 4.1g of 5-azido-5-deoxy-1,2-0-isopropylidene- 
a-D-glucuronolactone, except that after hydrogenation, di-t-butyl carbonate 
(4.08g, 20 mmol) was added to the filtrate which was then set aside overnight. 
The EtOAc was then removed in vacuo to yield a yellow solid (6.0g) which 
was purified by flash chromatography on silica (elution with 10% v/v EtOAc: 
CH202). 5-(N-t-Butyloxycarbonyl)amino-5-deoxy-1,2-0-isopropylidene -(x-D- 
glucuronolactone (29) was obtained as a white solid (4.4g, 82%) after 
evaporation of the solvent. [a]23D -= +58.8' (c = 0.1 CHC13)- 
1H NMR (400 MHz, 
CDC13) 8 1.38 (3H, s, Me), 1.50 (9H, s, Me of t-butyl), 1.55 (3H, s, Me), 4.77 (1H, 
dd, H5,9.0,4.3), 4.80 (1 H, d, H2,3.7), 4.82 (1 H, d, H3/ 2.9), 4.93 (1 H, dd, H4,4.1, 
3.0), 5.10 OH, d, NH, 8-9), 5.91 (1H, d, H1,3-6). MS (EI) found m/z 315.1309, calc. 
for C14H2107N, 315-1318 (M+-). 
5-(N-t-Butyloxycarbonyl)amino-5-deoxy-1,2-0-isopropylidene-6,6-[2H2]-CC-D- 
glucose (29a). 
LiAID4 (50 mg, 1.2 mmol) was added to dry THF (5 mL) under N2 
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followed by 6,6- [2H 21-5- (N- t-butyloxycarbo nyl) amino -5 -d e oxy- 1,2-0- 
isopropylidene-cc-D-glucuronolactone (168 mg, 0.5 mmol). The reaction was 
stirred overnight at room temperature and then an excess of EtOAc was added 
followed by a drop of water. After hydrolysis, a further amount of water (10 
mL) was added and the mixture was extracted with EtOAc (3 x 10 mL) . The 
combined organic extracts were washed with water (2x 10 mL) and dried 
(MgS04). Removal of the solvent in vacuo left a clear oil (160mg) which TLC 
and 1H NMR showed to contain a trace of lactol. The oil was dissolved in 
EtOH (5 mQ and deuterium oxide (2 mQ was added followed by a trace of 
NaBD4. The reaction was left for 45 min. at room temperature after which 
time TLC and 1H NMR showed that only glycol was present. The solvent was 
evaporated in vacuo and aliquots of MeOH (4 x 20 mQ were added and 
evaporated in vacuo to leave the title compound as a white solid (140 mg, 
83%). 1H NMR (220 MHz, CDC13) 5 1.31 (3H, s, Me), 1.46 (9H, s, Me of t-butyl), 
1.52 OH, s, Me), 3.10 (1 H, br. s, OH), 3.80 (1 H, t, H5,8.5), 4.10 (2H, m, H3 & HQ, 
4.62 (1H, d, H2,3.7), 5.10 (1H, br. s, OH), 5.50 (1H, br. d, NH, 8.4), 6.00 (1H, d, H1, 
3.7). MS (CI) found m/z 322.183 calc. for C14H24DN207 m/z 322.183 (M + H)+. 
5-(N-t-Butyloxycarbonyl)amino-5-deoxy-1,2-0-isopropylidene-a-D- 
glucose (protio). 
0, f, OH 
0 p. 0 OH 
(- 
Illý NHBOC 
1H NMR (400 MHz, CDC13) 5 1.34 (3H, s, Me), 1.48 (9H, s, Me of t-butyl), 1.51 
OH, s, Me), 2.65 (1 H, br. s, OH), 3.70-3.80 (2H, m, H5 & H6), 3.99-4.07 OH, m, H6 
& H3 & HQ, 4.56 (1H, d, H2,3.7), 5.04 (1H, br-s, OH), 5.35 (1H, br. d, NH, 8-4), 
5.90 (1H, d, Hl, 3.7). MS (CI) m/z 320 (M + H)+. 
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5-(N-t-Butyloxycarbonyl)amino-5-deoxy-1,2-0-isopropylidene-ot-D- 
glucuronolactol (protio). 
0 OH k%I,. 
H 
0 
C- 
ý 0 NHBOC 
1H NMR (400 MHz, CDC13) 6 1.35 (3H, s, Me), 1.42 (9H, s, Me of t-butyl), 1.48 
(3H, s, Me), 3.27 OH, d, OH, 5.3), 4.10 (1H, m, H5), 4.61 (1H, d, H3,4.5), 4.70 (lH" 
d, H2,3.6), 4.83 (1H, t, H4,4.7), 5.32 (2H, m, NH & H6), 5.98 (1H, d, Hl, 3.6). MS 
(CI) m/z 318 (M + H)+. 
5-Amino-1,5-dideoxy-l-sulphonic acid-D-glucitol (nojirimycin bisulphite) 
(30). 
Gaseous sulphur dioxide was bubbled through a suspension of 6,6- 
[2H2]-nojirimycin bisulphite (82 mg) in water (2 mL) for 10 min. The reaction 
was then set aside for 65h at 35-40'C. After this time TLC (BuOH : AcOH : H20 
: EtOAc) indicated that no starting material remained. One main fraction was 
present, with a minor faster moving component. The solution was then 
cooled to O'C and methanol was added (20 mL). The crystalline bisulphite 
adduct (82 mg, 72%) was collected by filtration. M. N. 125-126'C (dec. ) lit2.145- 
147'C (dec. ). [(X]23D = -10.4' (c = 0.02 H20)- 1H NMR (400 MHz, D20) 8 3.08 (1H, 
d, H5,10.0), 3.50 (1H, t, H3 or H4,9-3), 3.55 (1H, t, H3 or H4,9.4), 3.79 (1H, dd" 
H2,9.0), 4.01 (1H, dd,, H1,10-3). The analogous protio compound compared 
well with the published spectrUM135. IR (nujol mull) ij 3600-3000 cm-1 (br. 
strong, OH), 3120 (s, medium, NH), 1580 (weak, OH bend). The IR spectrum 
was identical to that given in the literature2 (isolated from a natural source). 
Analysis. Found C 27.73, H 5.82, N 5.31, S 12.40%, calc. for C16H15O8NS, C 
27.59, H 5.79, S 12.48,0 5.36 %. 
The bisulphite adduct was converted to nojirimycin and 1-deoxynojirimycin 
in the usual way2. 
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6,6-[2H2]-Nojirimycin (31). IH NMR (400 MHz, D20). Two conformers were 
found in solution (a: 0 2.25: 1)136.8 2.58 (IH, d, H5P, 9-0), 2.98 (IH, d, H5a, 
9.0), 3.10 (1H, t, H4a, 8.9), 3.12 (1H, m, H2), 3.20 (IH, t, H3 or H40,8.8), 3.29 (IH, 
t, H3 or H40,8.8), 3.43 (1H, dd, H2a, 8.8,3.4), 3.56 Q H, dd, HUC, 8.8,8.2), 4.11 
(1H, d, H10,8.2), 4.69 (1H, d, Hlcc, 3.4). 
6,6-[IH2]-Nojirimycin. IH NMR (400 MHz, D20). Assignments were made by 
homonuclear 1H COSY spectroscopy. 5 2.61 (IH, ddd, H50), 3.01 (IH, ddd, 
H5a), 3.11 (1H, t, H20,9.2), 3.15 UH, t, H4a, 9.2), 3.21 (IH, t, H40,9.3), 3.30 UH, 
t, H3P, 9.2), 3.45 (2H, m, H6a & H2a), 3.58 (2H, m, HUc & H60), 3.77-3.84 (2H, 
m. H6a & H6P), 4.12 (1H, d, H1P, 8.2), 4.68 (1H, d, Hla, 3.4). The IH NMR 
spectrum compared well with the published spectrum136 (no assignments 
made). 
6,6-[2H2]-Deoxynojirimycin (32). (51% from bisulphite adduct) ICE123D ' +43.21, (c 
= 0.1 H20) lit value2 +47'. 1H NMR (220 MHz, D20) 8 2.40 UH, dd, Hlax. 10.7), 
2.50 (IH, d, H5,9.8), 3.10 (1H, dd, H1eq- 12.9,5.3), 3.20 (IH, t, H3 or H4,8.9), 3.30 
(1H, t, H3 or H4,8.9), 3.45 (1H, m, H2). The same protocol could also be used to 
prepare unlabelled DNJ which was identical with an authentic sample. MS 
(CI) m/z 376 (M + H)+, 316 (M +H- AcOH)+. Compared to authentic peracetyl 
DNJ, the deuterated derivative was enriched to 99 atom % (dideutero). 
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5-Amino-1,5-dideoxy-l-sulphonic acid-6,, 6-[3H21-cc-D-gIucitoI (33). 
NaBH4 (50 mg, 1.27 mmol) was added to anhydrous diglyme (2 mL, ex 
NaBH4). AIC13 (60 mg, 0.45 mmol, anhydrous) was added next followed by 5- 
(N-t-butyloxycarbonyl)amino-5-deoxy-1,2-0-isopropylidene-(x-D- 
glucuronolactone (100 mg, 0.32 mmol) as a solid. The reaction mixture was 
stirred at room temperature for 90 min. after which time water (I drop ) was 
added. After the AIC13 had been destroyed, more water was added (10 mQ and 
without delay, the reaction mixture was extracted with EtOAc (3 x 30 mQ. The 
organic extracts were dried (Na2SO4) and concentrated to give 130 mg of crude 
solid (diglyme was still present by 1H NMR). TLC (30% EtOAc : CH2Cl2) 
showed a mixture of lactol and glycol, although no starting material was 
present. EtOH (10 mL) was added followed by NaBH4 (50 mg, 1.27 mmol) and 
the reaction was set aside for 30 min. After this time TLC showed that glycol 
only was present and the EtOH was removed by distillation. EtOAc (30 mL) 
was added next followed by extraction with water (2 x 20 mL). The solution 
was dried (Na2SO4) and concentrated to give 100 mg of the title compound as 
a white waxy solid. Traces of diglyme were still present by 1H NMR and the 
yield was estimated to be 83%. The bisulphite adduct was then formed from 
this crude product in the usual way. 
The shorter reaction time in this procedure was preferred to that when 
NaBT4 was used. 
NaBT4 (Amersham, ~ 50 mCi/mmol) was substituted into the above 
reaction scheme except that it was reacted with the lactone for 3h before excess 
NaBH4 (100 mg, 2.6 mmol) was added to complete the reaction. After stirring 
at room temperature overnight, the work-up was identical to that above 
except that the EtOH/NaBH4 step was omitted. The glycol was converted 
directly to nojirimycin bisulphite, yield 9.5mg, 43 x 106 dpm. 
j_[13C]-D, L-GIyceraIdehyde (34). 
The method of Serianni et aI113,114,115 was followed exactly to yield 1.20g 
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(90% over 2 steps) of the title compound. The enrichment was 50 atom % 13C 
and this was not diluted further in the fermentation studies. 13C NMR (62.4 
MHz, D20, natural abundance) 8 90.56 (Cl) 74.88 (C2) 62.78 (0). Lit. 8 91.2,75.5, 
63.4. The observed 13C NMR spectrum was after equilibration in D20 for 36h 
where hydrated glyceraldehyde was the main species. The 1-[13C]-D,, L- 
Glyceraldehyde had one main peak at 8 90.58 ppm and weaker resonances at 
higher frequency, including a free carbonyl signal at 8 205.48ppm. These were 
attributed to the C1 resonances of dimers and oligomers of glyceraldehyde. 
The spectrum was identical to that reported in the literature. 
3-0-Methyl-D-glucose. 
3-0-Methyl-1., 2,, 5,6-0-diisopropylidene-a-D-glucose (35). 
Sodium hydride (2.8 g,, 80% dispersion in mineral oil, 92 mmol) was 
added to dry THF (200 mL in a 500 mL round bottomed flask. After cooling to 
O'C, 1,2,5,6-0-isopropylidene-(x-D-glucose (20g. 70 mmol) was added as a solid 
in several portions. At the end of the addition, the reaction was stirred for a 
further 30 min. before MeI (6 mL, 94 mmol) was added dropwise. The reaction 
was left to stir overnight after which time TLC (20% EtOAc: CH202) indicated 
that only the methyl ether was present. EtOH (10 mQ was added to quench 
any excess NaH and the solution was concentrated to a turbid pale yellow oil. 
CH202 (100 mQ was added and this was washed twice with water (50 mQ and 
then brine (50 mQ. Dried (MgS04) and concentrated to a colourless syrup 
(24.8g, >100%). 1H NMR (220 MHz, CDC13) 8 1.33-1.50 (12H, 4s, Me), 3.49 (3H, s, 
OCH3), 3.80 (1H, d/ H3,2.8), 4.00-4.18 (3H, m, H4 &2x H6), 4.31 (1H, dt, H5,7.8' 
5.6), 4.60 (1H, d, H2,3.9), 5.90 (1H, d, H1,3.9). MS (CI) m/z 275 (M + H)+, 259 (M 
+H- CH4)+. 
This residue was not purified further and 12.4g (45 mmol) was 
hydrolysed in the usual manner to yield 7.29g (84%) of 3-0-methyl-D- 
glucopyranoside (36). 1H and 13C NMR indicated that the pyranose form of 
the hexose was present only, with a P: a ratio of 1.29.1H NMR (400 MHz, 
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D20) 8 3.20-3.40 (6H, m, H2-H4 (oc and P)), 3.50 OH, m, H5P), 3.54 OH, s, OMe 
(cc and P)), 3.60-3.70 (2H, m, H6 ((x and P)), 3.75 (2H., m,, H6cc,, H5(x),, 3.80 (1H, dd, 
H6P, 12.3,1.9), 4.55 (1H, d, H1p, 7-7), 5.12 (1H, d, Hla, 3.6). 13C NMR (100.6 
MHz, D20) 8 60-41,60.69,61.04,61.22,69-58,69.70,71-61,72.09,74.09,76.42, 
83-34,85.97,92-69 (Cl), 96.47 (CI) 14 signals. MS (CI) m/z 380 (M + NH4)+, 303 
(M +H- AcOH)+. 
3-Deoxy-D-glucose. 
3-0-Phenoxythiocarbonyl-1,2,5,6-0-diisopropylidene-(x-D-gluco-hexofuranose 
(37). 
1,2,5,6-0-Is opropyli den e- (x-D-glucose (8g, 31 mmol) was dissolved in 
CH3CN (100 mQ and pyridine (5 mL, anhydrous). To this was added 
phenylthionochloroformate (Lancaster Chemicals, 5.9g, 34 mmol) and DMAP 
(trace). The solution was left to stir at room temperature for 24h after which 
time TLC (30% EtOAc : toluene) showed a trace of starting material with a 
much stronger, faster migrating component. The reaction mixture was 
concentrated after 48h to give a yellow/red crude solid which was re- 
crystallised twice from EtOH. Yield of the title compound, 7.75g (64%). M. N. 
101-1030C. [(X]23 D= -46.9' (c = 0.16 CHC13). H NMR (250 MHz, CDC13) 8 1.57 (3H, 
s., Me), 1.46 (3H., s, Me), 1.36 QH, s, Me), 1.39 QH, s, Me), 4.10 (2H, m, 2x H6), 
4.35 (2H, br-m, H4 & H5), 4.80 (1H, d, H2,3.7), 5.66 (1H, br. s, H3), 6.00 (1H, d' 
3.7), 7.10-7.50 OH, m, aromatic H). After 48h in CDC13 the product had 
decomposed slightly. MS (CD m/z 397 (M + H)+,, 381 (M +H- CH4)+. 
3-Deoxy-1,2,5,6-0-diisopropylidene-D-ribo-hexofuranose (38). 
Bu3SnH (8.1 mL, 30 mmol) was added to dry toluene (100 mQ under 
N 2. AIBN (trace) was added followed by heating to 70'C. 3-0- 
Phenoxythiocarbonyl-1,2,5,6-0-diisopropylidene-oc-D-gluco-hexofuranose 
(7.7g, 20 mmol) in toluene (50 mQ was added dropwise at this temperature 
over 1h. Heating was continued for a further 3h after which time TLC (20% 
Et20 : toluene) showed that a slower migrating component was present 
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compared to the starting material. An additional high Rf impurity was also 
identified. The solution was then evaporated and the residual colourless oil 
was purified by flash chromatography (20% Et20: petrol (40-60'C)) to yield the 
title compound as a clear colourless syrup (3.57g,, 76%). 1H NMR (250 MHz, 
CDC13) 8 1.32 (3H, s, Me), 1.36 (3H, s,, Me),, 1.43 (3H,, s., Me), 1.52 (3H, s, Me), 1.76 
(1H, ddd, H3exo 13.2,9.9,4.5), 2.20 (1H, dd, H3endo 13.2., 4.1), 3.82 (1H, m, H5), 
4.10-4.20 (3H, m, 2x H6), 4.76 (1H, t, H2,4.3), 5.82 (1H, d, H1,3.7). MS (CI) m/z 
245 (M + H)+, 229 (M +H- CH4)+. 
3-0-(Tri-n-butyltinmethylthioether)-1,2,5,6-0-diisopropylidene-a-D-gluco- 
hexofuranose (39). 
This impurity was isolated from the above reaction. 1H NMR (250 
MHz, CDC13) 5 0.84 (9H, t, CH3,7.2), 1.00-1.60 (30H, m, CH2 (butyl), CH3 
(isopropylidene)), 3.97 (1H., dd,, H4,, 8-6., 5.2), 4.02-4.14 (2H, m), 4.15-4.25 (2H, m), 
4.59 (1 H, d, H2,3.7), 4.81 (1 H, d, OCH2., 10.2), 4.88 (1 H, d, OCH2/ 10.2), 5.76 (1 H, 
d, H1,3.6). 13C NMR (62.4 MHz, CDC13) 8 13.43 (Me, butyl), 25.20-28.39 (CH2 
(butyl), CH3 (isopropylidene)), 67.06,69.86,72-31,80.18,80.89,82.88,104.9 
(OCH2)/ 108.8 (3' Q, 111.5 (3' Q. MS (CO m/z 611,613., 615 (M + NH4)+- IR 
(film) -o 2986-2855 cm-1 (CH aliphatic), 1458 (CH2-S),, 1373 (d, gem dimethyl). 
3-Deoxy-D-glucose (40). 
Acid hydrolysis of 3-Deoxy-1,2,5,6-0-diisopropylidene-D-ribo- 
hexofuranose in the usual fashion gave the title compound as a syrup, 1-9g 
(81%). 1H and 13C NMR showed that the compound existed as a mixture of 
pyranose and furanose forms ((x and P anomers in each case). Pyranose 
(P: (x 
2.18). Furanose (P : (x 3-0). Lit137.51% P-pyranose, 26% (x-pyranose, 17% 
P- 
furanose, 6% a-furanose. 1H NMR (400 MHz, D20) 8 1.46 (1H, q, H3ax. 
pyranose P, 11-5). 1.69 (1H, q, Hax. pyranose (x, 11.4), 1.90-2.10 
(3H, m, H3eq- 
pyranose (x, H3endo and H3exo furanose ), 2.30 (1H, 
dt, H3eq. pyranose P, 12.0, 
4.9). The region between 3.30-4.20 ppm was complicated and could not 
be 
interpreted. 5 4.50 (1H, d, H1 pyranose P,, 7.8),, 5.05 (1H., d., H1 pyranose (x,, 
3-5)., 
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5.18 (1H, s, Hl furanose 0), 5.24 OH, d, Hl furanose (x., 4.0). 13C NMR (100.6 
MHz, D20) 8 31-49 (C3, ccf), 33-39 (C3, Of), 34.28 (C3, ap), 38.86 (C3, Pp), 61.21 (C6, 
ccp), 61.47 (C6, Pp), 63-13 (C6, ccf), 63-43 (C6,, Of)., 64.79 (C4, ap), 65-00 (C4, Pp), 
67.08 (C2, ccp), 69.30 (C2, Pp), 71.25 (C5, ccf), 72-76 (C5, ocp)., 73.52 (C2, ocf), 74.71 
(C5, Of), 76.18 (C2, Of), 77-50 (C4, af), 79.76 (C4, Of), 80-33 (C5, Op), 91-50 (Cl, ap), 
97.04 (Cl, af), 98.49 (Cl, Pp), 102.29 (Cl, Of). Where (x and P refer to the two 
anomers of the furanose (f) and pyranose (p) formS137 
5-Deoxyglucose. 
5-0-(Phenoxythiocarbonyl)-1,2-0-isopropylidene-a-D-glucuronolactone (41). 
1,2-0-Isopropylidene-(x-D-glucuronolactone (8g 37 mmol) was 
dissolved in CH3CN (100 mQ with pyridine (6 mL, 74 mmol, anhydrous) and 
DMAP (trace). Pheny1chlorothionoformate (7.1g, 40 mmol) was added 
dropwise at room temperature and the reaction was stirred at this 
temperature overnight. After this time, TLC (20% EtOAc : CH202) indicated 
that only one sugar active component was present with no trace of starting 
material. The solvent was then evaporated and the yellow oil was crystallised 
from petrol (40-60'C) to give an off white solid. Recrystallisation from 
EtOH/petrol 40-60 gave the title compound as white needles, 10.26g (79%). 
M. N. 102-104'C. [a]23 D-= +108.6' (c = 0.44 CHC13). 1H NMR (250 MHz, CDC13) 8 
1.40 (3H, s, Me), 1.58 OH, s, Me), 4.89 (1H, d, H2,3.7), 4.98 (1H, d, H3,3.0), 5.28 
(1H, dd, H4,4.3,2.9), 6.12 (2H, dd, Hl & H5,4.3,3.6), 7.20 (2H., m., aromatic H). ' 
7.30-7.50 (3H,, m, aromatic H). MS (EI) m/z 352 (M)+-, 337 (M - CH3*)+. 
5-Deoxy-1,2-0-isopropylidene-a-glucuronolactone (42). 
The method was identical to that when preparing 3-Deoxy-1,2,5,6-0- 
diisopropylidene-D-ribo-hexofuranose. The title compound was Produced in 
88% yield following crystallisation from petrol (40-60'C). M. Pt 86-87'C. 
1H 
NMR (250 MHz, CDC13) 8 1.39 (3H, s, Me), 1.58 (3H, s, Me), 2.78 (2H, M, H5), 
4.81 (1H, d, H3,3.3), 4.84 (1H, d, H2,4.1), 5.02 (1H, dt, H4,3.3,1.5), 6.00 (1H, d, 
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Hl, 4.1). MS (CI) m/z 218 (M + NH4)+, 201 (M + H)-'-. 
5-Deoxy-1,2-0-isopropylidene-a-xylo-hexofuranose (43). 
LiAIH4 (0.7g, 18 mmol) was added to THF (50 mL, dry) in a 250 mL 
round bottomed flask. 5-Deoxy-1,2-0-isopropylidene-(x- glu curon ol ac tone 
(4.38g, 22 mmol) was dissolved in THF (50 mL, dry) and added dropwise to the 
LiAlH4 suspension over 45 min. After 2h at room temperature, TLC (5% 
MeOH : EtOAO showed that all the starting material had reacted to give a 
single product of lower Rf. Sufficient Na2SO4- 1OH20/Celite (1 :1 v/v) was 
added to quench the excess LiAlH4 and the solution was filtered to leave a 
clear colourless solution. Concentration in vacuo gave a white, waxy solid, 
3.8g (85%). [a]23 D= +129.2' (c = 0.08 H20)- 1H NMR (250 MHz, D20) 5 1.30 (3H, 
s, Me), 1.46 (3H, s, Me), 1.81 (2H, q, H5,6.7), 3.62 (2H, m, H6), 4.09 (1H, d, H3/ 
2.6), 4.23 (IH, dt, H4,6.7,2.6), 4.61 (1H, d, H2,3.8), 5.95 (1H, d, H1,3.8). MS (CI) 
m/z 222 (M + NH4)+, 205 (M + H)+. 
This was hydrolysed in the usual way to give 3-3g, (100%) of 5-deoxy- 
xylo-hexofuranose (44). Two anomers were present in approximately equal 
ratios. Only the furanose conformer could be detected by 1H and 13C NMR 
spectroscopy. 1H NMR (250 MHz, D20) 8 5.36 (1H, d, Hlcc, 4.7),, 5.08 (1H,, s, 
H1P). Below 8 4.75 ppm the spectrum could not be assigned. The 13C NMR 
chemical shift values were identical with authentic 5-deoxy-xylo- 
hexofuranose prepared by a different route75.13C NMR (62.4 MHz, D20) CC 
anomer 8 31.98 (C5), 81.59 (C4), 96.51 (Cl). P anomer 5 32.58 (C5), 76-20 (Q), 
79.91 (C4), 102.52 (Cl). Peaks were also present at 8 77.03 and 76.96 (C2 cc and P, 
C3 cc), 59.59 and 59.45 (C6 cc and P). 
3-0-Methyl-1-deoxynojirimycin. 
This was synthesised from 3-0-methyl-1,2,5,6-0-isopropylidene-(X-D- 
glucofuranose according to the strategy of Inouye et al, who had prepared 1- 
deoxynojirimycin from 1.2,5,6-0-isopropylidene-(x-D-glucofuranose2. The 
procedures were the same unless otherwise stated. 
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3-0-Methyl-6-0-triphenylmethyl-l,, 2-0-isopropylidene-ec-D-gluco- 
hexofuranose (46). (52% yield from 3-0-methyl-1,2,5,6-0-isopropylidene-a-D- 
gluco-hexofuranose (45)). 1H NMR (250 MHz, CDC13) 8 1.35 (3H, s, Me), 1.50 
OH, s, Me), 2.80 (1 H, d, OH, 7.1), 3.24 (1 H, dd, H6,9.3,4-5), 3.32 (3H, s, OMe), 
3.40 (1H, dd, H6,9.3,5.6), 3.76 (1H, d, H3,3.0), 4.18 (1H, m, H5), 4.28 UH, dd, H4, 
7.4,3.0), 4.55 (1H, d, H2,3.7), 5.90 (1H, d, H1,4.1), 7.20-7.50 (15H, m, aromatic 
H). MS (CI) m/z 476 (M)+-, 399 (M - C6H5. )+. The compound was very 
hygroscopic. 
3-0-Methyl-6-0-triphenylmethyl-1., 2-0-isopropylidene-a-xylo-hexofuran-5- 
ulose (47). Swern101 oxidation of the corresponding alcohol produced the title 
compound in 53% yield. 1H NMR (250 MHz, CDC13) 8 1.30 (3H, s, Me), 1.50 
OH, s, Me), 3.22 OH, s, OMe), 3.96 (1 H, d, H6,18.2), 4.05 (1 H, d, H6,18-6), 4.14 
(1 H, d, H4,3.4), 4.52 (1 H, d, H2 or H3,3.7), 4.90 (1 H, d, H2 or H3,3.7), 5.91 (1 H, 
d, H1,3.7), 7.20-7.50 (15H, m, aromatic H). MS (CI or EI) no MH+ or M+- (EI) 
m/z 444 (M - CH20)+-, 260 (M - Ph3COH)+-. 
The formation of the hydroxylamine oxime (48) from the title 
compound was modified from the literature as follows: 
3-0-Methyl-6-0-triphenylmethyl-1,2-0-isopropylidene-a-xylo- 
hexofuran-5-ulose (2.8g, 5.9 mmol) was dissolved in pyridine (100 mL, dry) 
with NH20H. HCI (2.8g, 40 mmol). The solution was stirred at 70'C for 19h 
after which time TLC (20% EtOAc : pentane) showed the presence of two 
oxime isomers. The solution was concentrated in vacuo to leave a colourless 
oil. This was dissolved in CH2CI2/CHC13 (50 mL, 1: 1 v/v) and washed with 
water (3 x 50 mQ followed by brine (1 x 50 mQ. After drying (MgS04) and 
evaporation, 2.82g of a white foam/glass was obtained (98%). Two geometric 
isomers were present in a ratio of 2: 1 by 1H and 13C NMR spectroscopy. 1H 
NMR (250 MHz, CDC13) major isomer 5 1.18 (3H, s, Me), 1.37 (3H, s, Me), 1.80 
(1 H, s, OH), 3.20 (3H, s, OCH3), 3.80 0 H,, d., H6,14.9)., 3.85 (1 H,, d,, H6., 14.9), 4.18 
(1H, d, H3 or H4,3.3), 4.37 (1H, d, H2,3.7), 5.26 (1H, d, H3 or H4,3.2), 5.65 OH, 
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d, H1,3.7), 7.04-7.40 (15H, m, aromatic H). Minor isomer 8 1.26 OH, s, Me), 1.53 
(3H, s, Me), 2.80 (1 H, s, OH), 3.02 (3H, s, OCHA 3.73 (1 H, d, H6,14.9), 4.01 (1 H/ 
d, H3 or H4,3.2), 4.47 (1H, d, H6,14.9), 4.50 (1H., d, H2,3-9), 5.34 (1H, d, H3 or 
H4,3.1), 5.92 OH, d, H1,3-9), 7.04-7.40 (15H, m, aromatic H). 13C NMR (62.4 
MHz, CDC13) major isomer 8 58.25,, 62.57,77.15,81.94,84-13,87.18" 104.5" 111.8., 
154.6 (C-N). Minor isomer 8 57.45,, 58.80,, 78.35,, 81.45,85.00,87.37,104.6,11.6, 
152.3 (C-N). In addition, 4 isopropylidene methyl peaks were present at 8 
26.25,26-32,26-81,26.87. Several aromatic resonances were observed between 8 
123-150 Ppm. MS no molecular ion could be observed under EI or CI 
conditions. 
5-Amino-3-0-methyl-6-0-triphenylmethyl-1,2-0-isopropylidene-a-D-gluco- 
hexofuranose (49). 
This was prepared according to Inouye 2, except that the crude product 
was purified by flash chromatography (7% MeOH : CH202, Si02). Crude yield 
(75%) as a white foam. Yield of gluco amine, 18%. 1H NMR (220 MHz, CDC13) 
8 1.35 OH, s, Me), 1.50 OH, s, Me), 2.15-2.35 (2H, br. s, NH2), 3.30-3.50 (6H, m, 2x 
H6, H5, OMe), 3.84 (1 H, d, H3,3.2), 4.25 (1 H, dd, H4,8.0,3.2), 4.62 (1 H, d' H2, 
4.0), 5.95 (1H, d, H1,4.0), 7.25-7.65 (15H, m, trityl H). MS (CI) m/z 476 (M + H)+, 
413,319. 
A small amount of the ido amine was also recovered. 1H NMR (250 
MHz, CDC13) 5 1.32 (3H, s, Me), 1.52 (3H, s, Me), 2.40 (2H, br. s, NH2), 3.02 (3H, s, 
OCH3), 3.20 (1 H, d, H3,3.2), 3.30 (1 H, m, H5), 3.42 (1 H, dd, H6,12.6,9.2), 4.25 
(1H, dd, H4,8.2,3.2), 4.49 (1H, d, H2,3.9), 5.90 (1H, d, H1,3.9), 7.20-7.50 (15H, m, 
trityl H). 13C NMR (62.4 MHz, CDC13) 8 26.1,26.5,50.7,57.1,64.0,81.5,81.6,83.6, 
104.4,111.3,126-128,143.6 ppm. 
5-Amino-5-deoxy-3-0-methyl-1,2-0-isopropylidene-a-D-gluco-hexofuranose 
(50) (78%). 1H NMR (250 MHz, D20) 8 1.29 OH, s, Me), 1.45 OH, s, Me), 3.09 
(1H, m. H5), 3.40 (3H, s, OMe), 3.51 (1H, dd, H6,11.5,6.3), 3.70 (1H, dd, H6,11-5, 
3.4), 3.89 (1H, d, H3,3.0), 4.00 (1H, dd, H4,8.7,3.0), 4.83 (1H, d, H2,3.7), 5.92 (1H/ 
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d, H1,3.7). 
5-Amino-5-deoxy-3-0-methyl-D-glucose-1-0-sulphonic acid (51) (25%). M. N. 
124-125'C. [a]23D -= +0.3' (c = 0.18 H20). 1H NMR (400 MHz,, D20) 8 3.21 (1H/ 
ddd, H5,11.3,4.5,2-9), 3.33 (1 H, t, H3,9.4), 3.61 (3H, s, OMe), 3.70 (1 H/ t, H4,9.7), 
3.87 (1H, dd, H6,12.9,4.5), 3.92 (1H, dd, H6,12.9,2.9), 3.94 (1H, t, H2,9.4), 4.12 
(1H, d, H1,10.5). 13C NMR (100-62 MHz, D20) 8 58-00,60-85,61-21,67.43,69.66/ 
71.09,86.20 (Cl) 7 peaks. Analysis found C 33.4, H 6.0, N 5.0% calc. for 
C7H1507NS, C 32.7, H 5.9, N 5.4%. 
5-Amino-5-deoxy-3-0-methyl-D-glucose (52). (70 %). 
Two anomers were present in aqueous solution cc: P, 2.86 : 1. Compare 
this with nojirimycin, (x: P, 2.25: 1.1H NMR (400 MHz, D20) (x anomer 8 3.02 
(1H, ddd, H5), 3.23 (1H, t, H4,9.6), 3.33 (1H, t, H3,9-6), 3.48 (2H, m, H6 & H2), 
3.55 (3H, s, OMe), 3.80 (2H, m, H6(x & H6P), 4.67 (1H, d, H1,3.5). P anomer 5 
2.61 (1H, ddd, H5), 3.09 (1H, t, H3,9.2), 3.18 (1H, t, H2,8.9), 3.30 (1H, t, H4,9-6), 
3.55 (3H, s, OMe), 3.58 (1H, m, H6), 3.80 (2H, m, H6(x & H6P), 4.12 (1H, d, Hl/ 
8.1). 13C NMR (100.6 MHz, D20) 8 53.97,57.25,60.32,60.58,61.69,62.38,71.07/ 
71.66,72.32,75.62,79.25,82.81,84.35,86-55 14 peaks, (x and P anomers. 
5-Amino-1,5-dideoxy-3-0-methyl-D-glucose (53) (82%). 1H NMR (250 MHz, 
D20) 8 2.36 (1H, dd/ Hlax. 10.8,12.5), 2.45 (1H, ddd, H5,9.3,6.1,3.0), 3.00 (1H, 
dd, Hleq- 12.1,5.2), 3.05 (1H, t, H3 or H4,9.3), 3.21 (1H, t, H3 or H4,9.3), 3.45 
(1H, ddd, H2,9.3,10.8,5.2), 3.55 (4H, m, OMe & H6), 3.72 (1H, dd, H6,11.5,3.0). 
13C NMR (62.4 MHz, D20) 8 49.57,60.77,61.43,61.98,71.13,71.72,89.02 ppm (7 
peaks). MS (CI) found m/z 346.1508 calc. for C15H2408N m/z 346.1502 (M + 
H)+. 
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